cell_line_id,drug_id,response
YD-8,44491742,4.162245932134171
KO52,51039095,1.8517691823265992
BT 112,11427553,3.7884247720646873
OE33,docetaxel-tanespimycin (2-1 mol-mol),0.0839374715830857
KO52,135875424,3.01966044425059
NCI-N87,25183872,-2.1426120555107824
L3.3,piperlongumine-MST-312 (1-1 mol-mol),2.794540893097308
TE 441.T,36462,0.1000718625113496
SK-MEL-28,445091,4.3007151256708465
KO52,71466380,4.947279567827718
SNU-216,5978,-3.1004514665439835
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
BT 112,25183872,-1.8103797909861916
JHUEM-7,11214940,1.5777405725342055
GOS-3,44607531,1.5266968302788424
L3.3,24771867,2.302026780280536
TE-14,5278396,3.451892990607735
SNU-1077,216468,4.221133217458946
SK-MEL-28,11609586,3.4405879062717384
KE-39,3136844,4.342976017638663
GOS-3,6917907,-5.627090987822961
KE-39,11485656,2.227722528153515
TE 441.T,5284373,2.4067293610179106
SW1573,23725625,4.357604161446221
JHUEM-7,6914657,-3.112365649276011
SK-MEL-28,44202524,4.379747746299274
SNU-1077,10231331,3.484337251970082
YD-38,10231331,-1.3870760442434895
TE 441.T,445643,4.053678977050013
KO52,16736978,2.222216886070048
YD-8,25195348,5.853643444602765
KE-39,16720766,4.546084140767303
SK-MEL-28,67156097,4.393624339595105
YD-8,124202324,2.8742041026946596
SK-MEL-28,23635314,4.127704587314434
KE-39,54618305,4.948156947347383
SF295,9929138,4.960030945136907
YD-38,6623618,2.1348072370285345
KE-39,24856436,3.387816018334062
OE33,60750,-1.6166809824997617
GOS-3,135411,0.9391696009475228
SNU-216,44185566,2.8284110720577944
TE 441.T,6918328,0.4200582103899206
KO52,11609586,2.913368530947096
YD-8,11152667,-1.506864416830652
JHUEM-7,9911463,3.659236793496393
KE-39,11626560,1.956808029215874
TE 441.T,4705,3.429293976923017
SF295,72376,0.6979097544539823
KO52,salermide-PLX-4032 (12-1 mol-mol),5.165396088213933
NCI-N87,doxorubicin-navitoclax (2-1 mol-mol),-2.375472287210564
SNU-216,erlotinib-PLX-4032 (2-1 mol-mol),1.89111562006772
TE-14,2858523,3.2662108159252945
YD-8,16219061,3.09744286971822
KE-39,54618305,4.948156947347383
B-CPAP,3825829,3.169966347621692
YD-8,219104,3.5957332803631323
YD-8,11626560,1.5530364177818132
SNU-216,44491742,4.347867819055225
JHUEM-7,JQ-1-UNC0638 (2-1 mol-mol),-1.108952996086482
SF295,568763,0.589438080855472
JHUEM-7,11178236,-3.5105066295157843
KE-39,400769,-0.5095886152507402
KE-39,71729975,0.1981470064909886
KO52,100016,6.24417827042609
KE-39,9825149,1.9410582316331728
SK-MEL-28,6450551,3.516250339851913
L3.3,1716436,3.5741303666735633
SK-MEL-28,navitoclax-PLX-4032 (1-1 mol-mol),0.389238788180305
NCI-N87,navitoclax-sorafenib (1-1 mol-mol),-0.0367825564296656
KO52,3825829,1.880917675310284
NCI-N87,9866186,-0.0362526715344146
OE33,24821094,3.54635565995629
NCI-N87,1242560,3.6090545678814983
YD-38,119607,6.099875538236118
BT 112,54618164,3.5492837733522205
KE-39,445091,4.999033906756457
NCI-N87,24180719,3.957157119616887
OE33,10302451,2.926424279202946
TE-14,53495165,-0.7615839944483337
YD-8,3825829,4.049048632362995
SNU-1077,navitoclax-MST-312 (1-1 mol-mol),0.8913326642927005
KO52,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.410719813767284
TE 441.T,11625818,4.2092536605530135
Hs 611.T,3136844,4.24096122939903
B-CPAP,tanespimycin-gemcitabine (1-1 mol-mol),1.3298493303497043
JHUEM-7,135984461,4.346774383555173
SNU-216,16722836,1.1608339021538483
SK-MEL-28,5329102,2.8419143811814913
SNU-216,11955716,-0.8822249769229805
TE-14,52947716,3.1732034672795875
Hep 3B2.1-7,11404337,0.0289427466491547
KE-39,439501,-0.0752815835977172
TE-14,135984461,4.3356196573929
NCI-N87,100016,7.118039999797619
TE-14,2871966,0.4437222312458658
NCI-N87,637858,1.7879892218708664
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
YD-8,135423438,0.9954856602627224
NCI-N87,11238147,1.7339284670687316
L3.3,24901704,4.5240834828138095
NCI-N87,5311281,2.449994968111211
JHUEM-7,alisertib-navitoclax (2-1 mol-mol),-1.3911406571635951
KO52,1566236,1.4428264325400242
KE-39,3038522,3.2295476949923874
B-CPAP,135440466,2.00446155370997
YD-38,11455910,1.5894943212861383
KO52,126941,-4.363414933437974
NCI-N87,56946209,-4.157058230951839
YD-8,9911830,1.9962756690281929
SNU-1077,148198,-1.03431054543621
BT 112,5351362,1.3510507237988774
OE33,11612883,3.5221161379379975
SNU-1077,3825829,4.049018603201765
TE-14,5566,3.109422527023262
TE-14,135421197,1.7423329869648043
Hep 3B2.1-7,6610355,5.954765023044178
KO52,selumetinib-navitoclax (8-1 mol-mol),-1.982956418902813
SF295,613753,3.096512023119067
SNU-216,44507138,2.1948578780938814
L3.3,15953870,4.520919895902943
Hs 611.T,doxorubicin-navitoclax (2-1 mol-mol),-3.7368363030965654
NCI-N87,3081361,1.4568926260691408
Hs 611.T,23939,4.369791381281301
KE-39,6436223,-3.3115059571357417
SNU-1077,3815108,2.841716747219865
KE-39,11238147,3.713228695438772
KO52,docetaxel-tanespimycin (2-1 mol-mol),-5.1615589988724215
JHUEM-7,3384730,5.064840535114842
YD-38,4259181,0.0281637492495702
OE33,5291,4.100901259612058
KE-39,54639024,4.382341904180532
JHUEM-7,46191454,0.2697350797052546
KE-39,46224516,3.9046510157068255
KO52,6184667,1.650378416289273
B-CPAP,11612883,2.7358118615928366
Hep 3B2.1-7,72376,-2.5842514891624884
KE-39,2126,5.971386354859058
GOS-3,65064,3.2866798747983585
SNU-216,11257553,1.0275699515884966
B-CPAP,54639701,4.512705510925618
YD-38,ISOX-bortezomib (250-1 mol-mol),0.4693385843266243
B-CPAP,44507138,1.9476690283796445
Hs 611.T,23582824,0.1140568808044189
YD-38,navitoclax-piperlongumine (1-1 mol-mol),2.139179557452878
OE33,52912189,2.434086733871051
TE-14,56946209,-3.8371276458520778
YD-8,JQ-1-UNC0638 (2-1 mol-mol),2.771778742465765
B-CPAP,387447,-4.237504830751881
Hs 611.T,16725315,2.898635520094024
Hs 611.T,5328940,-0.422105766889467
B-CPAP,15547703,2.731541485710416
Hs 611.T,135984461,2.1518456912790507
SNU-1077,11178236,-4.2956560843661205
Hs 611.T,9444,3.2553177810802048
Hs 611.T,2729026,2.5246263779141453
SNU-1077,31703,0.2109886329086631
Hs 611.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.110673163960407
YD-8,11647372,1.2851189488565986
KO52,16720766,0.6419660963639499
SNU-216,3552672,2.006250184773747
KO52,5287620,-2.460280488193722
SF295,5329102,3.14028540074618
BT 112,salermide-PLX-4032 (12-1 mol-mol),5.150071894755857
KO52,11707110,-6.904897916995384
SNU-1077,selumetinib-BRD-A02303741 (4-1 mol-mol),4.189870854212877
Hs 611.T,16065773,1.80760253955414
SF295,1242560,4.9592610385486315
TE 441.T,5287969,-2.5247854073249245
TE 441.T,6610216,4.146097180963395
TE-14,675434,4.393840052258565
BT 112,selumetinib-decitabine (4-1 mol-mol),6.418283242663844
YD-8,2828334,6.23916264624694
B-CPAP,72193861,0.4999551540918637
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796
SK-MEL-28,selumetinib-decitabine (4-1 mol-mol),2.13770336621051
SNU-216,selumetinib-UNC0638 (4-1 mol-mol),4.785585222565971
KE-39,46224516,3.9046510157068255
KO52,3854666,-0.4105607896605044
JHUEM-7,375860,-0.5506223236134746
TE-14,5329102,2.4513756587511857
KO52,2733526,4.161479785187153
OE33,126941,-3.974727275368632
Hs 611.T,54678924,2.8409575384591736
TE-14,ISOX-bortezomib (250-1 mol-mol),0.689552332809445
GOS-3,71304818,3.432284958440276
SK-MEL-28,216345,4.760826301733561
TE 441.T,44491742,3.759624787095016
Hs 611.T,2871966,-2.368490368475895
Hs 611.T,135875424,2.7263445003410536
TE 441.T,322968,3.586599917424751
OE33,10385095,1.0575455043550728
JHUEM-7,3081361,1.1903814732345688
YD-38,5746,1.894310930407794
BT 112,5281321,0.9074041531401555
TE 441.T,216345,1.5099442643650116
GOS-3,119182,1.862888663663923
GOS-3,24951314,2.597884619205853
B-CPAP,doxorubicin-navitoclax (2-1 mol-mol),0.582190958380646
TE 441.T,11455910,0.1965703482136005
YD-38,176870,-1.365758615052037
KE-39,piperlongumine-MST-312 (1-1 mol-mol),2.040458418548574
Hs 611.T,44493528,4.184302816514897
NCI-N87,1239801,5.115918121174403
GOS-3,136227924,2.1351760440562533
YD-8,46907787,3.160935680087681
KE-39,123631,1.2600830788760988
TE 441.T,73707371,7.119622486558907
NCI-N87,72734382,4.464771871646434
YD-38,16720766,-0.2528373809891789
YD-38,65628,4.316413155478777
KE-39,11396600,3.848773124810753
NCI-N87,72193870,2.948099148236623
KE-39,568763,1.2890727054350877
NCI-N87,262093,3.0008468279122607
SNU-1077,3543504,4.1557787883322606
BT 112,984333,1.584927202136717
YD-38,71304818,2.91033512553829
Hs 611.T,285033,-5.093391478074478
SF295,3854666,4.284983950639361
OE33,135875424,4.864853081585439
Hep 3B2.1-7,25195348,2.955791428131732
YD-8,9868037,3.0733964994503244
L3.3,168312962,-1.2002539688883909
SK-MEL-28,5470400,1.2133275140914848
SNU-1077,46398810,3.015075111637921
KE-39,53232,3.986419715634147
KO52,11228183,-4.013409516363687
JHUEM-7,navitoclax-piperlongumine (1-1 mol-mol),0.3587972188720395
Hep 3B2.1-7,136227924,5.40641673036814
L3.3,24951314,1.4054712073944002
TE-14,439501,-3.001573063863178
SK-MEL-28,24964624,3.0237245783497144
NCI-N87,11404337,-0.8803091706648726
TE 441.T,3552672,1.4921637874892284
NCI-N87,20959075,-3.4539866912118784
KE-39,10410894,3.265010081493446
YD-38,24180719,4.600103743095947
SW1573,53392493,3.256582971351183
KO52,676352,1.6863796828761293
NCI-N87,10231331,4.183605147658756
JHUEM-7,168313200,3.430060131832228
L3.3,984333,-1.3131333034824293
NCI-N87,71304818,2.1951958800989133
YD-38,44486219,3.4914572976209346
YD-38,9967941,4.915948737435257
B-CPAP,navitoclax-sorafenib (1-1 mol-mol),1.07140085648009
YD-8,25150857,2.3631685028134544
YD-8,44493528,4.2998537557563346
NCI-N87,3025986,-2.1031012904407818
SNU-1077,44137675,3.7361071963131858
TE 441.T,3038522,2.7230314239046707
OE33,72734382,5.2524587547950805
KE-39,65064,5.11272287356881
OE33,46843906,2.27506456486943
B-CPAP,54619238,5.255956817941979
GOS-3,4917,3.642810744950485
NCI-N87,15547703,1.070685995489879
KE-39,16725315,3.5990851811512403
KE-39,11152667,0.74958800909379
KE-39,208908,0.8342774772445833
Hep 3B2.1-7,3854666,3.158608075491721
Hs 611.T,25150857,0.721592680667691
YD-38,56946209,-4.099178938106398
YD-38,135411,0.5996233659487772
NCI-N87,24901704,2.2078626603453664
JHUEM-7,11955716,-2.804770203271417
KE-39,10231331,4.477976749120646
TE 441.T,carboplatin-UNC0638 (2-1 mol-mol),1.4833424452661312
KE-39,89928392,0.902975111582136
OE33,5287969,-1.9094288433640256
SK-MEL-28,selumetinib-JQ-1 (4-1 mol-mol),-0.6682697886543986
B-CPAP,24772860,0.4550512643264998
L3.3,16720766,-1.973453330210062
OE33,67291369,1.7664014894471822
TE 441.T,9935249,2.3228197055940556
L3.3,71466380,3.127104498422419
Hs 611.T,serdemetan-SCH-529074 (1-1 mol-mol),0.4492810877743362
SNU-1077,1641662,3.616725979118272
SF295,448949,2.9940610977103455
L3.3,44543605,3.679570515799513
B-CPAP,168313047,2.654561497495477
YD-38,2729026,3.0794771028962753
Hep 3B2.1-7,5329102,2.0312161402251556
B-CPAP,52912189,3.2590712280352583
SF295,25183872,-0.4443256775822993
TE 441.T,46215462,1.3266046767366175
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
SF295,9825149,2.95912191329992
KE-39,5284373,4.108960473804643
Hs 611.T,9887053,1.7338078284968432
KE-39,72193861,3.4588346249762534
Hs 611.T,6438330,0.9911371502414524
B-CPAP,54613361,-1.5101356569841191
SW1573,54626689,3.958399976383255
KE-39,44185566,2.219569875640091
SNU-1077,16722836,1.5669441897808989
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
Hep 3B2.1-7,10231331,1.1707245730964018
YD-8,navitoclax-birinapant (1-1 mol-mol),3.490795645603815
SNU-216,44819697,-1.895882945285985
NCI-N87,11609586,1.5678533381622328
TE 441.T,1242560,3.25377311649576
KE-39,104842,1.1494054436800256
SNU-216,11507802,1.4243975230006038
Hs 611.T,5280436,-0.4591533881724744
KE-39,3676137,4.663329391632706
SNU-216,68056272,3.411251532127361
SNU-1077,4261,2.6699673905919696
Hs 611.T,JQ-1-MK-0752 (1-1 mol-mol),1.6004197834829663
TE 441.T,10127622,5.1659343374816125
TE 441.T,selumetinib-MK-2206 (8-1 mol-mol),2.916322573945283
TE 441.T,1239801,3.434384801374823
TE 441.T,6184667,3.173920114410577
YD-38,12001922,1.852128176270752
TE 441.T,2126,5.200977994947506
SF295,carboplatin-etoposide (40-17 mol-mol),1.823138350284034
NCI-N87,11455910,1.6652699053284308
YD-8,3552672,2.336510078255813
KE-39,11609586,3.026982810256724
NCI-N87,46191454,1.700307220457573
KO52,11175137,1.294092661003282
SNU-216,7326481,2.6936193795359533
JHUEM-7,11640390,3.5194655079391857
SF295,5460769,2.0646753609737125
Hs 611.T,5311281,2.8850029754458064
KE-39,421610,5.566154561454864
KE-39,9908783,5.748750979730715
TE 441.T,23582824,0.3738805159209457
SF295,selumetinib-UNC0638 (4-1 mol-mol),4.941629082671042
YD-38,613753,2.798212756613697
OE33,168313016,4.477619540995002
SNU-216,2733526,3.2341597144404073
NCI-N87,42642645,0.5523493290598761
SNU-1077,44589607,2.849893862801054
YD-38,11152667,-0.8447422607526522
SNU-1077,selumetinib-decitabine (4-1 mol-mol),5.435287074602724
KE-39,6623618,2.180925070245112
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
KO52,3062316,2.7101880307468047
SF295,6914657,-4.928801611366654
NCI-N87,168312962,2.346349065468924
OE33,navitoclax-pluripotin (1-1 mol-mol),0.9170427891027672
L3.3,11178236,-1.5128667899079982
SNU-216,9933475,1.608495726084367
NCI-N87,24856436,-1.0645338149753525
SF295,3815108,3.3473077124451063
YD-8,54143018,4.014642236255498
JHUEM-7,49766530,-0.0352390480057696
KE-39,613753,3.317859583771952
KE-39,3062316,1.989758349210964
YD-8,66577038,3.168300886602997
KO52,11455910,0.9067852842316652
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
B-CPAP,104842,-3.0909198505111144
SNU-216,445643,4.002544643771802
TE 441.T,4917,2.892871092151233
JHUEM-7,5311281,0.9593410501369758
B-CPAP,25183872,-0.7864118052297527
YD-38,docetaxel-tanespimycin (2-1 mol-mol),-6.046510152925682
Hs 611.T,46215462,0.5630490865398994
TE-14,JQ-1-vorinostat (2-1 mol-mol),-0.1779983088333628
TE-14,208908,0.6851238803419405
TE-14,42611257,3.491443930705766
SK-MEL-28,6184667,2.5329996148763163
BT 112,71466578,4.453393330882409
SW1573,6917907,-6.296104468024424
SNU-216,56963564,1.0977043213495503
TE 441.T,6438330,1.0080434865499013
L3.3,11612883,3.0937227516492767
KE-39,24771867,5.944751904846296
JHUEM-7,31703,-1.6318454147160704
TE-14,168313200,3.700677169997579
B-CPAP,2733487,6.302381879581772
L3.3,49850262,4.243504406455669
GOS-3,11214940,1.8063167684007233
KO52,9935249,-1.4350246650055785
KE-39,9825149,1.9410582316331728
YD-8,65064,4.498532470774199
BT 112,BRD-K55473186,3.914494657267586
JHUEM-7,36314,3.1831920881425058
JHUEM-7,7251185,2.276113292965344
KO52,24785538,-0.0334605587751474
BT 112,24964624,1.8320643006347463
OE33,4261,0.4728815735010953
YD-38,241158,4.218003156068375
B-CPAP,2841722,3.84496663124297
TE 441.T,9549297,3.3617461996176523
KO52,24964624,2.970521329302971
SK-MEL-28,tanespimycin-gemcitabine (1-1 mol-mol),3.7506715255055343
KO52,3384730,2.162623457031388
KO52,24821094,2.869182341163551
JHUEM-7,1641662,3.469626078091439
SW1573,31703,0.7694714266266048
GOS-3,5281672,4.273337523665355
Hs 611.T,24753719,2.639825501985761
JHUEM-7,11964036,0.7648051456612326
KE-39,5738263,4.084504768293086
TE 441.T,BRD-A02303741-navitoclax (2-1 mol-mol),1.1952494012190105
Hs 611.T,107985,-4.128065548423904
YD-8,10296883,4.26925641885348
Hep 3B2.1-7,44486219,4.406709015852199
TE 441.T,24951314,1.2174355092637226
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
L3.3,docetaxel-tanespimycin (2-1 mol-mol),-3.9282194992049546
JHUEM-7,54618164,3.823825423336211
YD-8,53481919,3.5018247603888404
BT 112,44197249,1.805481072961874
TE-14,6914657,-4.4319819983205715
GOS-3,71751553,4.284016393111424
L3.3,11497983,4.314112910656769
L3.3,375860,0.2158630030269858
TE-14,44202524,1.8111102949434932
YD-8,445643,3.7964641558738688
YD-8,5329102,1.6984603402864296
BT 112,5460769,1.283415330936559
TE 441.T,11497983,4.031475372359196
TE 441.T,54613361,0.582802224737856
SF295,53232,0.9695284418052078
TE-14,15983966,-4.6031079614695525
KE-39,2949965,4.248558977491982
SNU-1077,23725625,5.509681038807162
TE 441.T,68056272,3.6011483392674863
GOS-3,6610216,4.739620593848468
SK-MEL-28,23725625,5.112081717822141
SK-MEL-28,navitoclax-MST-312 (1-1 mol-mol),1.3794636689456534
SNU-1077,4259181,2.3802371330202137
SF295,71466578,5.072600124872265
SNU-216,72734382,5.426456747724787
SK-MEL-28,2858523,3.231693296931409
GOS-3,262093,3.1165245547903804
NCI-N87,4261,0.8200487533079858
TE 441.T,erlotinib-PLX-4032 (2-1 mol-mol),2.6470834141543804
NCI-N87,3503,2.784967297602414
NCI-N87,409805,4.5069551273823585
TE 441.T,16038120,-0.9393028579439044
TE-14,24856436,0.2311061315082642
YD-38,151289,-0.2665025738669385
SNU-1077,5351362,2.377712922072383
YD-38,49793307,-3.338323519960946
YD-38,11609586,2.6866258489707815
B-CPAP,6610355,5.531584540000207
SF295,11178236,-2.041777779057679
Hep 3B2.1-7,5351362,2.675512677207152
SNU-216,44607530,0.8853825110355424
JHUEM-7,10184653,0.8524941419446748
SF295,selumetinib-PLX-4032 (8-1 mol-mol),4.690355242967967
OE33,4917,4.192196732252219
TE 441.T,969516,2.20897919720769
SNU-216,60700,0.9165995392145524
YD-8,11427553,2.049391717183717
SNU-216,3634881,3.17164277995117
GOS-3,16065773,2.51000734865302
KE-39,4096211,4.989230592504944
YD-38,107970,2.360175771455579
L3.3,9926054,1.9335911906728165
KO52,7251185,1.4009576735019478
NCI-N87,54686904,4.2918164398278815
GOS-3,4477,0.980296597324464
SNU-216,9884685,-1.507922407291845
KE-39,selumetinib-PLX-4032 (8-1 mol-mol),6.861097822886508
BT 112,15953870,4.403390528576976
SK-MEL-28,3815108,3.819854777392354
TE-14,148124,-4.465123316500658
KE-39,638278,3.6133315433839455
KO52,9866186,-0.5103275036604222
TE 441.T,135875424,2.9590043348173225
B-CPAP,53232,0.8188511536428992
KE-39,24964624,2.267142563952713
NCI-N87,3385,5.19418058853999
SNU-216,11455910,0.3573804688779068
KO52,67291369,3.207372114299005
YD-8,3689413,-2.153430400522153
TE-14,119607,5.463307114433471
TE 441.T,50905018,3.407727257087799
TE 441.T,11656518,1.3560894699369077
SNU-1077,44819697,-0.6774807829742782
BT 112,25195348,3.9880227699607262
KE-39,445091,4.999033906756457
JHUEM-7,24951314,1.2473556697176558
Hs 611.T,selumetinib-vorinostat (8-1 mol-mol),2.75896517659524
TE 441.T,11234052,4.2146720804176265
SK-MEL-28,656346,3.623925904090985
NCI-N87,702558,5.013224249903468
TE 441.T,11640390,1.033452361518378
TE-14,navitoclax-PLX-4032 (1-1 mol-mol),4.073268000219647
TE-14,15547703,3.183280089151661
Hep 3B2.1-7,4917,3.013547990910925
SNU-216,387447,-4.222955466200769
GOS-3,ISOX-bortezomib (250-1 mol-mol),0.1639381713704753
OE33,44137675,3.2640779547469436
BT 112,10113978,3.5580397718856496
SNU-1077,3384730,1.7373502464877797
TE-14,3081361,1.8442660048159123
Hs 611.T,66577038,1.872094427168669
TE 441.T,11396600,2.898111820402536
GOS-3,17755052,3.2453279413753147
JHUEM-7,26596,-1.8551798961299688
TE-14,9823820,4.620875838895175
TE 441.T,JQ-1-navitoclax (2-1 mol-mol),0.9820543393276062
B-CPAP,5738263,3.3747888621680207
KE-39,176870,3.2545182858471953
SNU-1077,135440466,1.2504033920677526
SK-MEL-28,9825149,2.466048508580774
NCI-N87,crizotinib-PLX-4032 (2-1 mol-mol),2.5035050425609673
SF295,439501,-2.4386536619135137
TE-14,6610355,5.121175599302492
KO52,24771867,-3.917806210376699
JHUEM-7,374536,2.8371018707127065
BT 112,49766530,0.144276899282749
SNU-216,5746,3.315700427171305
B-CPAP,5351362,0.984097997363641
JHUEM-7,25227462,-6.059565497478323
JHUEM-7,10074640,2.4809812187935436
Hep 3B2.1-7,51039095,-0.2751836050394881
KO52,9911463,3.5355164060453004
KE-39,9929138,5.605001473491643
SNU-216,3038522,2.4857596476620376
B-CPAP,452548,0.2886295190968743
KE-39,216468,3.956294605283877
SNU-216,9936388,0.9315958331188322
B-CPAP,9907093,4.2889241184998825
B-CPAP,54619267,2.2660883824751337
OE33,serdemetan-SCH-529074 (1-1 mol-mol),2.664502494439147
NCI-N87,vorinostat-navitoclax (4-1 mol-mol),0.7685195358482984
KE-39,168313200,1.6918255094583214
BT 112,60700,-2.8896776101219515
YD-8,1750826,-3.2226271071481123
Hep 3B2.1-7,31703,-0.3301761309822593
JHUEM-7,2871966,0.3047669100796996
Hs 611.T,6610355,3.366431966674078
KO52,11977753,-0.926133463520109
B-CPAP,10127622,5.805135395633265
TE 441.T,navitoclax-sorafenib (1-1 mol-mol),0.887728471369114
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
TE 441.T,55508,3.9822994435950902
YD-8,4259181,0.3383272267042485
KO52,135398516,2.6603419606687564
KE-39,44241473,4.750329858029805
OE33,104842,-1.0297306276566784
KO52,16065773,1.718324313076395
YD-8,6505803,-0.4521993512764767
OE33,6184667,3.9460581178751473
GOS-3,168313016,4.456848917287458
OE33,3689413,1.522493576982794
KE-39,168312962,1.831477708522254
B-CPAP,135411,1.7170212116885226
SNU-1077,10074640,3.2926421330033837
SNU-1077,23635314,3.6537158971816392
JHUEM-7,JQ-1-carboplatin (1-1 mol-mol),-0.0092802597518256
SNU-1077,6918878,4.982410606922502
SK-MEL-28,322968,3.9440584072931375
NCI-N87,11647372,-1.5140697510658656
KE-39,216239,3.497758173664419
TE 441.T,26596,-1.4712296697044354
YD-8,216239,2.8857236357634655
OE33,tanespimycin-gemcitabine (1-1 mol-mol),-2.5278604317727313
SNU-216,9911830,2.1398912486664026
TE-14,57519531,1.7705437656842578
SF295,54454,0.017400250409685
JHUEM-7,15547703,2.9203929854808317
KO52,44202524,1.2331460749640877
TE 441.T,5329102,1.5086836686423244
NCI-N87,15953870,2.623738434863841
Hep 3B2.1-7,5311,1.3035655137086448
KO52,6505803,1.22031024799857
NCI-N87,36462,0.3600781388020123
KO52,44493528,4.373207696272561
Hs 611.T,decitabine-navitoclax (2-1 mol-mol),1.5457683598430108
JHUEM-7,71680916,4.772874327895641
SK-MEL-28,44185566,3.1920858927006983
KE-39,156414,4.025830312298652
YD-38,72376,-2.7078002254952684
OE33,23582824,0.7259333766636283
SF295,262093,3.7346493602329462
TE-14,54613361,-1.0025611290728191
SF295,serdemetan-SCH-529074 (1-1 mol-mol),2.458023046026203
GOS-3,72376,-1.137393114335449
KE-39,5278396,4.063811246360968
BT 112,119182,-1.0754477765372774
TE 441.T,1716436,1.8501117419808528
SNU-216,89183176,4.367459435091247
SW1573,54618164,4.339091959582753
JHUEM-7,44486219,4.165203149222617
Hep 3B2.1-7,ISOX-bortezomib (250-1 mol-mol),0.8570911025892699
SF295,135398516,2.385761524246111
Hs 611.T,60750,-7.343264339076902
KE-39,44486219,6.242583973184527
TE 441.T,1323703,3.650886184693926
YD-38,168313047,2.6440382714586277
KE-39,11626560,1.956808029215874
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
L3.3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.501199697080603
B-CPAP,24771867,2.555650366496606
SNU-1077,327653,3.4488214544204108
L3.3,11640390,3.7293417266479905
SNU-216,168312962,2.1007158447474743
SNU-216,445091,5.253145466035039
L3.3,9840324,5.709572906398099
TE 441.T,25161177,4.57869352023314
KE-39,52947716,3.3015192136458205
Hs 611.T,44185566,1.6873461690440663
SNU-216,carboplatin-UNC0638 (2-1 mol-mol),3.775865800874376
KE-39,5311,1.0787821402256168
TE 441.T,11485656,0.4823826130235241
GOS-3,984333,1.7865923354783255
JHUEM-7,44493528,4.303413387370261
TE 441.T,327653,2.387297951651056
Hs 611.T,5351362,0.8596120528570375
B-CPAP,23635314,-2.2199735472205395
Hep 3B2.1-7,44607531,3.424824120427649
TE 441.T,54619267,3.62579615105429
L3.3,46191454,1.113033924578524
KE-39,4578,4.450266495583275
SNU-1077,107970,2.607215080284504
SF295,46398810,3.368980510961915
TE-14,11404337,-0.8774681002045693
Hs 611.T,9933475,1.605311060153359
KO52,42642645,-0.8739064396706098
SK-MEL-28,448949,3.238404607580412
TE 441.T,4578,4.2344005798027675
B-CPAP,44589607,3.2580421536509574
BT 112,72376,-2.818069890055989
L3.3,3025944,4.713949011742796
SNU-216,7251185,1.8033335851683228
BT 112,10385095,0.9487594139156588
Hep 3B2.1-7,168313047,2.740154506541457
Hs 611.T,5284616,-6.061980923687256
L3.3,4788,5.85214112282752
SNU-1077,11175137,2.980099739351046
SNU-216,1714884,3.44111438656502
BT 112,135875424,2.6326015677965087
Hs 611.T,3011155,4.323994031754243
SK-MEL-28,49793307,2.4799743183356897
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
YD-8,16725315,5.013629583525294
JHUEM-7,44566777,-0.2375299751384852
GOS-3,9935249,3.5788705539521315
SW1573,11404337,-1.3449252751203844
B-CPAP,44607531,1.6956688742545236
TE-14,2742550,4.106621802038204
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
SNU-216,navitoclax-piperlongumine (1-1 mol-mol),1.18336766030724
TE-14,25150857,2.4184084482613506
GOS-3,387447,-4.946086426612472
TE 441.T,10322450,2.5137861182837207
B-CPAP,5113032,5.349013734099232
SW1573,54686904,4.039437320121271
BT 112,11455910,0.2027348347828513
KE-39,53232,3.986419715634147
L3.3,navitoclax-sorafenib (1-1 mol-mol),2.85899880302019
SNU-216,49836020,4.392080781330326
TE 441.T,148198,-7.570550283496053
YD-38,54613361,-0.3869003944931092
BT 112,navitoclax-gemcitabine (1-1 mol-mol),-4.253008173611593
L3.3,44491742,6.349276489474054
YD-38,51039095,2.9380633657207733
KE-39,219104,3.854039065759246
L3.3,26596,-0.871586326159775
Hs 611.T,piperlongumine-MST-312 (1-1 mol-mol),0.9947686553129172
L3.3,54619267,4.657132666629917
BT 112,selumetinib-navitoclax (8-1 mol-mol),3.948164534074535
L3.3,65628,4.284850303510067
KO52,71304818,3.049404193562579
L3.3,5287620,-1.4617046509205764
JHUEM-7,6918736,-3.584037511653784
SNU-216,6918328,-1.6385139859210605
Hep 3B2.1-7,11626560,1.834990976462628
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568
OE33,11719255,3.780620794772801
Hep 3B2.1-7,15953870,2.3473696237911175
Hep 3B2.1-7,11178236,-2.0767038859193803
L3.3,11609586,3.8992408569207018
YD-8,2945648,2.8008863810505873
JHUEM-7,24964624,1.3812203269919547
B-CPAP,serdemetan-SCH-529074 (1-1 mol-mol),2.365307132566549
L3.3,9935249,4.2075706542966955
Hs 611.T,5282054,2.2484999312435265
KO52,16038120,-0.794820665214537
JHUEM-7,11455910,0.2186713515547739
SW1573,107970,2.0608182724975266
OE33,5978,3.3733453677762304
SNU-1077,2858523,3.01508829517467
KE-39,6610216,4.077734835238396
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
YD-8,285033,-1.8984148294735084
TE-14,navitoclax-birinapant (1-1 mol-mol),3.503571738112873
KE-39,676352,2.0662009549778704
TE-14,613753,3.4385269932011
Hs 611.T,6918837,-4.3807539990386095
SK-MEL-28,400769,0.2291963522634262
B-CPAP,2126,3.7809134747205433
OE33,3634881,3.388109632090494
SK-MEL-28,3062316,3.6672926372166
YD-8,46843906,4.015586038915998
YD-38,11427553,3.3100380685196
NCI-N87,241158,3.56045646229574
KO52,44489675,3.934012643953168
KO52,3038522,1.8551480195818488
OE33,6914657,-3.0788344071594738
SNU-1077,44493528,3.708438186415119
KE-39,73707398,1.3252144554958445
NCI-N87,49850262,3.22497182450996
JHUEM-7,4917,3.1457767862931054
KO52,JQ-1-carboplatin (1-1 mol-mol),0.6520623811208981
NCI-N87,6918878,2.817621762559668
TE 441.T,5328940,1.8162925297446155
Hep 3B2.1-7,selumetinib-navitoclax (8-1 mol-mol),1.8236870784242016
YD-8,crizotinib-PLX-4032 (2-1 mol-mol),1.7734837444184717
SNU-216,135411,3.273149769706094
YD-8,6438330,2.2083353285168377
SNU-216,9549297,3.882390204911674
SW1573,9911463,3.734935340044018
TE-14,36314,4.067164205607542
KE-39,9444,5.314846845399724
TE 441.T,16219061,3.7718744241522346
JHUEM-7,23582824,-0.4134518845075093
YD-38,2749,1.6680500375808704
SNU-1077,2729026,3.1553914055465047
OE33,16065773,2.0176883406007557
BT 112,6610216,4.1837874586497765
KE-39,11234052,4.426214441977921
TE-14,36462,2.704845630868705
KE-39,15983966,1.9494927934805544
Hs 611.T,6252,-1.0281041849834551
OE33,selumetinib-piperlongumine (8-1 mol-mol),3.379459589159851
YD-38,BRD-A02303741-navitoclax (2-1 mol-mol),-0.2666516254735072
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
L3.3,3062316,1.4450663843809155
SF295,selumetinib-vorinostat (8-1 mol-mol),2.6390667810596624
TE 441.T,16736978,0.9580178538653972
TE 441.T,56649450,2.4399268990024012
KE-39,23582824,2.1696583807079275
SNU-1077,71304818,2.134778117100761
JHUEM-7,5746,1.3503095363365143
OE33,selumetinib-navitoclax (8-1 mol-mol),2.78652535811442
OE33,24951314,1.570698013239212
L3.3,11404337,0.7171912876466348
Hep 3B2.1-7,5291,3.535966512674248
Hs 611.T,carboplatin-UNC0638 (2-1 mol-mol),1.3943266036810182
SF295,SNX-2112-bortezomib (250-1 mol-mol),-1.0029952457856188
TE-14,8515,4.691290159599005
NCI-N87,1716436,1.6921610156965474
SF295,decitabine-navitoclax (2-1 mol-mol),4.786128519521136
L3.3,65064,4.762523259447735
BT 112,219104,3.367056596744358
KE-39,46174525,4.365046515434029
KO52,1242560,3.1925977163120267
SNU-1077,44507138,3.898901958117883
KE-39,11234052,4.426214441977921
YD-8,doxorubicin-navitoclax (2-1 mol-mol),-0.757010809719607
TE-14,carboplatin-UNC0638 (2-1 mol-mol),3.8273262495621143
SK-MEL-28,selumetinib-MK-2206 (8-1 mol-mol),1.0745935629977668
Hs 611.T,23635314,-4.6983837296806135
Hs 611.T,3543504,4.5569056437018425
GOS-3,25183872,-0.8854682014750674
TE-14,piperlongumine-MST-312 (1-1 mol-mol),2.2546641574624027
SF295,241158,3.864746766488878
OE33,25262965,-3.0997225092728735
YD-8,9907093,4.458824128138645
KE-39,107970,2.31854003043047
Hs 611.T,46843906,1.902730681717527
KO52,selumetinib-piperlongumine (8-1 mol-mol),-0.5207684143564267
Hs 611.T,11427553,1.4904899541531251
OE33,71304818,2.789862992520126
NCI-N87,9936388,-5.070095106907016
NCI-N87,4788,6.175336883845895
SF295,44185566,3.169316962823794
OE33,11404337,0.6160671156841868
SNU-216,46215462,1.4229536083265848
YD-38,9936388,-5.278764060182601
Hs 611.T,selumetinib-piperlongumine (8-1 mol-mol),2.2399185708917124
Hs 611.T,5329102,0.9131536765756388
TE 441.T,119182,-1.0590771583172296
KO52,2729026,2.182339538385487
NCI-N87,erlotinib-PLX-4032 (2-1 mol-mol),3.0192784761472
B-CPAP,crizotinib-PLX-4032 (2-1 mol-mol),1.2873163572314887
YD-8,6184667,3.1421858236064235
L3.3,151289,1.4499844825237675
KO52,72193861,-1.1014673459413422
NCI-N87,10113978,2.582247145825502
YD-38,637858,1.9824428087241075
TE-14,568763,2.618980082462389
OE33,16659841,4.96499269921396
SNU-216,JQ-1-MK-0752 (1-1 mol-mol),5.3985213291534
Hs 611.T,BRD-A02303741-navitoclax (2-1 mol-mol),1.1146059217016966
YD-38,409805,3.7875636051814663
Hs 611.T,1641662,3.2038448944342637
Hep 3B2.1-7,JQ-1-vorinostat (2-1 mol-mol),1.6170565221791997
Hs 611.T,selumetinib-navitoclax (8-1 mol-mol),3.110658833620367
YD-8,24951314,1.71060998865463
L3.3,3815108,3.6939531026178
L3.3,10184653,0.0220617179423389
YD-38,984333,0.696067523171479
B-CPAP,BRD-A02303741-navitoclax (2-1 mol-mol),1.892651156535057
SNU-216,UNC0638-navitoclax (1-1 mol-mol),2.629430823091792
KE-39,JQ-1-navitoclax (2-1 mol-mol),0.0790402407130846
Hep 3B2.1-7,219104,3.647803204428215
JHUEM-7,11404337,0.6000529311141187
KO52,crizotinib-PLX-4032 (2-1 mol-mol),0.3620509137021238
Hep 3B2.1-7,navitoclax-MST-312 (1-1 mol-mol),2.5026055464868007
GOS-3,crizotinib-PLX-4032 (2-1 mol-mol),1.48580275068934
OE33,11238147,1.8300303593829852
NCI-N87,76446078,4.157863043796239
KO52,54454,4.035257146285459
BT 112,462382,-0.8334021028816797
Hs 611.T,25062766,0.5386555117745635
TE 441.T,54618305,3.9313540825452775
KE-39,54649381,3.8116402123721578
SK-MEL-28,31703,0.4439696500586977
TE 441.T,5280436,1.3742861420449088
KE-39,9933475,1.400657947751707
SW1573,11626560,2.096503053081923
KE-39,2729026,2.715568279593477
OE33,49793307,-4.94968855926888
TE-14,9936388,-5.01118425035393
TE-14,123631,0.428908787786111
SNU-216,2871966,-0.923170924915774
Hs 611.T,9908783,6.264389360711776
TE-14,23725625,6.225977205697723
SNU-1077,3634881,3.0237658175436204
TE 441.T,71466380,5.412558378929979
TE 441.T,56949517,4.629785609179926
JHUEM-7,89928392,1.1586048072991315
YD-8,9915743,1.4308611377432014
B-CPAP,969516,2.5464692939990834
OE33,9927531,5.791665708309609
NCI-N87,11213558,1.0018400483751706
SNU-216,57330099,4.208941987405072
B-CPAP,6505803,1.185723298587951
GOS-3,54618771,2.751038853336045
Hs 611.T,119607,6.043778506723619
SK-MEL-28,16741245,3.085707484967514
GOS-3,10184653,2.042716455984749
KO52,49793307,-2.661951064063904
TE 441.T,71304818,1.895657201116581
NCI-N87,54613361,-1.4178620324204825
TE-14,26596,-1.531582993203474
JHUEM-7,71576739,4.492980004205545
KO52,387447,-5.494795804144642
SNU-216,6852167,2.5800071539870846
NCI-N87,36314,2.766113993056904
YD-8,navitoclax-MST-312 (1-1 mol-mol),1.7163356064773547
KE-39,44489675,3.66901218347382
SNU-216,36462,2.86106389441445
NCI-N87,5329102,2.120238068250485
BT 112,6918837,-0.2659992739621661
KO52,156422,3.399553477356099
BT 112,9915743,1.837502115717176
TE 441.T,9840324,6.4205746910052675
YD-8,452548,0.7666794967881028
KE-39,16065773,1.9907820848182145
Hs 611.T,3634881,1.9623654970627349
KE-39,71304818,2.3198950996012515
KE-39,9911830,2.572250482212608
Hs 611.T,637858,0.871054087636222
BT 112,5335621,3.6179814635651377
BT 112,12003241,0.1954695576836523
TE 441.T,462382,-0.1295044509688392
SK-MEL-28,25105715,3.414843394812394
L3.3,54649381,4.658116253691046
NCI-N87,5746,-2.0970985848352837
KO52,9444,3.771327538481611
TE 441.T,64971,3.267500054274099
SNU-216,126941,-3.6157884313638258
SNU-216,docetaxel-tanespimycin (2-1 mol-mol),-2.955516595615088
TE 441.T,6450551,2.8437483634937215
B-CPAP,11214940,0.8407381176330342
SF295,44819697,-1.169097334417276
KE-39,44607531,1.2324934173201474
TE 441.T,46199207,3.399485077203314
NCI-N87,decitabine-navitoclax (2-1 mol-mol),0.6446345774598216
NCI-N87,25262965,-2.609521679715104
SF295,11404337,1.1305596027792637
YD-8,17759555,4.675684554869825
Hep 3B2.1-7,11497983,3.837054379025077
YD-8,969516,3.325354242438773
TE 441.T,carboplatin-etoposide (40-17 mol-mol),0.9968923804280664
Hs 611.T,19582717,3.30705627833961
YD-8,5291,3.66370848447405
KE-39,3025944,4.4635566230619945
Hep 3B2.1-7,10385095,2.639944911413333
KE-39,45279963,3.4988491023820716
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
TE-14,11609586,3.0408936509554914
BT 112,24951314,0.7149145611857288
SNU-216,421610,2.757393166744035
Hs 611.T,5738263,2.286334810299833
SK-MEL-28,46907787,3.835105129876131
KE-39,vorinostat-navitoclax (4-1 mol-mol),0.0592807411548529
OE33,9926054,1.932041644306032
KE-39,11640390,4.498462110577166
JHUEM-7,54619267,3.930692600684294
TE-14,25161177,4.28175027465073
JHUEM-7,45279963,3.810394630077175
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
KE-39,327653,3.149148027412197
YD-8,24180125,3.6955333195671938
TE 441.T,2742550,3.688066908856028
JHUEM-7,25126798,3.738067975046635
KE-39,89928392,0.902975111582136
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
YD-8,56973724,2.610030858184056
KO52,56649450,4.374413775432872
Hs 611.T,3025986,-4.496645094049803
SK-MEL-28,24821094,3.6825272543365233
BT 112,11964036,2.3781270120302556
SNU-216,25227462,-0.5690075475952759
OE33,107985,-4.064645418730777
TE 441.T,6918638,0.7814615450050921
KO52,3465537,1.4492421646178062
SNU-216,46843906,3.868254626427013
YD-38,44632017,0.7623024199362133
SF295,446155,0.7972651769701273
KE-39,9866186,5.4228444415850525
YD-38,9825149,2.3945743779420328
JHUEM-7,11507802,0.4184250140015549
SK-MEL-28,219104,4.539871765849737
KO52,selumetinib-MK-2206 (8-1 mol-mol),-0.3185685393152556
SNU-216,11238147,2.1537777107230416
SNU-1077,9911463,3.723863128468891
TE-14,vorinostat-carboplatin (1-1 mol-mol),3.4576074929446
KE-39,135999136,4.6219900849735325
KO52,71576739,5.251943964885362
KE-39,5351362,1.2382997191060965
KE-39,568763,1.2890727054350877
TE 441.T,docetaxel-tanespimycin (2-1 mol-mol),-7.611222578121889
OE33,984333,1.0291445437949012
TE-14,2126,4.8645468757468
GOS-3,9825149,2.947863727591062
YD-38,9926054,1.970357209117647
TE-14,46398810,2.467371666565784
SNU-216,51039095,2.9385235111794827
OE33,11626560,2.1041567289537846
B-CPAP,54618771,-0.888157328254987
TE 441.T,tretinoin-navitoclax (4-1 mol-mol),3.320877684010679
Hep 3B2.1-7,vorinostat-carboplatin (1-1 mol-mol),2.3068971453553435
L3.3,135440466,3.532632366582018
Hs 611.T,168312962,3.2856643728353925
KO52,46926350,-4.487744142578648
OE33,2708,6.821069396590593
TE 441.T,54765302,3.3707588990922615
B-CPAP,445643,3.9372212515223985
YD-38,60750,-3.418274798981765
KE-39,selumetinib-PLX-4032 (8-1 mol-mol),6.861097822886508
SF295,104842,-3.799159416952957
GOS-3,5113032,4.836446064307081
YD-8,24771867,2.3430098767377263
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327
SNU-216,44484893,4.190162590266464
Hep 3B2.1-7,12001922,1.6092774927634723
L3.3,56649450,3.0657913461458564
BT 112,67156097,-1.0460495753019483
SW1573,5479543,3.675213844165782
Hep 3B2.1-7,1242560,3.0144913298726306
YD-8,1641662,3.7116044926087146
OE33,66577038,3.0840279389618077
B-CPAP,71466380,5.72068384087767
SW1573,11228183,1.3544411199442492
JHUEM-7,2729026,2.278155757312377
JHUEM-7,46199207,2.803889105727764
SF295,6852167,3.343016827643526
YD-38,4788,5.915705304294396
NCI-N87,JQ-1-navitoclax (2-1 mol-mol),0.0624511044953225
YD-8,selumetinib-vorinostat (8-1 mol-mol),2.8906615427618982
YD-8,24785538,0.9876350008475095
SNU-1077,5113032,5.013204732466425
KE-39,11955716,-1.4895818134404846
SNU-1077,49766530,-1.9738465664800544
GOS-3,4578,4.471088168951713
SW1573,216468,2.7570678542174294
KO52,serdemetan-SCH-529074 (1-1 mol-mol),2.372423406417755
SNU-1077,638278,3.5420439981494254
BT 112,9907093,5.482705363653191
SNU-216,65064,5.2443933180383295
YD-38,9935249,3.800527323611882
YD-8,9935249,3.870405994417823
YD-38,46191454,0.601497502213216
YD-38,3062316,-1.5307799933324873
SNU-1077,6505803,4.592101417459953
TE 441.T,46191454,1.8143411605619288
OE33,9911463,4.318006925608157
NCI-N87,5282054,3.4882884399441125
JHUEM-7,5287620,-2.16834390542723
JHUEM-7,49793307,-5.223906833613333
YD-8,409805,3.827275743082073
SF295,24748573,2.395821918737598
YD-8,navitoclax-PLX-4032 (1-1 mol-mol),3.137916156556902
KE-39,25126798,4.078237420502305
GOS-3,44185566,2.676138755124573
SW1573,71466380,3.629171273590213
L3.3,148198,-4.142602322676729
Hs 611.T,26596,-1.6290206215335707
OE33,11178236,-2.949746650584844
KO52,119607,5.619128288871563
L3.3,60750,-5.123801682120219
KE-39,9952709,5.01466122235801
JHUEM-7,6252,-0.6838813235058673
B-CPAP,25126798,3.9395584253439258
BT 112,31703,-2.420524319729687
SF295,400769,0.0619568045666215
TE-14,285033,-1.6140076799735457
KO52,675434,4.169961289776668
JHUEM-7,9887053,4.4427477773471145
SNU-1077,241158,4.367473186933375
Hs 611.T,446155,2.082810696487054
SNU-216,148124,-4.152128230067924
JHUEM-7,216239,1.9657689443394817
B-CPAP,3384730,0.948588967959913
BT 112,2828334,5.978817648129075
SNU-1077,6852167,3.093534637774652
Hs 611.T,1750826,-3.331889142664563
KO52,107985,-4.972333164700203
Hs 611.T,navitoclax-piperlongumine (1-1 mol-mol),0.4922158073235406
OE33,969516,2.632797629373086
NCI-N87,16736978,0.698711777805788
KE-39,selumetinib-tretinoin (2-1 mol-mol),6.162287151844962
SF295,11485656,3.5430104374180806
JHUEM-7,46174525,4.16654361698855
L3.3,11507802,1.6932869737181035
YD-8,2858523,3.2041590177045665
TE-14,3689413,2.902593123647125
BT 112,11719255,0.9914291642812176
KO52,1716436,3.4089505729900615
TE-14,selumetinib-vorinostat (8-1 mol-mol),2.42996649499285
KO52,vorinostat-carboplatin (1-1 mol-mol),1.526755959462623
Hs 611.T,carboplatin-etoposide (40-17 mol-mol),-0.3193374895074411
SNU-216,5738263,3.544912371195603
SNU-216,5460769,1.6923637113112366
Hs 611.T,11640390,3.307087841181284
Hs 611.T,136227924,1.5120677878583844
B-CPAP,1641662,2.641871424967457
SNU-1077,10385095,2.8092985891088444
TE-14,25062766,2.4465300984427834
Hs 611.T,11175137,1.3729243060665188
KE-39,25195348,3.12017559444377
Hs 611.T,25262965,-5.382583142350373
SW1573,104842,-2.57352069349058
SF295,10385095,1.9844654960624617
KE-39,5284616,2.799589028326303
TE 441.T,6917907,-6.579118960193998
GOS-3,9926054,2.0544356724695776
KO52,10074640,3.368382528062951
Hep 3B2.1-7,12003241,-1.3373877223864783
L3.3,11364421,-3.724172704719069
KE-39,11494412,5.804036993573256
TE 441.T,445091,4.523056258688619
Hs 611.T,151289,0.7556153766832656
B-CPAP,51039095,2.4263361872279456
SNU-216,327653,3.2539044842694183
KE-39,15547703,1.7331793905971136
Hep 3B2.1-7,16722836,1.6346770689455403
GOS-3,16725315,5.248800956635294
KE-39,10427712,4.785980320384278
KE-39,322968,3.9954940366420297
KE-39,135875424,3.891762591841876
KO52,9903786,1.3206822748757847
KO52,375860,-1.0348961069797258
KE-39,6917907,3.4636504669535215
OE33,135411,0.1035302974867378
BT 112,54143018,0.6919547440728372
YD-8,136227924,3.733712180219105
TE-14,44489675,3.6400910314318606
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815
JHUEM-7,16659841,3.5134635694670524
Hs 611.T,5287620,-2.413645738426364
YD-8,6450551,2.2155909562952685
SK-MEL-28,2708,5.4002065413787275
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077
NCI-N87,16038120,-0.0105690503285029
YD-38,446155,1.8612220546146192
Hep 3B2.1-7,6623618,2.3517376851828726
GOS-3,24964624,2.7234427755560233
BT 112,selumetinib-UNC0638 (4-1 mol-mol),4.250486145990314
L3.3,15983966,-2.6250326320128066
SK-MEL-28,JQ-1-vorinostat (2-1 mol-mol),2.398214143945904
L3.3,675434,4.909949648038981
OE33,702558,5.7298924677891625
TE 441.T,10385095,0.7638238428487356
BT 112,44486219,4.929058970539822
BT 112,10231331,5.608675026595674
TE 441.T,5287620,1.2195653034476974
KE-39,selumetinib-tretinoin (2-1 mol-mol),6.162287151844962
JHUEM-7,71751553,3.8993350668195874
SNU-1077,100016,6.64200464659652
NCI-N87,387447,-5.408237770865747
B-CPAP,11626560,1.847886697389426
BT 112,36462,-0.1329200912201302
Hep 3B2.1-7,124202324,2.4115397020619453
Hep 3B2.1-7,452548,0.6029668649629754
YD-8,6918289,3.053778903951025
KO52,72734382,3.7619867854642663
SK-MEL-28,selumetinib-navitoclax (8-1 mol-mol),1.214744577584393
Hep 3B2.1-7,1750826,-1.655777027766404
KO52,11214940,1.4370538288764154
Hs 611.T,9884685,-2.4852647330534383
OE33,10113978,5.030208704856358
TE-14,72734382,4.5399953302309735
SK-MEL-28,46199207,3.878150631525568
OE33,25227462,-0.0519137832935216
KO52,54619267,3.343465510835603
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884
SNU-216,136227924,2.452598137182288
TE 441.T,3854666,0.9289040865316472
JHUEM-7,46215462,1.2748682455186626
TE 441.T,375860,0.1054494227896346
SF295,11612883,3.737014041841419
Hs 611.T,148198,-3.7604102025742345
YD-8,4096211,2.9365859982689315
Hs 611.T,2858523,2.9943974026631084
KO52,409805,5.182082476499644
KE-39,52912189,1.824719595124253
OE33,9907093,3.924447394010023
B-CPAP,25262965,0.0515151425678239
B-CPAP,11222830,1.6970126110627293
NCI-N87,5287620,-2.9994225662437928
KE-39,11152667,0.74958800909379
KO52,9967941,3.749170046879557
KO52,24951314,0.169569428706958
SNU-216,24772860,-2.09837085727617
TE 441.T,tretinoin-carboplatin (2-1 mol-mol),4.105803267618285
L3.3,216239,2.590745343804584
L3.3,carboplatin-etoposide (40-17 mol-mol),2.812808375332559
SK-MEL-28,vorinostat-navitoclax (4-1 mol-mol),4.020713865160522
TE 441.T,11494412,0.8893803866671172
TE 441.T,25105715,3.584471780752103
B-CPAP,11396600,0.7084279408075309
NCI-N87,46224516,3.4075734240800624
OE33,16736978,1.4689201358854649
BT 112,5282054,3.2552997941378226
B-CPAP,73707398,1.14773007898321
L3.3,11964036,1.0452508880612652
B-CPAP,10385095,0.9210921841581224
TE-14,11640390,3.827823856737784
SF295,ISOX-bortezomib (250-1 mol-mol),0.5576704948928314
BT 112,374536,1.8950859806063296
YD-8,55283,2.8386191542284007
B-CPAP,11404337,-1.1633647036433346
SW1573,2858523,3.1892649395611556
TE 441.T,ISOX-bortezomib (250-1 mol-mol),2.326213330158226
TE 441.T,5282054,2.066281782246845
NCI-N87,tanespimycin-gemcitabine (1-1 mol-mol),-4.9778446176040845
OE33,46215462,1.585783977146365
B-CPAP,44819697,-2.6722684986578247
SK-MEL-28,5978,5.732425336762653
OE33,selumetinib-decitabine (4-1 mol-mol),3.309412318087147
JHUEM-7,136227924,2.4332957155572688
YD-38,6918328,0.3729203345521322
SNU-216,262093,2.2180002949269793
KO52,9549297,1.130259430761993
Hep 3B2.1-7,36462,2.768405314394988
YD-38,452548,0.3359210212160434
NCI-N87,carboplatin-UNC0638 (2-1 mol-mol),3.4159981227624394
Hs 611.T,2708,2.861727852355751
NCI-N87,11396600,3.282772907192936
BT 112,piperlongumine-MST-312 (1-1 mol-mol),1.6765220415179445
JHUEM-7,6918328,0.5362707723228177
BT 112,23582824,0.9685063545248322
OE33,navitoclax-piperlongumine (1-1 mol-mol),3.1148131946028013
KE-39,4788,5.3862218822227925
Hs 611.T,409805,3.119650007352079
NCI-N87,6852167,1.8373876080574163
NCI-N87,navitoclax-PLX-4032 (1-1 mol-mol),1.558715689605079
Hs 611.T,445643,4.326929012679254
SW1573,25154868,3.281093993360062
Hs 611.T,60700,-2.724608043740349
NCI-N87,9926054,1.7069639615174013
B-CPAP,9967941,2.4730364955418853
BT 112,327653,2.6431646979441012
YD-38,444795,4.9688300992603
SF295,322968,4.885131861384079
Hep 3B2.1-7,3385,5.57638309571322
BT 112,9926054,1.759668872476805
KE-39,5282054,2.8493216674901896
YD-8,644241,2.56753139102049
GOS-3,11222830,1.7526889108260606
OE33,16038120,1.3807426405769108
SNU-216,5282054,2.7577918644529267
OE33,11455910,2.709307324033481
KO52,168313200,1.5421636413024
JHUEM-7,24785538,0.0330026249712562
SNU-216,12003241,-2.3730818081536955
BT 112,11222830,1.5105140978241234
B-CPAP,984333,-0.6051463992030891
YD-38,serdemetan-SCH-529074 (1-1 mol-mol),1.8475478354025596
SK-MEL-28,452548,3.305743794456603
BT 112,5328940,1.9807564403861109
KE-39,3081361,1.3988203553755596
NCI-N87,selumetinib-piperlongumine (8-1 mol-mol),3.3316492796689112
L3.3,168313047,3.843757543685879
YD-8,51039095,-0.2899532723267104
GOS-3,3025944,4.406147026305863
Hs 611.T,3081361,1.583848207218291
SNU-216,54618795,3.171506842627551
BT 112,1750826,-2.206420752683485
NCI-N87,23725625,5.7035859672182125
SNU-216,11719255,3.4273768528884982
KE-39,25102847,2.4320728341381517
SK-MEL-28,4259181,1.166453283270818
SNU-216,135440466,1.959606006857138
SF295,10074640,3.6425650625535897
TE-14,57330099,4.310700710168813
YD-8,11719255,2.4151031872867397
JHUEM-7,107970,1.950560118304485
KO52,5282054,2.455165915117943
KO52,53495165,-2.774880309384125
TE-14,46174525,4.633748098628278
KE-39,1750826,-2.36387280589116
TE 441.T,25227462,-4.6466783434013434
SF295,984333,0.3367134026999984
OE33,148198,-2.7707811749574196
SNU-216,148198,-4.857755213358989
TE 441.T,613753,2.064133623362826
TE 441.T,selumetinib-vorinostat (8-1 mol-mol),3.7277184259028378
KE-39,2733526,4.766803704899474
YD-8,11507802,2.799805869196936
YD-8,24964624,2.5606551305717455
SF295,5311,1.7794369465589015
SNU-216,5280436,3.4535045578814016
Hs 611.T,46943432,2.371802595815265
L3.3,JQ-1-vorinostat (2-1 mol-mol),2.1502729900256807
SNU-216,54678924,1.994073400208429
Hep 3B2.1-7,73707438,4.515086793447455
KO52,46398810,1.739829044633002
KO52,426756,3.509057105571762
KE-39,46215462,1.6742241157614868
Hep 3B2.1-7,119607,3.8735911841342783
JHUEM-7,5282054,3.350633038728166
SNU-216,salermide-PLX-4032 (12-1 mol-mol),4.687186515637412
B-CPAP,16038120,1.2112783851664366
JHUEM-7,6505803,0.2461537124409258
BT 112,71751553,4.665557673334606
SNU-1077,151289,4.212022708260447
BT 112,6505803,0.1257905254161033
KE-39,BRD-A02303741-navitoclax (2-1 mol-mol),0.7696843090662393
B-CPAP,4261,1.9002738315508088
TE 441.T,4788,5.996671612745717
KO52,24901704,1.8747752688503028
YD-8,10385095,1.4410870728115226
YD-8,46398810,2.5554282020008094
OE33,6610216,4.3835431989355635
B-CPAP,44493528,4.579013970980452
TE-14,1714884,3.6737599462044583
YD-8,53495165,0.9440837926278288
YD-38,23635314,-2.822192874167392
B-CPAP,9866186,1.8476989957521583
JHUEM-7,1750826,-2.1362292193438965
L3.3,51039095,3.7013514518444617
JHUEM-7,erlotinib-PLX-4032 (2-1 mol-mol),1.849076309987276
KO52,6852167,2.1234945146220645
B-CPAP,2742550,3.2183332694531677
BT 112,262093,1.8523945417932268
SNU-216,9826308,0.915829887667062
BT 112,9911830,1.5924575123512974
KO52,vorinostat-navitoclax (4-1 mol-mol),-2.6787404148123843
SW1573,5351362,2.395315345585997
KE-39,12001922,1.538248730222034
GOS-3,42642645,0.8540004409462456
NCI-N87,219104,3.2437824126869415
KE-39,carboplatin-UNC0638 (2-1 mol-mol),3.611149814611224
B-CPAP,9929138,3.6088246512600457
KO52,54143018,0.4285373524333706
YD-8,44589607,2.9595252781326784
SNU-1077,16720766,-1.5512387650039812
Hep 3B2.1-7,5746,2.448675279478492
TE-14,54618771,0.7402705360744307
B-CPAP,42642645,1.2545407873532517
YD-38,568763,0.0925266784242715
KE-39,1242560,3.7605808784005625
SF295,15953870,3.68553477527874
SK-MEL-28,9840324,5.381113811344041
SNU-1077,654092,-1.0014927314306907
OE33,JQ-1-MK-0752 (1-1 mol-mol),0.4290491817441692
KE-39,16659841,4.997685648914552
KO52,3025944,4.052272043795827
YD-8,carboplatin-etoposide (40-17 mol-mol),3.699189794658081
KO52,148198,-6.726627358418003
TE 441.T,17755052,0.8250315616483301
L3.3,49793307,-1.834464681937742
YD-38,5280436,4.585818685288783
KE-39,122327,6.317857137620034
Hep 3B2.1-7,10427712,4.336192818143491
KE-39,42642645,1.367345124375733
JHUEM-7,17755052,0.3051122815290938
YD-38,erlotinib-PLX-4032 (2-1 mol-mol),-1.9947686006051497
SW1573,1750826,-4.895155026964416
BT 112,1716436,2.062857445676959
KE-39,54618164,4.766262408385177
YD-38,16741245,4.556042333062202
GOS-3,374536,2.2437065899634843
BT 112,44819697,0.0659575190296443
GOS-3,753704,4.989890215550621
OE33,89928392,1.5742114105683112
SF295,24964624,2.4635902673217456
TE 441.T,44185566,1.1710583771356151
SNU-1077,262093,2.74279505858148
SNU-1077,BRD-K58730230,4.372466359234828
TE-14,11485656,2.3244152057135934
B-CPAP,613753,3.3144945395536003
TE-14,46907787,0.3694296946140285
B-CPAP,5287620,-2.9540281885432735
KE-39,227681,3.9577273305254113
KE-39,25195348,3.12017559444377
SNU-216,1242560,3.492198623937285
SNU-216,72193861,1.899693938246185
KE-39,9866186,5.4228444415850525
SF295,168313047,3.539588092733674
SNU-216,10322450,3.800791101615317
Hep 3B2.1-7,9911830,1.7769280634909912
SNU-216,208908,0.6957755014742779
SF295,9967941,5.1416848590318995
YD-38,5470400,0.3753067973764124
TE 441.T,selumetinib-piperlongumine (8-1 mol-mol),4.4519093178463445
YD-38,168313016,6.308402556942436
SNU-1077,168312962,0.1799345841951062
B-CPAP,11364421,-3.632311492746059
GOS-3,24180125,3.35218152246705
GOS-3,3689413,-2.185831490776692
YD-8,5335621,4.375821722730707
KE-39,serdemetan-SCH-529074 (1-1 mol-mol),2.1213072373059885
KE-39,24772860,-2.1888261700101954
TE-14,56649450,2.166599598587956
B-CPAP,11507802,1.067948865191383
KE-39,3676137,4.663329391632706
JHUEM-7,9911830,1.3841062029972715
TE-14,135411,0.5329688265157383
YD-38,24856436,0.3286492857202097
SNU-1077,11640390,2.9587298758438316
Hep 3B2.1-7,52947716,-4.451035580134199
YD-8,25102847,2.057476964760047
SNU-216,16065773,2.9059591533260813
SW1573,3062316,2.075650426956439
OE33,6918328,-1.1967730377411518
SNU-1077,72376,3.5182408095269073
YD-8,637858,2.173572899934862
YD-8,23725625,6.782116953404122
SK-MEL-28,24748573,5.3109310210303455
OE33,71751553,4.3154384433130355
YD-38,252682,7.500045069347969
BT 112,5978,-4.255189500155859
KO52,4477,0.8813587896449887
TE-14,100016,6.976624848230786
KO52,241158,3.6727095918533
JHUEM-7,11427553,1.505680425653513
OE33,71466445,3.9319707229949703
NCI-N87,216345,3.97830172236079
B-CPAP,6918328,-0.1092026368614908
Hep 3B2.1-7,selumetinib-PLX-4032 (8-1 mol-mol),2.307602355683176
B-CPAP,10074640,3.043104069078904
SNU-216,984333,0.2572508487705686
GOS-3,11152667,0.5000513857969126
TE-14,6505803,-1.7378811047388565
TE 441.T,2733526,4.0345216500732235
Hs 611.T,3689413,-2.7004104072546133
KE-39,ISOX-bortezomib (250-1 mol-mol),0.8981560210811207
YD-8,24889392,3.1391484247952777
KE-39,9936388,1.1689372039333712
TE-14,serdemetan-SCH-529074 (1-1 mol-mol),2.350866314768636
SNU-216,46174525,4.3204118405279255
KO52,753704,4.242778315458095
TE 441.T,44632017,0.997805663061036
Hs 611.T,44607531,0.8847893661786449
OE33,11964036,1.4744458350921272
L3.3,selumetinib-UNC0638 (4-1 mol-mol),5.288673066884017
KE-39,25150857,2.5807263536749607
TE 441.T,57330099,4.3680398337150095
Hs 611.T,15983966,-4.349041198579808
KE-39,5280436,3.8449675100084417
Hs 611.T,168313200,3.4582352812742516
JHUEM-7,52912189,0.2472065202892593
L3.3,54143018,0.1799627669965377
SF295,6918328,0.1842414717583212
L3.3,4261,2.1698969963780055
TE 441.T,44607530,1.859279931276101
SNU-1077,11214940,1.023851206507241
BT 112,5287620,-2.7532847329497883
B-CPAP,67291369,2.842700694962032
KE-39,52947716,3.3015192136458205
SF295,2729026,3.154243256509534
BT 112,6852167,2.8502822773493315
Hep 3B2.1-7,5278396,2.438013509739587
TE-14,crizotinib-PLX-4032 (2-1 mol-mol),2.790681196268514
SK-MEL-28,11485656,3.743045528473451
SNU-216,5494449,1.9310955055256367
SF295,crizotinib-PLX-4032 (2-1 mol-mol),2.36869335976651
BT 112,25150857,1.6816948486973082
SF295,5566,3.0439357019586746
TE-14,16725315,4.8843074522296295
KE-39,2733526,4.766803704899474
B-CPAP,5335621,5.443588151339274
NCI-N87,44507138,1.5580904379761216
Hep 3B2.1-7,71466445,5.312056535197058
Hs 611.T,44491742,3.458740390209698
OE33,JQ-1-UNC0638 (2-1 mol-mol),1.6826826815341247
KO52,2746,2.0900422497447906
SF295,6438330,3.2704650749353728
Hs 611.T,72376,-3.6545364456282514
KE-39,16013152,4.246331494143776
B-CPAP,selumetinib-navitoclax (8-1 mol-mol),2.2794598948076525
L3.3,erlotinib-PLX-4032 (2-1 mol-mol),3.685667045141098
BT 112,3634881,1.0045650301958045
KE-39,322968,3.9954940366420297
TE 441.T,46224516,0.283738462352693
Hs 611.T,46907787,1.0011001882698198
YD-8,44137675,3.4700993938772324
OE33,24797083,1.6231264177904576
GOS-3,135999136,4.682109520485855
NCI-N87,8515,4.286102801865053
L3.3,navitoclax-piperlongumine (1-1 mol-mol),3.3771859534422703
KO52,navitoclax-piperlongumine (1-1 mol-mol),-2.989352719606275
KE-39,3465537,4.350124533164427
SK-MEL-28,613753,3.2736385592087527
TE-14,9868037,4.140324513825515
YD-8,9908783,5.744379377370956
TE 441.T,72193861,1.5185390994902612
B-CPAP,107970,2.366266521836174
OE33,100016,6.493432597771833
L3.3,5460769,1.7814582708772182
OE33,2729026,3.172703771276418
B-CPAP,89183176,5.401425967113139
BT 112,44632017,0.9715199152864828
SF295,44507138,3.2424072407553792
GOS-3,439501,-3.404828566068769
TE-14,71466380,4.317857344031299
NCI-N87,6918837,-4.459129390963203
KE-39,6852167,2.989668764419295
JHUEM-7,176870,2.1277798122521094
B-CPAP,salermide-PLX-4032 (12-1 mol-mol),4.772900953481165
Hep 3B2.1-7,3025944,4.2120956813862325
NCI-N87,6610216,4.734758596227503
L3.3,387447,-2.8513357804813553
SNU-1077,439501,-0.9206139201693064
SNU-216,25161177,4.203635980102748
Hs 611.T,126941,3.528520091647756
B-CPAP,44489367,4.992783705245297
BT 112,25102847,2.5247869657619395
JHUEM-7,327653,3.126202180618715
TE 441.T,135984461,4.21306533466607
YD-38,6610355,4.249088051905564
KE-39,135659046,4.845551344520264
KE-39,9868037,3.621529869698051
KE-39,135440466,2.490274182929518
SNU-216,119607,5.474554011556866
SNU-216,16659841,4.323338252730809
SNU-1077,400769,-0.3055004816783465
Hs 611.T,445091,4.262324044397264
NCI-N87,selumetinib-MK-2206 (8-1 mol-mol),0.3550893984048577
YD-38,44819697,-0.750279161021677
NCI-N87,11626560,1.9254713694635637
SNU-1077,42642645,1.1218523174966224
Hep 3B2.1-7,23725625,5.5559924316278435
TE-14,9907093,4.298951887624449
B-CPAP,4378219,2.1409307713074353
BT 112,26596,-1.3919420546275056
YD-38,selumetinib-vorinostat (8-1 mol-mol),0.9831282675647876
SNU-216,56946209,-4.877294025941971
SNU-1077,54618164,4.137569965283994
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959
OE33,selumetinib-tretinoin (2-1 mol-mol),6.078218001134302
Hep 3B2.1-7,702558,5.48943695230274
KE-39,46398810,2.5573643680926432
SNU-216,5328940,0.816126960446068
TE 441.T,2949965,2.2899971760803073
SNU-216,4788,5.268494458023438
KE-39,10184653,0.6332517224813795
Hs 611.T,6918736,-1.9778844605478405
GOS-3,89928392,1.6340555670682608
YD-38,25150857,2.2281189620323008
BT 112,16722836,2.2677202044282976
SNU-216,24180125,5.748491941008621
SW1573,4096211,3.236722527011662
JHUEM-7,selumetinib-decitabine (4-1 mol-mol),4.060789479990773
Hs 611.T,4259181,0.1161520407552913
TE-14,168312962,3.4603256122768355
GOS-3,serdemetan-SCH-529074 (1-1 mol-mol),2.2992374685315533
SK-MEL-28,46191454,3.2888923577411333
SNU-216,46199207,3.6310581715590673
JHUEM-7,11485656,1.7197285505227566
YD-8,654092,-0.8686607010204063
Hep 3B2.1-7,5281321,-1.2657392258228009
YD-38,135875424,3.801699719504721
KE-39,5494449,3.012336343565584
KE-39,53393127,4.4066047849251655
SNU-216,9935249,2.9187421404972165
TE-14,9933475,1.5684971656253826
GOS-3,6438330,5.388884852572475
KE-39,10184653,0.6332517224813795
KO52,6918878,1.008757664965314
YD-38,10385095,1.2654205909097365
YD-8,15983966,1.014640671892096
OE33,5566,3.228481945044996
Hs 611.T,3825829,3.8788340383084767
TE-14,46926350,-3.484137029842133
BT 112,15547703,3.043535770474186
KO52,56963564,-1.0767290882933307
KE-39,10074640,3.0601585781096268
SNU-216,3503,1.445976442365677
TE 441.T,6852167,2.229580798352396
JHUEM-7,44489675,4.154647994164329
JHUEM-7,462382,0.9048845181666758
SF295,216239,2.6819667616867804
Hs 611.T,25183872,-1.844128869238045
SW1573,135875424,1.8143158468632437
TE-14,15953870,3.387978036470922
BT 112,49793307,-3.616736826753609
Hep 3B2.1-7,25150857,2.2110671335342733
YD-8,15547703,3.876361457328563
TE-14,46224516,3.000812964487585
JHUEM-7,9933475,1.5880397804267905
Hep 3B2.1-7,65064,5.234298047086212
YD-38,piperlongumine-MST-312 (1-1 mol-mol),3.285608866825205
Hep 3B2.1-7,73707398,1.151761195316654
B-CPAP,67156097,-1.5064504611567109
YD-38,44493528,4.189502567524798
SW1573,60700,0.5293530759970745
YD-8,3854666,3.395603852355968
JHUEM-7,44202524,1.495097381233924
NCI-N87,salermide-PLX-4032 (12-1 mol-mol),5.428528810612746
TE 441.T,3465537,1.109247742302779
YD-8,72734382,4.785719030428051
L3.3,71304818,3.108733273598676
OE33,25062766,1.618132937557501
YD-38,168312962,3.566909723958424
KO52,49766530,-2.9689315906411413
KE-39,5328940,1.2417733744928583
OE33,676352,2.6182948450693027
YD-8,216345,4.535987762651242
JHUEM-7,16736978,0.2612625302248401
SNU-216,46907787,3.852045832322763
GOS-3,44819697,0.5869793417455883
OE33,44566777,0.6328964048889911
KE-39,vorinostat-carboplatin (1-1 mol-mol),2.810386853434761
Hep 3B2.1-7,10302451,4.252461968415576
NCI-N87,44589607,2.3758044537421026
Hs 611.T,252682,6.093732220647968
KE-39,44484440,3.4843450825893973
SNU-1077,11427553,3.133065225486414
SK-MEL-28,568763,0.9297123705024438
SK-MEL-28,54678924,3.6337720025858
BT 112,6918328,1.0363276408883513
KE-39,44491742,3.945663107977575
JHUEM-7,vorinostat-navitoclax (4-1 mol-mol),2.5378629346574946
YD-38,16722836,1.1307328441727311
B-CPAP,25102847,2.584814595115363
YD-8,46215462,1.7489393153094872
BT 112,3503,0.8637202569317721
Hs 611.T,9915743,-0.4075331774048215
JHUEM-7,6918878,3.0932283055268512
TE-14,SNX-2112-bortezomib (250-1 mol-mol),-2.4021869864872603
Hs 611.T,6918328,-1.1939211929881746
KE-39,selumetinib-BRD-A02303741 (4-1 mol-mol),5.809798702623815
JHUEM-7,4578,4.2382968636831535
KE-39,23725625,5.622319720398273
NCI-N87,5278396,3.196450874168962
SK-MEL-28,piperlongumine-MST-312 (1-1 mol-mol),2.3735820734622006
Hep 3B2.1-7,123631,2.537990719576873
B-CPAP,JQ-1-navitoclax (2-1 mol-mol),0.5903029448050835
SNU-216,9825149,2.4338095218248794
Hep 3B2.1-7,4477,-0.0557749869807642
NCI-N87,31703,-2.5850470675010175
GOS-3,135440466,3.2261535122506295
SNU-1077,984333,1.7185936454570083
TE-14,89183176,5.9644863398947905
TE-14,5746,0.906830651267076
SNU-216,123631,-0.3500729676131077
SNU-216,135398516,1.937669925049277
YD-38,216345,4.4915437818048325
Hep 3B2.1-7,4788,4.732837755236901
Hep 3B2.1-7,159324,3.436377788042606
KE-39,navitoclax-piperlongumine (1-1 mol-mol),-0.2152074007553692
L3.3,66577038,3.645952100238679
TE-14,5113032,4.5670743899745245
SNU-216,241158,4.2881581162179305
Hep 3B2.1-7,17759555,3.58954952466779
GOS-3,9866186,0.992376150226647
Hep 3B2.1-7,10127622,2.2069143160944895
TE-14,44486219,3.6443522708971745
SNU-216,45279963,3.88317733361902
SF295,navitoclax-gemcitabine (1-1 mol-mol),0.7622773628981511
B-CPAP,135875424,3.307629887397838
YD-38,24964624,2.635886673115533
TE 441.T,135999136,1.6397829738151082
KO52,navitoclax-birinapant (1-1 mol-mol),-2.4193601330067267
YD-38,56963564,-0.5588398385004562
KE-39,6918837,-3.138673306335868
SNU-1077,11234052,3.386244403850262
JHUEM-7,11234052,3.906986952802379
YD-38,52912189,0.9413561313554776
BT 112,24785538,-0.31795448088545
KE-39,BRD9876-MK-1775 (4-1 mol-mol),3.886379360768492
B-CPAP,16720766,-0.0542134941135855
BT 112,100016,6.504213631006025
B-CPAP,168312962,-2.242670395698556
SNU-216,71466380,5.187111337737049
L3.3,11152667,-1.6552573738209355
BT 112,135999136,1.34167975240954
NCI-N87,46174525,4.699807035348161
BT 112,53495165,-3.2644950718857255
SNU-216,5566,3.0388673549220178
YD-8,10231331,5.266552071230695
SNU-1077,8515,4.803726365696702
NCI-N87,11364421,-4.7214998150919065
KO52,374536,-2.868980977087777
SNU-1077,11238147,4.353998599384084
Hs 611.T,9866186,-0.2161850451138603
Hs 611.T,5335621,4.030077497436074
TE-14,6436223,-4.414768579613021
YD-38,107985,-3.704885076305192
KE-39,168313047,2.2332329252634584
SK-MEL-28,53232,4.789899773327052
KE-39,613753,3.317859583771952
SNU-1077,124202324,3.0238569925896113
Hep 3B2.1-7,25154868,4.296826538489659
JHUEM-7,241158,3.726297808510672
TE-14,25105715,3.27330564947439
TE 441.T,11507802,0.7950690798154194
SNU-216,702558,4.895818993514928
B-CPAP,753704,5.841811531303964
B-CPAP,72734382,5.762194800032224
SNU-1077,11152667,0.5302678511241536
SW1573,9840324,5.095993559480237
KO52,4788,5.9251451184243455
YD-8,42642645,0.5447742050526033
TE 441.T,9866186,0.071586275661553
Hs 611.T,11719255,0.8283937909943156
BT 112,5311281,1.2927719080632414
TE 441.T,2130404,2.865967675854056
SNU-216,17755052,-1.633790764199148
KE-39,24785538,4.0612751994912335
Hep 3B2.1-7,11485656,2.176020084132011
SW1573,52912189,3.9296893768173065
Hs 611.T,3101542,4.754983330166655
TE-14,71304818,2.537898681049355
NCI-N87,400769,-1.2757727144105298
JHUEM-7,navitoclax-pluripotin (1-1 mol-mol),-2.7805642205903593
YD-8,navitoclax-pluripotin (1-1 mol-mol),-0.5711065804436923
GOS-3,6918638,1.663921744527482
TE-14,44819697,-0.1519907050740515
TE-14,66577038,2.6979346894127
KO52,445643,3.829050066229971
TE-14,11507802,1.0111349435521184
SNU-1077,969516,4.920096093874863
Hs 611.T,613753,2.8165703811915597
YD-8,5351362,1.6415350348808246
NCI-N87,6505803,-6.101345662019038
KE-39,3062316,1.989758349210964
L3.3,9911463,4.128757247123474
SF295,654092,0.0189018784899866
YD-8,serdemetan-SCH-529074 (1-1 mol-mol),2.534681680043658
L3.3,135398516,2.485669059846241
SNU-216,135421197,1.0326096520006542
Hep 3B2.1-7,5470400,-2.616097768869996
KO52,JQ-1-vorinostat (2-1 mol-mol),-1.1971582258759
TE-14,2746,3.3749666856765304
L3.3,23725625,5.56548732943537
NCI-N87,ISOX-bortezomib (250-1 mol-mol),-0.226060851576525
SW1573,10026128,4.237670104162456
SK-MEL-28,16065773,2.9091581541249223
JHUEM-7,9926054,1.641999407547345
TE 441.T,5566,3.0387832662798964
YD-8,9911463,3.690343271752708
KE-39,docetaxel-tanespimycin (2-1 mol-mol),2.396953201231709
TE 441.T,135411,0.5500346816082857
YD-8,selumetinib-UNC0638 (4-1 mol-mol),2.6843150773739453
GOS-3,5282054,3.980081801292934
B-CPAP,3025944,4.582050785449419
L3.3,44632017,1.809753180552785
KE-39,5328940,1.2417733744928583
KO52,5284616,3.214737678420765
BT 112,24821094,1.850576537519091
SNU-216,5281321,-2.0921736744745156
GOS-3,16659841,4.90242511664039
YD-38,136227924,2.6123275605059075
KE-39,10385095,1.3052459079941114
NCI-N87,11222830,1.733835072175261
Hs 611.T,JQ-1-carboplatin (1-1 mol-mol),1.233772265287216
SNU-1077,10427712,5.108868018236591
YD-38,6918878,1.9544943666312664
L3.3,5329102,3.0035184311097245
YD-38,6610216,4.740393089069458
OE33,2746,2.7393344543249443
L3.3,SNX-2112-bortezomib (250-1 mol-mol),1.42333058116923
BT 112,71680916,4.277413325515947
SK-MEL-28,navitoclax-birinapant (1-1 mol-mol),3.597068820497229
KO52,6450551,0.7972942512543331
OE33,3854666,4.486907351479266
SF295,452548,-0.238215744941623
SNU-1077,5329102,2.42663042456867
SNU-1077,selumetinib-MK-2206 (8-1 mol-mol),3.771389515092964
L3.3,322968,4.952946424555438
BT 112,3136844,3.8258170991022222
KO52,JQ-1-MK-0752 (1-1 mol-mol),1.137098893083227
NCI-N87,alisertib-navitoclax (2-1 mol-mol),-1.7331970522410185
OE33,selumetinib-vorinostat (8-1 mol-mol),1.9103124902448312
SF295,2708,4.6592874760103795
SNU-1077,54649381,3.672520779647441
KE-39,25227462,2.8999512206362867
SF295,11238147,3.954653767747053
TE-14,984333,1.2070523658842751
B-CPAP,44202524,1.220918078886342
KE-39,navitoclax-sorafenib (1-1 mol-mol),0.8141438831550822
GOS-3,11404337,1.2142789078350222
KO52,2742550,3.525067743551677
Hep 3B2.1-7,9926054,2.8753203525792026
Hs 611.T,10410894,1.861902823105788
KO52,46224516,1.1439524692050589
L3.3,1242560,3.353722310779613
B-CPAP,10427712,4.570782311965759
OE33,44819697,0.2875723166616361
Hs 611.T,322968,1.9991889288726985
SNU-1077,216345,4.12510316244265
KE-39,44487872,4.457727251314366
YD-8,tanespimycin-gemcitabine (1-1 mol-mol),-0.3043825539609709
TE 441.T,3384730,2.376241707074279
BT 112,11152667,1.095866512531577
KE-39,107970,2.31854003043047
SW1573,448949,2.6434946381292703
JHUEM-7,208908,1.9888781233805737
TE 441.T,5311281,0.8068962369720073
YD-8,11214940,1.0637832201595108
KO52,25102847,1.7246116477249929
TE 441.T,25150857,0.8690399659770709
SF295,4259181,0.2902320947492574
Hep 3B2.1-7,969516,2.78544012674228
Hs 611.T,10427712,3.4989942349899645
JHUEM-7,JQ-1-vorinostat (2-1 mol-mol),-1.265812269763504
KO52,5278396,3.3505834178575964
KE-39,navitoclax-gemcitabine (1-1 mol-mol),0.4577354128073778
TE 441.T,16065773,1.8800785086294824
SNU-216,15953870,2.862027857822619
KO52,11507802,0.3147818183904139
BT 112,969516,2.869310026352302
L3.3,1566236,3.261153981033622
SF295,24951314,1.477967399067711
Hs 611.T,11364421,-6.081344851630196
SNU-216,675434,4.503602806823805
JHUEM-7,selumetinib-navitoclax (8-1 mol-mol),2.7635146626485256
KO52,5978,-3.230844863320846
SNU-1077,24856436,1.1327276677914395
JHUEM-7,73707398,0.8849918098478027
Hs 611.T,462382,0.1674960625020105
TE-14,25195348,4.552546722022142
SNU-1077,24901704,2.743135685281435
YD-8,16722836,1.043469744130907
BT 112,2858523,2.609953955894282
Hs 611.T,9826308,-1.2831822021204369
TE-14,44607531,1.0565875774081055
NCI-N87,SNX-2112-bortezomib (250-1 mol-mol),-4.305728707352715
B-CPAP,124202324,2.5126269670225994
TE 441.T,753704,4.281731848171136
BT 112,375860,-0.4292821848483891
JHUEM-7,2749,1.3082739323619237
GOS-3,JQ-1-UNC0638 (2-1 mol-mol),2.0742730655318233
YD-8,16038120,0.5633322906687026
OE33,216345,4.44282779465598
SF295,5282054,3.6326515094468976
SK-MEL-28,11612883,5.069449441061208
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
L3.3,73707438,4.465616964273929
SW1573,135411,2.599466343128946
YD-8,25154868,4.975027029918458
SNU-1077,3025944,4.915661762266775
NCI-N87,selumetinib-PLX-4032 (8-1 mol-mol),3.8712321401270406
SK-MEL-28,vorinostat-carboplatin (1-1 mol-mol),4.275906027755069
KE-39,9935249,3.082096285966509
NCI-N87,24180125,2.059368273959215
YD-38,54618164,4.14569311536785
NCI-N87,15983966,-4.100894125332804
KO52,26596,-3.758446698642679
KE-39,24753719,4.8851025960405074
SK-MEL-28,44819697,1.1558418850564092
GOS-3,2749,1.7643517607481882
SF295,9926054,3.0771086967152845
JHUEM-7,6450551,1.7942384478328788
YD-8,46191454,1.6533383090175473
TE-14,135875424,2.9954156144381203
SK-MEL-28,52947716,-6.546554666809958
KO52,2708,3.123821220671842
SNU-216,400769,-0.8267203800498377
TE-14,6918837,-2.4656946388437255
SNU-1077,ISOX-bortezomib (250-1 mol-mol),0.925773470547737
YD-8,2742550,3.780440690417096
YD-38,navitoclax-gemcitabine (1-1 mol-mol),-1.376406906038253
KO52,72376,-3.1710971417333726
YD-38,159324,3.3433539214120516
SW1573,24180125,4.83914798243841
SNU-1077,selumetinib-PLX-4032 (8-1 mol-mol),4.363264972999689
KE-39,11657048,4.694406687626931
KO52,285033,-3.0760712671003896
JHUEM-7,53495165,-3.1314756111432236
TE 441.T,7326481,2.610340700385677
KE-39,17755052,3.062972722223711
TE-14,16038120,1.4445788120789431
KE-39,44589607,3.0776272038529475
B-CPAP,262093,2.8121848345775784
YD-8,11175137,2.9389718766102906
KO52,16725315,3.1980251151125705
TE-14,JQ-1-MK-0752 (1-1 mol-mol),0.7868462182929333
KE-39,49766530,-2.0647642539816715
TE-14,44484893,5.1201558300438625
NCI-N87,25102847,3.5806366762623645
BT 112,10296883,3.9999728699442607
NCI-N87,136227924,3.040461203265333
YD-8,24821094,2.929241602776678
SK-MEL-28,654092,0.5441939646786474
SNU-1077,135999136,1.6213426965056292
KE-39,54618795,3.2996037885705927
KE-39,44607531,1.2324934173201474
SW1573,5282054,2.2636648441362417
KE-39,11364421,0.2339323182946827
Hep 3B2.1-7,2749,1.4477080023113305
KE-39,10302451,3.0941257531868858
NCI-N87,54619267,3.778794485594146
YD-38,3689413,0.3954861349850884
NCI-N87,3634881,3.127468365851455
YD-8,11404337,-1.7651477779753342
NCI-N87,135440466,2.814988966864087
OE33,11152667,-0.6577753900315373
SNU-1077,erlotinib-PLX-4032 (2-1 mol-mol),3.997115114671339
GOS-3,44241473,4.447421169667303
OE33,11625818,4.843865529588344
YD-8,15953870,3.5713699030166186
TE 441.T,46907787,3.123657521861764
BT 112,11626560,1.4312107958608666
Hs 611.T,24821094,0.9445558353923768
SK-MEL-28,24180125,3.6660135560508142
OE33,vorinostat-navitoclax (4-1 mol-mol),1.1238349202976667
TE 441.T,135440466,1.4153428871143716
KO52,73707398,0.5433059802196046
BT 112,decitabine-navitoclax (2-1 mol-mol),5.309394661219557
SK-MEL-28,selumetinib-PLX-4032 (8-1 mol-mol),2.641553313699231
KE-39,24856436,3.387816018334062
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054
TE 441.T,10302451,3.78756460057488
SK-MEL-28,6914657,-2.0042888154328344
SNU-216,vorinostat-navitoclax (4-1 mol-mol),1.7629538031708885
YD-8,docetaxel-tanespimycin (2-1 mol-mol),-1.5629664362824751
YD-8,navitoclax-piperlongumine (1-1 mol-mol),2.544833640493428
SNU-1077,322968,3.904848920505325
KE-39,3543504,4.7094782670385475
SF295,10302451,4.330260751201553
KE-39,3081361,1.3988203553755596
KE-39,753704,5.009174848734236
GOS-3,8515,4.692167574261379
L3.3,374536,1.2868097755844614
SNU-216,1566236,1.785015766563616
YD-8,53232,1.7923845474925033
Hs 611.T,439501,-3.691204716302381
TE-14,42642645,1.3983104503701576
GOS-3,613753,3.227220710192061
Hep 3B2.1-7,49766530,-1.5968741678942395
SNU-1077,246676,5.4377451130468435
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
JHUEM-7,44632017,0.9432703317183572
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
OE33,5311,1.2863561200816664
YD-8,4705,3.8146154447521146
Hs 611.T,46926350,-4.631315490401831
Hep 3B2.1-7,9825149,1.2107085723984887
SF295,3503,2.7159653827410355
Hs 611.T,262093,0.9776083871947168
SNU-1077,44543605,4.154950294832259
SW1573,3503,1.662872296112478
TE 441.T,serdemetan-SCH-529074 (1-1 mol-mol),0.9246707880688446
BT 112,60750,-4.243293157722899
JHUEM-7,4521392,4.016477728370682
JHUEM-7,selumetinib-vorinostat (8-1 mol-mol),2.3580216719117284
NCI-N87,5281672,5.2421020595736145
Hep 3B2.1-7,navitoclax-piperlongumine (1-1 mol-mol),2.342675220136375
YD-38,20959075,-3.5580886326999175
L3.3,654092,0.3260809528195456
Hs 611.T,11497983,2.8823121008945236
KE-39,24775005,3.7793317686622903
Hs 611.T,24901704,2.091215429755936
SK-MEL-28,56946209,0.4976009870921759
JHUEM-7,44137675,1.945241597383145
SNU-1077,JQ-1-vorinostat (2-1 mol-mol),1.661185971145615
Hs 611.T,216239,1.7794585451064322
KO52,44589607,1.6213501013448446
KE-39,12003241,0.559414259019648
SNU-216,3543504,4.444613120947592
SNU-1077,navitoclax-birinapant (1-1 mol-mol),2.274223223308886
NCI-N87,151289,0.0450530603050232
NCI-N87,439501,-2.2970478950560715
Hs 611.T,vorinostat-carboplatin (1-1 mol-mol),3.144700037898093
NCI-N87,135411,0.0487965919912929
SW1573,44185566,2.872643000979188
BT 112,11609586,3.092948816829803
BT 112,51037431,5.205147276612667
GOS-3,4261,3.5553215793215185
Hs 611.T,49766530,-2.7427307114148545
KO52,11364421,-5.790016441966964
GOS-3,448949,2.9478585654130263
SW1573,10385095,0.5068001344623563
KE-39,selumetinib-navitoclax (8-1 mol-mol),1.4458639992966646
TE-14,54143018,-0.7694237201008571
KE-39,25262965,-0.0093824287359457
TE 441.T,11719255,2.6614811304249417
YD-8,10113978,1.4967891530862965
Hs 611.T,45279963,3.56639954670695
KO52,25126798,3.67676175110437
TE-14,9825149,2.4662096098050754
SNU-1077,5566,3.5894057119663993
Hep 3B2.1-7,126941,-3.038985953830582
SK-MEL-28,5328940,2.9501467839577744
KE-39,serdemetan-SCH-529074 (1-1 mol-mol),2.1213072373059885
OE33,54618164,4.547083841535975
YD-8,53392493,2.3611593558483066
B-CPAP,24951314,0.9268221935923368
OE33,11175137,3.7940887690992855
SF295,5281321,-1.0284803078097726
KE-39,71304818,2.3198950996012515
L3.3,126941,-2.2408794553514735
B-CPAP,56963564,-0.6464241889145811
KE-39,54596490,4.684539429557116
Hep 3B2.1-7,11656518,0.170791411533647
B-CPAP,5328940,1.9207769307249352
SK-MEL-28,15983966,3.2325576409024306
YD-8,82146,4.39228659038304
JHUEM-7,1716436,3.3976454809646426
SW1573,2729026,2.4001203305493397
BT 112,44185566,2.3471539577419835
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
KE-39,tanespimycin-gemcitabine (1-1 mol-mol),2.3625667461042363
KE-39,71680916,5.592111276065997
BT 112,selumetinib-MK-2206 (8-1 mol-mol),3.149156895525344
Hep 3B2.1-7,5566,2.9169630024130724
B-CPAP,6918878,1.5397343685525162
NCI-N87,2733487,6.3981873446173285
NCI-N87,452548,-1.772451424496647
B-CPAP,6917907,-4.328736065913287
OE33,6918837,-4.942667208986794
B-CPAP,5278396,3.4451534548070804
BT 112,409805,3.8696760433856774
YD-8,6918328,0.3268020780062931
SNU-216,52947716,-1.051191200256004
TE 441.T,5743,3.6433871182506175
BT 112,3025944,4.482277488188436
L3.3,11175137,3.713617877823204
SNU-1077,71680916,4.721412518258323
NCI-N87,168313047,2.984513904409232
SNU-216,9926054,1.7628487898715297
L3.3,57519531,2.574296584662942
OE33,navitoclax-MST-312 (1-1 mol-mol),2.7767901134896604
L3.3,11625818,4.38532777510286
KE-39,54618771,0.8543301924142261
YD-8,selumetinib-JQ-1 (4-1 mol-mol),3.141432259202229
KE-39,tanespimycin-gemcitabine (1-1 mol-mol),2.3625667461042363
KE-39,3384730,3.7070900081119
Hs 611.T,navitoclax-MST-312 (1-1 mol-mol),0.5551074088401289
SNU-216,57519531,2.0798230337162296
BT 112,44489675,3.682584405613984
B-CPAP,135421197,1.178862358485884
Hs 611.T,16013152,4.086907930455013
SNU-216,crizotinib-PLX-4032 (2-1 mol-mol),2.2475648646248025
NCI-N87,24951314,0.3588892807295563
Hep 3B2.1-7,54618771,-0.219926675598239
YD-38,23725625,6.081880019673405
TE-14,navitoclax-sorafenib (1-1 mol-mol),2.6278003982474787
GOS-3,57519531,1.810044257027968
SNU-1077,374536,4.4212076979679305
YD-38,135398516,1.5709585782681432
YD-8,49766530,-2.0839194852213976
B-CPAP,44632017,0.6151309315152113
JHUEM-7,navitoclax-MST-312 (1-1 mol-mol),0.7965231198258467
TE-14,2729026,3.0361749345722626
NCI-N87,89928392,0.9456157368763274
TE 441.T,24978538,2.0567927172310028
TE-14,107985,-3.6830592516934697
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
KO52,10231331,-1.770944789563704
NCI-N87,444795,4.906796024963376
SNU-216,54626689,5.715021569760538
JHUEM-7,25150857,3.01223903868364
TE 441.T,54454,3.576402500194246
TE-14,9926054,1.5943832140078456
B-CPAP,57519531,4.004957994093651
SF295,docetaxel-tanespimycin (2-1 mol-mol),-1.3504710645288256
SNU-1077,5282054,4.106676604062682
YD-38,11964036,-0.0659792164554548
SNU-1077,vorinostat-navitoclax (4-1 mol-mol),1.5809730916962734
YD-8,49867926,4.297673709287735
KO52,carboplatin-etoposide (40-17 mol-mol),3.309104191597652
JHUEM-7,72193861,0.706328795322279
YD-8,4788,6.071994479446302
YD-8,selumetinib-tretinoin (2-1 mol-mol),6.635581773153188
SNU-216,44607531,1.0987283628876423
OE33,5287620,-1.0908956094988789
Hs 611.T,11494412,-0.0466996238947274
SNU-1077,6918837,-2.0302065892211916
NCI-N87,3815108,3.1427265495234513
YD-38,3825829,3.4785077609672057
YD-38,selumetinib-tretinoin (2-1 mol-mol),0.1336494168228399
YD-8,54678924,2.5377672134217435
KE-39,24775005,3.7793317686622903
L3.3,crizotinib-PLX-4032 (2-1 mol-mol),2.765628359334359
YD-8,11222830,1.0279037219326927
SK-MEL-28,11152667,4.172027715871216
SNU-216,decitabine-navitoclax (2-1 mol-mol),2.181603295226871
SF295,navitoclax-birinapant (1-1 mol-mol),2.8120952021298526
YD-38,10427712,4.8867086879497545
KE-39,16725315,3.5990851811512403
SK-MEL-28,9926054,3.4888277398466765
Hep 3B2.1-7,24772860,-2.4877708229560698
GOS-3,9936388,2.12022290506738
YD-8,navitoclax-gemcitabine (1-1 mol-mol),1.3225182449197073
NCI-N87,10410894,1.83413876253328
TE 441.T,65064,3.1243900665572384
Hs 611.T,10302451,2.003286438841951
SNU-216,10427712,3.9705426888084214
KO52,selumetinib-JQ-1 (4-1 mol-mol),-1.2096541805376022
B-CPAP,5311281,2.231361409647184
Hs 611.T,6918638,0.1647262246694485
YD-38,104842,-1.5188595036514532
BT 112,4788,5.347186098301908
JHUEM-7,322968,2.718046514914308
KE-39,9967941,2.56940062250581
Hep 3B2.1-7,2828334,6.035830704503776
KO52,44185566,1.2667683963107288
GOS-3,25150857,1.9006273010690065
OE33,168313200,4.319769864025677
SK-MEL-28,4917,3.066656209778127
JHUEM-7,54613361,-0.8057680403927349
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
YD-38,10302451,0.2221462011029107
SNU-216,vorinostat-carboplatin (1-1 mol-mol),1.9524115972675864
YD-38,100016,6.21667674155364
KO52,262093,1.2878327274871448
YD-38,doxorubicin-navitoclax (2-1 mol-mol),-0.2530652341021826
JHUEM-7,82146,4.339540493770147
TE 441.T,426756,4.4195589542827864
SNU-216,11427553,3.0406962885554467
Hs 611.T,71304818,1.7643501549477851
TE 441.T,9911830,2.062678121502997
YD-38,5287620,-2.950057087169329
JHUEM-7,3854666,0.7941739350816123
SW1573,25150857,3.3863948467965717
JHUEM-7,serdemetan-SCH-529074 (1-1 mol-mol),2.0625230900739657
SNU-216,16038120,1.3117535051919935
KO52,9927531,4.721929704585103
KE-39,2126,5.971386354859058
SF295,73707398,1.6695998936889058
SNU-216,8515,4.27176731188738
TE 441.T,675434,4.157451635723815
Hs 611.T,73707398,-1.1602307486634975
YD-8,2126,4.624858365561851
SF295,49836020,5.953375339581455
Hs 611.T,54619267,3.857958253150578
SK-MEL-28,selumetinib-BRD-A02303741 (4-1 mol-mol),3.6626824854303086
B-CPAP,9840324,3.889396997757569
TE 441.T,navitoclax-PLX-4032 (1-1 mol-mol),0.6188347089805195
KE-39,637858,2.1285067674718374
TE 441.T,119607,5.682891982302103
SNU-1077,11404337,-0.4720370259421129
L3.3,452548,-0.800912327932342
B-CPAP,BRD-K27188169,4.5022536360254986
YD-8,4477,1.1292057160395828
BT 112,135421197,2.023572470173789
KE-39,navitoclax-MST-312 (1-1 mol-mol),0.6605550109712996
KO52,136227924,2.4006650771153923
TE-14,2949965,3.398761439739322
SK-MEL-28,3503,2.655926478699229
BT 112,5746,-0.397041971069554
BT 112,11494412,1.153463963183282
BT 112,16736978,2.096742119081054
YD-38,46398810,2.405298564513697
SNU-1077,4477,-1.0120620923671768
KE-39,5329102,2.0429162006260566
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
YD-8,11167602,2.315498397427602
B-CPAP,46191454,1.9154724168312085
B-CPAP,216345,4.206842261809917
JHUEM-7,selumetinib-BRD-A02303741 (4-1 mol-mol),4.810620689703725
Hs 611.T,10184653,0.97935180213632
TE 441.T,44589607,-0.200979078237225
KO52,400769,-1.2212933891917823
OE33,10296883,3.414380068882816
TE 441.T,11152667,-1.20408962070059
L3.3,3825829,3.356100526361819
Hs 611.T,56649450,1.2987449899856396
SW1573,126941,-1.0305779796426808
B-CPAP,100016,6.506572981316216
TE 441.T,19582717,3.7615233646109134
SNU-1077,JQ-1-navitoclax (2-1 mol-mol),0.5291421057412008
TE-14,44462760,4.457889131283873
OE33,46926350,-4.3039480497161335
Hep 3B2.1-7,9936388,1.3594944323688356
Hep 3B2.1-7,216345,4.196710950743181
YD-8,4261,2.40406466094162
GOS-3,637858,2.327239346274226
BT 112,2749,-0.764976916755987
SNU-1077,3854666,3.1308724985393255
B-CPAP,8515,3.305571052734727
KE-39,24978538,-0.2539808437524994
Hs 611.T,72199292,0.7741467404813812
SNU-216,54619267,4.091283104128005
NCI-N87,44202524,1.5092428544055756
KE-39,16722836,1.1586688757429142
L3.3,2746,3.431089753490113
TE 441.T,24856436,-0.2818059712724387
KE-39,452548,2.893764704485056
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315
KE-39,159324,3.584614004631027
NCI-N87,54649381,3.6397596564561487
GOS-3,409805,3.6304586799066967
KE-39,navitoclax-birinapant (1-1 mol-mol),0.0912747000919814
Hs 611.T,54613361,0.3967700579974597
KO52,9933475,1.739633318252188
TE-14,49793307,-2.215277168072713
KE-39,4521392,3.820577252344618
KE-39,25150857,2.5807263536749607
OE33,11955716,-2.0650128232823364
KE-39,17759555,3.152380592963218
GOS-3,25102847,2.4743602573672585
GOS-3,123631,3.414822398468875
L3.3,11485656,2.040790548836277
L3.3,36314,2.044128713808568
YD-8,2841722,4.733958021687277
YD-8,11977753,-2.68445470248679
YD-8,9926054,2.068126295394322
L3.3,25150857,3.2841029560324246
KO52,10113978,2.712870801438083
SNU-216,135875424,3.0610068784934885
TE-14,6918328,-0.3790829330672501
KE-39,65064,5.11272287356881
B-CPAP,25062766,1.9365359844600436
TE-14,12003241,-0.291419040743519
L3.3,100016,6.042484334243821
B-CPAP,3815108,2.49779395406492
KE-39,54618771,0.8543301924142261
KO52,123631,3.1226138864158903
SNU-1077,5278396,3.261977388263693
KE-39,156414,4.025830312298652
SNU-216,12001922,1.864153419618113
BT 112,637858,1.3708104354326625
SK-MEL-28,51037431,2.176317274658726
L3.3,4096211,2.2417011569185763
SF295,42642645,1.0127855753280748
OE33,613753,3.411474615027808
JHUEM-7,984333,1.1979599882445968
SNU-216,135423438,1.816422149531831
SNU-1077,123631,2.741510645866922
YD-8,135440466,0.98060002871852
Hs 611.T,227681,1.8195839391673536
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
GOS-3,322968,4.726179979484062
Hs 611.T,5281321,-4.842109783490502
KE-39,54649381,3.8116402123721578
GOS-3,SNX-2112-bortezomib (250-1 mol-mol),-0.0982198118702868
YD-8,71304818,2.9643287808222025
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
TE 441.T,11175137,1.619787178375928
SNU-216,3025944,4.138947236971317
TE 441.T,49836020,3.964912597269393
KE-39,2858523,2.690923627236344
KE-39,4917,2.6993900205990866
SW1573,3384730,1.5192292760027193
KO52,25154868,5.228534318622467
KE-39,JQ-1-vorinostat (2-1 mol-mol),0.4197456531616845
L3.3,1750826,0.7937145951404149
TE-14,676352,2.265036527357979
TE-14,25227462,0.6406425918845066
YD-38,53232,2.21843429082388
Hs 611.T,11612883,2.2755649908010263
BT 112,135398516,1.757671095611884
OE33,135440466,3.0626542754151744
YD-8,6852167,2.601588502277786
SNU-216,11625818,3.7247477006141985
NCI-N87,11683005,3.6426598339920297
SNU-216,227681,4.069937917101889
SF295,71304818,2.8074932440890352
TE-14,216239,2.5939682730829188
SNU-1077,637858,2.311785541808234
GOS-3,53392493,2.045340494319027
GOS-3,6914657,-2.554831261851343
Hep 3B2.1-7,984333,0.6518370088753827
JHUEM-7,navitoclax-sorafenib (1-1 mol-mol),1.8815532041113092
SNU-216,11485656,2.7250861397389463
YD-8,9927531,5.007831795650313
YD-38,5460769,0.587016845611175
KE-39,selumetinib-BRD-A02303741 (4-1 mol-mol),5.809798702623815
YD-38,44589607,2.736235168586606
YD-38,6918837,-1.9603786582931453
B-CPAP,9903786,2.2781712830719316
KO52,16722836,0.8284373841019596
KE-39,3854666,4.449857131704124
JHUEM-7,439501,-3.5721158792487646
Hs 611.T,24964624,-0.7644006333245535
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
SK-MEL-28,168312962,-1.5398903743512435
TE-14,16722836,0.976659761466278
OE33,4378219,2.1039345864440433
TE 441.T,5311,1.6876547835303894
Hep 3B2.1-7,24951314,1.1281957792330906
L3.3,11626560,2.44177024695359
YD-38,10184653,-3.82777915318855
SW1573,3854666,2.927116287337192
GOS-3,119607,5.92961228058127
B-CPAP,24753719,4.549431908166172
NCI-N87,4259181,-0.3128226187706996
Hs 611.T,12001922,0.9714328775162276
BT 112,3552672,1.4281271446672807
NCI-N87,44632017,1.346248550233927
B-CPAP,445455,3.02228700826093
B-CPAP,ISOX-bortezomib (250-1 mol-mol),0.9973864966848812
KE-39,53495165,3.300789650083116
L3.3,10127622,6.808802938866309
B-CPAP,SNX-2112-bortezomib (250-1 mol-mol),0.3419783541511122
KO52,19582717,4.02566372539437
YD-38,selumetinib-BRD-A02303741 (4-1 mol-mol),1.726529060394152
YD-8,9936388,2.2646667902608724
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
TE 441.T,51039095,1.4475325378615844
Hs 611.T,24771867,0.1006087367285268
SNU-216,46398810,2.073816562442194
Hep 3B2.1-7,4261,3.51877017672355
SF295,44137675,5.032931190928139
TE-14,11955716,-1.565971579396732
YD-38,5282054,3.830335657875788
KE-39,24180125,2.8951506389407053
SK-MEL-28,24951314,3.07054519973718
Hep 3B2.1-7,9903786,2.792162090587101
SF295,46907787,3.23145207595968
SW1573,24951314,1.273840217876839
YD-38,5978,-1.9530397384298024
Hep 3B2.1-7,66577038,2.9908776065937497
KE-39,navitoclax-birinapant (1-1 mol-mol),0.0912747000919814
JHUEM-7,10410894,4.599491297270876
KO52,5328940,1.2036469066601834
Hs 611.T,702558,5.658700866639544
BT 112,2708,2.9934356963189304
Hs 611.T,11656518,-0.5876662235303677
YD-8,9866186,2.735650020983901
KE-39,25102847,2.4320728341381517
YD-38,44507138,1.6474032536163992
SW1573,4259181,2.0061423198913766
YD-8,387447,-3.9759575932823377
SK-MEL-28,3854666,3.183656457854027
TE 441.T,5291,3.789452149362892
NCI-N87,2841722,4.410495760007658
NCI-N87,984333,0.3233765721021273
BT 112,24772860,-3.2237648858189742
Hs 611.T,24785538,0.938467091147352
SNU-216,73707438,3.927379561891657
BT 112,16038120,1.1181319044078708
KE-39,11625818,4.741005492826134
BT 112,285033,-2.2130720086668836
SNU-216,16725315,4.715473045922443
KO52,25183872,-2.4696387093627807
TE-14,selumetinib-MK-2206 (8-1 mol-mol),2.2863932915997256
NCI-N87,654092,-0.6954721735465327
KE-39,3689413,-1.8420159541718293
SW1573,6610355,4.129027118562099
KE-39,46199207,2.43842073424698
L3.3,16725315,5.215482090576187
SW1573,16065773,3.287625611468905
TE-14,3025986,-0.4853927435927206
KE-39,9911463,3.415693188275342
KE-39,24821094,1.6802928572858271
NCI-N87,3543504,4.249309596150935
KO52,24180125,3.3572012584638613
Hep 3B2.1-7,6918837,-2.1140364415973005
OE33,107970,1.9682278614825048
SNU-1077,2945648,2.7051928991882073
B-CPAP,1750826,-3.823823351631485
KE-39,11175137,3.362137577301979
Hs 611.T,SNX-2112-bortezomib (250-1 mol-mol),-2.8445731465395023
Hs 611.T,53392493,1.8410371016257832
SK-MEL-28,441298,3.154659413422743
SNU-216,selumetinib-vorinostat (8-1 mol-mol),2.415634869676137
SNU-1077,2733487,8.302697103942196
KO52,3634881,3.08346578487488
L3.3,2874250,6.457091097770646
KE-39,126941,-2.7828178616251984
JHUEM-7,3062316,0.480363794433647
BT 112,252682,6.130098211071154
NCI-N87,navitoclax-pluripotin (1-1 mol-mol),-2.6023370603895337
TE 441.T,54618771,1.354234974700439
TE 441.T,49867926,3.93813153662813
OE33,4259181,0.9178629586058104
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
KE-39,46199207,2.43842073424698
YD-38,11178236,-2.848995889133555
YD-8,676352,2.488164336749702
GOS-3,168312962,3.853513662902144
KE-39,11257553,6.200460761986464
TE-14,11977753,-1.046506407642015
SK-MEL-28,11656518,2.5099458397006145
OE33,168312962,3.257297372441536
KE-39,44507138,1.957284753077253
NCI-N87,49793307,-2.95740399691262
SK-MEL-28,6918328,1.6260259804772523
Hep 3B2.1-7,400769,-0.6414390690663336
SNU-1077,452548,1.172143593642621
BT 112,tanespimycin-gemcitabine (1-1 mol-mol),-1.366722683150895
KO52,alisertib-navitoclax (2-1 mol-mol),-3.629170972120534
KO52,60700,-2.426926956892104
TE-14,11152667,0.6332718687769578
GOS-3,10302451,4.10350760632464
TE 441.T,73707398,2.754590712931621
L3.3,31703,-1.9667249709147607
OE33,selumetinib-JQ-1 (4-1 mol-mol),2.2373751377171938
KE-39,1566236,2.837512341107075
KE-39,49846579,3.0202206585589564
Hs 611.T,3384730,1.4112873627117273
B-CPAP,17759555,3.7290371728281944
YD-8,2733526,3.5062367586766836
B-CPAP,46199207,2.9698252348312963
NCI-N87,5460769,3.352422042402732
SNU-216,9868037,3.645721485009989
SNU-1077,168313047,3.2162291034503703
B-CPAP,654092,-0.163277958019971
KO52,9825149,1.8631876044655673
Hep 3B2.1-7,25262965,0.8423182993165146
SNU-216,selumetinib-PLX-4032 (8-1 mol-mol),3.8013199947022462
YD-38,JQ-1-MK-0752 (1-1 mol-mol),-3.746552719841539
KO52,54618771,1.4631554759036511
KE-39,9952709,5.01466122235801
JHUEM-7,9866186,0.4648370468543082
YD-38,17759555,2.700828571888378
KO52,322968,2.621400804192603
TE-14,119182,-0.544302547893501
SNU-216,24951314,0.6082856978526928
Hs 611.T,54618164,3.758252372543717
Hs 611.T,selumetinib-tretinoin (2-1 mol-mol),4.735509199758446
GOS-3,JQ-1-vorinostat (2-1 mol-mol),1.826489490547508
KE-39,71751553,4.448067406832394
Hep 3B2.1-7,89928392,1.396950134991398
GOS-3,11364421,2.246503341599216
NCI-N87,6918328,-0.6140119948836108
BT 112,1566236,1.551499234243426
Hep 3B2.1-7,6852167,2.3004574615198656
SW1573,53232,-0.4627324496874346
KE-39,11719255,3.4808501191509147
KE-39,navitoclax-pluripotin (1-1 mol-mol),-0.4984280760345316
OE33,135398516,1.655767694154752
KO52,2871966,-1.083117753240993
SNU-216,doxorubicin-navitoclax (2-1 mol-mol),-0.3226565332452495
SK-MEL-28,3025986,1.0141621518652342
KE-39,3136844,4.342976017638663
TE 441.T,3825829,4.967629977359632
L3.3,25126798,4.136340325033448
NCI-N87,navitoclax-birinapant (1-1 mol-mol),2.0087616801931953
SK-MEL-28,5311,2.6975320364679596
TE 441.T,navitoclax-gemcitabine (1-1 mol-mol),-3.872313979129053
SNU-216,53393127,3.716530473529192
GOS-3,9967941,3.548284114921986
KE-39,4917,2.6993900205990866
YD-38,119182,-0.4684316617425549
KO52,tretinoin-carboplatin (2-1 mol-mol),3.6636707238793624
OE33,24856436,0.7398013776341883
GOS-3,11175137,2.721300894926601
L3.3,5278396,3.196787051990793
SK-MEL-28,3038522,4.0586102618779245
KE-39,637858,2.1285067674718374
TE 441.T,5460769,2.227250069350157
YD-8,25105715,3.325556248276192
KO52,6252,-1.3570123270027108
SNU-1077,crizotinib-PLX-4032 (2-1 mol-mol),3.011939718165651
BT 112,10074640,3.3091637914687073
Hs 611.T,46191454,-0.9464406791011892
TE-14,9952709,2.981708246817344
OE33,42642645,0.9705663776809944
Hep 3B2.1-7,selumetinib-JQ-1 (4-1 mol-mol),1.068007517221539
JHUEM-7,4259181,0.2879228284005847
BT 112,1317464,4.14615022758794
Hs 611.T,11485656,1.370862895697381
Hep 3B2.1-7,navitoclax-pluripotin (1-1 mol-mol),-0.8139130493073924
B-CPAP,656346,-0.1957120455939244
NCI-N87,176870,1.1060804163410003
SNU-216,3689413,1.0802163076061988
SF295,11626560,2.404098314231099
SF295,969516,3.3546679619380564
YD-8,49850262,3.7509110667991736
L3.3,17755052,1.4516432874311858
TE-14,11364421,-5.823097598159696
SNU-216,11656518,1.6381880956311667
TE 441.T,11612883,1.6595645159053918
KO52,11626560,-0.7906152386558187
KO52,10410894,3.6577566389370304
L3.3,107970,2.7957953106701305
KE-39,9444,5.314846845399724
JHUEM-7,613753,2.971505518088734
TE 441.T,selumetinib-tretinoin (2-1 mol-mol),4.961039192171221
YD-38,5329102,2.015856396773705
SNU-216,53232,1.858905103984356
KE-39,100016,6.665188081944046
Hep 3B2.1-7,selumetinib-piperlongumine (8-1 mol-mol),2.251634802355752
GOS-3,44566777,1.372759140356778
TE-14,5460769,2.4898485363417917
SNU-216,10074640,3.344868705507218
YD-8,25262965,-1.542928389011739
JHUEM-7,JQ-1-navitoclax (2-1 mol-mol),-1.3593352546723596
GOS-3,60700,-0.2943345936745988
Hs 611.T,71751553,2.589968262099222
TE-14,24964624,2.246959171939491
B-CPAP,6918736,-2.2080588410094215
B-CPAP,6918289,2.3955979884135856
NCI-N87,60700,-1.3451868063168757
Hep 3B2.1-7,753704,5.157243531098819
YD-8,448949,1.587735779011906
KE-39,51039095,2.7316148787408427
SF295,126941,-0.9605474872122216
SF295,selumetinib-MK-2206 (8-1 mol-mol),3.90263595003992
Hep 3B2.1-7,446155,3.475346948597935
Hep 3B2.1-7,selumetinib-BRD-A02303741 (4-1 mol-mol),2.249491244384491
GOS-3,462382,0.0265721167554945
TE-14,4259181,-3.298060588196884
NCI-N87,11964036,0.5275056986755973
TE 441.T,24775005,2.980118551888832
SK-MEL-28,44607531,2.134976600780572
KE-39,5287620,-2.6517518735784495
GOS-3,6505803,2.171469842265414
L3.3,439501,-0.248470622878828
TE-14,5494449,3.33607935476747
KE-39,3465537,4.350124533164427
B-CPAP,9956119,1.850613025177622
GOS-3,6852167,4.136996914293619
Hep 3B2.1-7,10113978,1.4411484963843444
L3.3,159324,3.32597872906173
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
L3.3,72193861,1.4096427828350668
KE-39,3689413,-1.8420159541718293
SF295,2749,2.7004315966238757
KE-39,2828334,6.422070101852093
BT 112,675434,4.248539137201915
BT 112,selumetinib-JQ-1 (4-1 mol-mol),2.692883041543946
L3.3,12003241,-0.3315333583144895
KO52,46943432,4.605559929302298
TE 441.T,11238147,2.1227999933306663
NCI-N87,119182,-3.621619524843969
B-CPAP,docetaxel-tanespimycin (2-1 mol-mol),-5.525522845954553
JHUEM-7,753704,4.187441379139962
KO52,44819697,-2.4820963764953707
SNU-216,67156097,5.132066784918468
YD-8,11455910,2.3608003231552717
Hs 611.T,216468,1.31218613653852
KE-39,10113978,4.138536532448647
NCI-N87,6917907,-5.514556019160177
KE-39,9927531,6.019185228760376
Hs 611.T,135421197,0.2639365806220374
KE-39,10296883,3.8123665461282545
KE-39,124202324,2.527643739765998
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
Hep 3B2.1-7,168312962,0.9059799349779004
JHUEM-7,285033,-3.151788648314247
Hs 611.T,1716436,1.70748477144168
SK-MEL-28,JQ-1-carboplatin (1-1 mol-mol),4.173721186553183
NCI-N87,5470400,-1.6354434063399317
KE-39,2871966,0.1277928781522726
YD-38,4917,3.089558829015848
YD-8,4521392,4.941173654959916
Hep 3B2.1-7,24785538,0.8305444997148282
Hs 611.T,5978,-6.322089417024284
B-CPAP,5460769,4.36425483182296
KO52,6918837,-5.47001608437254
TE 441.T,374536,-8.101704814309118
SNU-216,66577038,3.122632953988705
TE 441.T,10427712,3.217027471903541
TE-14,3503,1.5755695310571736
KE-39,119607,4.996260341403349
YD-8,6610216,4.600166157453743
YD-38,66577038,2.4029252471110514
SK-MEL-28,selumetinib-vorinostat (8-1 mol-mol),1.183939454839272
KE-39,135421197,0.9510973278490732
BT 112,9933475,1.5933394130611254
SK-MEL-28,10385095,3.2557901504831306
TE 441.T,5426,4.225704142481899
GOS-3,969516,3.7661148918393823
NCI-N87,60750,-4.457686499395666
SK-MEL-28,285033,0.2575434442384768
TE-14,10127622,7.546370019698208
NCI-N87,135999136,4.294797881105147
JHUEM-7,selumetinib-PLX-4032 (8-1 mol-mol),4.4422752684891025
SNU-216,BRD-A02303741-navitoclax (2-1 mol-mol),3.1738229754094496
SW1573,409805,6.568626512075582
NCI-N87,24753719,4.36387060101307
L3.3,25154868,5.156852655599311
BT 112,25262965,-1.8877634388627147
KE-39,5566,2.5519005230377574
KO52,2858523,3.055649072846991
SK-MEL-28,9911830,3.7902815277231663
B-CPAP,10184653,1.9021781585872557
GOS-3,doxorubicin-navitoclax (2-1 mol-mol),-1.4068563769280584
KE-39,969516,3.3665912825733773
Hs 611.T,16722836,1.175996278286737
SK-MEL-28,11178236,-2.69133483363241
KE-39,6917907,3.4636504669535215
SK-MEL-28,4788,5.8874743333158985
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024
SNU-1077,navitoclax-sorafenib (1-1 mol-mol),1.842498946009811
SNU-216,613753,3.1139728260488484
SNU-216,439501,-2.844909600692544
BT 112,11485656,1.9046121738712176
KE-39,44137675,4.4813975845381755
GOS-3,46199207,3.558565735467231
SNU-1077,10113978,1.921238205807409
KE-39,327653,3.149148027412197
SK-MEL-28,doxorubicin-navitoclax (2-1 mol-mol),0.6137176516261809
Hep 3B2.1-7,71304818,2.2516759869447136
YD-8,9903786,2.667696713101927
Hep 3B2.1-7,656346,3.5555089253894026
KE-39,selumetinib-MK-2206 (8-1 mol-mol),2.7514173486302544
SW1573,119607,3.675967979424282
OE33,44491742,5.719021846419829
SF295,57519531,1.705733255061587
Hs 611.T,6610216,4.160309523547129
TE 441.T,4261,0.6291431544827749
SF295,17755052,2.9611170281076613
YD-8,6918736,6.385524567287694
TE-14,25126798,3.739030053617067
YD-8,decitabine-navitoclax (2-1 mol-mol),3.994685595112437
B-CPAP,JQ-1-UNC0638 (2-1 mol-mol),3.2358489904077974
KO52,57519531,1.8439662124610676
GOS-3,73707398,2.285638026393688
SNU-216,25262965,0.7721701443612651
SF295,36462,2.0611349093400926
GOS-3,1566236,2.0611902912111013
Hs 611.T,44632017,0.5782997876733177
YD-8,6610355,5.07814691981883
KO52,10127622,0.9080853553527672
SNU-1077,5328940,2.132939036215286
SNU-1077,selumetinib-navitoclax (8-1 mol-mol),2.57437827780129
SW1573,73707398,2.4757839790774123
JHUEM-7,5738263,2.3845993272884027
SNU-1077,675434,5.370968264478288
BT 112,3854666,0.1986005618410543
GOS-3,16736978,3.431687375441577
BT 112,selumetinib-BRD-A02303741 (4-1 mol-mol),5.118428363435484
GOS-3,5311,2.439895727975568
Hep 3B2.1-7,24856436,0.5999508460122013
SW1573,9926054,3.1618263718643513
KE-39,969516,3.3665912825733773
BT 112,54618771,1.3381626551406447
SNU-216,16720766,0.8809846524435709
NCI-N87,6918736,-4.217256713101777
YD-38,5281321,0.675198030693185
L3.3,409805,5.10307456372432
L3.3,73707398,1.2944525096848456
NCI-N87,6252,-1.400414082532842
OE33,56946209,-5.317816942016512
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
KO52,462382,0.1087271140115314
L3.3,44486219,4.220339607908531
JHUEM-7,9903786,1.8726211891462523
Hs 611.T,44566777,0.4297176154550633
KE-39,2828334,6.422070101852093
TE 441.T,3081361,2.6142066328682185
OE33,11222830,1.7569805272585186
KE-39,6852167,2.989668764419295
OE33,3025944,4.2858612810653005
TE-14,11455910,0.8853432614856256
TE 441.T,15547703,2.8355011762775417
OE33,selumetinib-UNC0638 (4-1 mol-mol),3.180599015528826
YD-38,3854666,0.4955683731799087
TE 441.T,6505803,-1.628255920679656
Hs 611.T,17755052,-0.9587455713064612
Hs 611.T,2945648,1.0461407300321148
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
L3.3,vorinostat-carboplatin (1-1 mol-mol),3.49555187429186
KO52,24978538,-3.3415990839313383
NCI-N87,10184653,-5.297353828317573
GOS-3,10074640,3.609406723020456
KO52,46907787,0.3317813334576328
BT 112,426756,4.127837359215836
Hep 3B2.1-7,5282054,4.195654910352121
OE33,53232,3.686167488343025
SNU-216,46224516,2.6643084527718286
TE-14,4378219,4.491971036424627
SNU-216,10302451,1.428515381214255
SK-MEL-28,JQ-1-navitoclax (2-1 mol-mol),2.6430063634081877
YD-38,54143018,-0.7993708531403734
B-CPAP,19582717,5.278680589390403
Hep 3B2.1-7,carboplatin-UNC0638 (2-1 mol-mol),4.182961554277728
L3.3,3503,3.0907711446371
SNU-216,71304818,2.736477931679623
JHUEM-7,selumetinib-tretinoin (2-1 mol-mol),5.22880395365309
NCI-N87,JQ-1-vorinostat (2-1 mol-mol),-1.1800761907808068
NCI-N87,52947716,-3.473486168283201
GOS-3,selumetinib-PLX-4032 (8-1 mol-mol),5.581542151485772
KE-39,11485656,2.227722528153515
KO52,navitoclax-PLX-4032 (1-1 mol-mol),-2.6384653458181
BT 112,9866186,-0.3818998278365069
B-CPAP,2708,4.8825948055163835
NCI-N87,57519531,1.4365599080949227
TE-14,3384730,1.7890988863095236
OE33,136227924,2.987067512543954
BT 112,52947716,-1.8173903777090337
Hs 611.T,3552672,1.4860409791595686
Hs 611.T,46398810,1.3540621284715122
SNU-1077,44241473,4.729716696280308
KE-39,11175137,3.362137577301979
SK-MEL-28,42642645,1.6429344569807516
L3.3,656346,0.8770519202421161
JHUEM-7,71304818,2.591667999650727
SNU-216,2949965,2.568714959584875
NCI-N87,11152667,-0.2953714197447944
TE 441.T,72199292,4.464736678161801
KO52,119182,-4.453173140639883
NCI-N87,54454,3.669804409798402
SK-MEL-28,11222830,1.7175848193972325
YD-8,navitoclax-sorafenib (1-1 mol-mol),2.877352629511259
YD-8,89928392,1.3533989026988826
Hep 3B2.1-7,409805,6.120261984134354
L3.3,25262965,-0.71498955679679
YD-8,2949965,3.0609642629133083
SNU-1077,9936388,2.8901032001990954
SNU-1077,387447,-4.3711527711694185
Hep 3B2.1-7,2858523,2.0978501918047026
TE 441.T,135659046,3.3291028889346066
YD-8,16065773,3.197824930494566
YD-8,24772860,-1.4663739289558224
JHUEM-7,crizotinib-PLX-4032 (2-1 mol-mol),1.0528686048988958
SNU-1077,25183872,-0.8765596964039514
SF295,11364421,2.6561083557326195
TE 441.T,168312962,4.12920079144077
SNU-216,9927531,4.928854217015946
YD-8,10427712,4.808988209021756
SK-MEL-28,135875424,5.515491244041513
Hs 611.T,50905018,4.49675699957726
YD-38,6505803,-1.6031716801172209
SNU-216,11222830,1.014411889305477
Hs 611.T,3062316,-1.6126258430359726
SNU-216,24180719,2.848757619364884
Hs 611.T,24797083,1.1787569066925891
JHUEM-7,65064,5.3351573700269
KE-39,1242560,3.7605808784005625
YD-8,11625818,4.711571191575779
SK-MEL-28,10074640,3.547996724828609
KE-39,JQ-1-MK-0752 (1-1 mol-mol),1.6726733394588664
SF295,vorinostat-navitoclax (4-1 mol-mol),2.085594905196653
OE33,44607531,1.334237424525441
SNU-1077,4917,3.55336300375808
B-CPAP,31703,-0.7132300755185688
TE 441.T,16725315,3.088519674994755
KE-39,9868037,3.621529869698051
SNU-1077,navitoclax-PLX-4032 (1-1 mol-mol),4.284771622261252
SF295,piperlongumine-MST-312 (1-1 mol-mol),4.017972735534295
NCI-N87,46199207,2.9512504868324565
KO52,carboplatin-UNC0638 (2-1 mol-mol),3.4121259588832538
BT 112,4378219,2.0035787751838057
B-CPAP,3503,2.2508501900255213
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
SW1573,11427553,4.057369297610019
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248
BT 112,6914657,-2.2779536161879044
YD-38,selumetinib-decitabine (4-1 mol-mol),0.0898560222901214
KE-39,24753719,4.8851025960405074
TE 441.T,53392493,4.098968257206057
Hs 611.T,54618771,-1.6189149218844685
SK-MEL-28,5281321,0.8314477877227711
Hep 3B2.1-7,44507138,4.806183926619429
SF295,17759555,3.956575115387604
KE-39,9935249,3.082096285966509
B-CPAP,25150857,2.3279804239835067
TE 441.T,3503,3.456719899712937
BT 112,89928392,0.5920656256018224
GOS-3,11625818,5.199223686092666
JHUEM-7,66577038,3.1107179638386175
BT 112,46199207,1.816162023423103
KE-39,56649450,4.017414806264263
KE-39,46907787,0.5111190203360444
GOS-3,49766530,-1.0492623989714644
KO52,53392493,1.8648519897041975
YD-38,selumetinib-MK-2206 (8-1 mol-mol),1.040437108024878
TE 441.T,52947716,-7.7315592116789
YD-8,3676137,3.885314783218408
GOS-3,11178236,0.4111622236569117
SNU-1077,9903786,3.350516769184116
TE 441.T,navitoclax-birinapant (1-1 mol-mol),-0.404464101851955
YD-38,3503,2.7991916820325136
YD-8,5287620,-1.9715121639799928
Hs 611.T,11507802,0.6290266602554199
SNU-1077,12003241,-1.4220834787906382
TE 441.T,15953870,3.627702948690547
BT 112,JQ-1-UNC0638 (2-1 mol-mol),2.705069065658094
YD-8,24901704,3.1814238875583585
NCI-N87,3025944,4.18610508240951
SW1573,54454,1.176648172779268
YD-38,702558,5.795263485649205
TE-14,JQ-1-navitoclax (2-1 mol-mol),0.0318613867060366
SNU-216,54618164,4.432293411615551
KO52,104842,-5.71337214933571
NCI-N87,2828334,6.0279909292271165
KE-39,decitabine-navitoclax (2-1 mol-mol),1.2325731360672605
L3.3,676352,2.5109454639647373
TE 441.T,53232,3.927095243981295
TE 441.T,44566777,-1.2682865822917189
Hep 3B2.1-7,17755052,1.7931208619651735
B-CPAP,3081361,3.333044863505124
Hep 3B2.1-7,3825829,4.187718301348179
KE-39,navitoclax-gemcitabine (1-1 mol-mol),0.4577354128073778
KE-39,24180719,4.116999771545502
TE-14,176870,1.5270121681279905
SNU-216,1750826,0.4145288494296801
SK-MEL-28,107985,-2.7940500151600296
JHUEM-7,23635314,-4.250939063965602
SNU-1077,54613361,5.090510226411371
SNU-216,6436223,-5.776381478312599
KE-39,4096211,4.989230592504944
TE 441.T,246676,4.366193760638462
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
SW1573,168313200,1.7327341920391253
TE 441.T,11317348,4.029228044972443
YD-38,9915743,-2.811758020987732
L3.3,753704,5.0689754221003875
YD-8,10302451,2.519210773741685
B-CPAP,decitabine-navitoclax (2-1 mol-mol),0.863745737663407
B-CPAP,4096211,1.3547168629560964
TE 441.T,156414,0.839328879560188
OE33,ISOX-bortezomib (250-1 mol-mol),0.4854080775005868
KO52,6438330,1.0398804577388443
SNU-216,46191454,0.776571208563394
SNU-216,6914657,-4.877986434653472
B-CPAP,4259181,0.2789779013360439
YD-38,10074640,2.9234644137530448
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
KO52,6918328,-1.4981845438810923
OE33,17755052,1.329278841200886
BT 112,navitoclax-sorafenib (1-1 mol-mol),1.1762931149119242
L3.3,5566,3.1406901276995094
BT 112,5278396,3.7905260034746218
Hep 3B2.1-7,BRD-K13185470,4.484971730521959
NCI-N87,1641662,2.907963520285112
SNU-1077,11222830,1.922347947337687
TE 441.T,navitoclax-MST-312 (1-1 mol-mol),0.3966866713301855
TE 441.T,11657048,4.303158298953813
TE-14,alisertib-navitoclax (2-1 mol-mol),3.1926120569177305
Hs 611.T,11626560,0.7873376297842944
YD-38,11497983,4.3604481340224
SNU-1077,5287620,-2.139811632813461
TE 441.T,6610355,3.6430841955039375
OE33,44493528,4.497258048563181
YD-8,107970,2.31722941739338
Hs 611.T,16659841,3.0693508217497936
SNU-216,24748573,1.6786194756017438
TE-14,23635314,-2.563783577017973
OE33,crizotinib-PLX-4032 (2-1 mol-mol),1.49539015166903
SNU-1077,24180719,3.4105724970727302
Hs 611.T,71680916,3.9888572389737114
BT 112,216345,1.4586490487599502
TE 441.T,10410894,2.617207939173619
NCI-N87,4917,2.911504588829893
YD-38,135398738,5.078320133426464
B-CPAP,375860,-0.8507879875115774
GOS-3,107970,2.255442380434802
NCI-N87,72193861,-0.2047514956394879
KO52,3689413,-4.063517257373306
YD-8,42611257,3.19679980391278
KE-39,24180125,2.8951506389407053
JHUEM-7,piperlongumine-MST-312 (1-1 mol-mol),1.1461002616382592
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
B-CPAP,selumetinib-MK-2206 (8-1 mol-mol),4.4400365262321175
GOS-3,selumetinib-UNC0638 (4-1 mol-mol),3.7794346913779577
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
B-CPAP,3038522,3.5963516655253907
SF295,637858,2.706804834358429
SF295,5284329,5.188047752910472
SK-MEL-28,71304818,2.250424055187842
KO52,25227462,1.3400451170529613
SF295,72193861,3.9622997215908087
KE-39,119607,4.996260341403349
KE-39,9911463,3.415693188275342
Hs 611.T,9825149,1.5292855639155298
GOS-3,49793307,-1.7592424650384757
YD-38,4096211,0.8582996852316679
Hs 611.T,10296883,2.1070249605904574
TE-14,11234052,5.269902194419078
B-CPAP,9826308,0.1917945613788681
OE33,5460769,3.7320924588923465
BT 112,2729026,1.695580673596315
TE 441.T,25062766,1.8861185060010517
SNU-1077,16725315,4.11344687119358
YD-38,5311,1.7266594401614792
BT 112,carboplatin-etoposide (40-17 mol-mol),1.4555391384046878
TE-14,322968,4.83635080811504
JHUEM-7,15953870,4.009699489789049
Hep 3B2.1-7,selumetinib-vorinostat (8-1 mol-mol),2.071849268804795
Hep 3B2.1-7,638278,3.5818606755202387
B-CPAP,5281321,-1.80536114011693
SNU-1077,448949,1.5791911231397144
YD-38,1750826,-0.2473780942075642
YD-38,5311281,4.380428486061311
KE-39,ISOX-bortezomib (250-1 mol-mol),0.8981560210811207
TE 441.T,11364421,1.5849770445720046
JHUEM-7,56963564,-0.4105683890675542
TE-14,51039095,3.4231923727642934
BT 112,selumetinib-vorinostat (8-1 mol-mol),2.3775465177087063
TE-14,12001922,2.3151035394403916
JHUEM-7,10302451,1.7373663186818131
YD-38,5328940,-0.0056077388228541
GOS-3,2113511,5.9542710024554
SK-MEL-28,73707386,4.4832416514767335
YD-8,4378219,2.399532986422255
GOS-3,salermide-PLX-4032 (12-1 mol-mol),5.528835129082399
Hs 611.T,11214940,0.9743579305468372
Hs 611.T,1242560,4.168507953483356
L3.3,119182,-1.782056546640076
KO52,16659841,2.257439927508027
L3.3,44185566,3.1226996854840836
TE 441.T,135421197,0.4096443090762519
TE-14,10184653,-1.7986710500950338
SK-MEL-28,crizotinib-PLX-4032 (2-1 mol-mol),1.1574831287891294
KE-39,135984461,4.3782777468955745
JHUEM-7,135398744,6.411220982649173
Hep 3B2.1-7,11609586,3.172957070034702
YD-8,selumetinib-navitoclax (8-1 mol-mol),4.335023783206367
YD-8,702558,4.53955953938176
YD-8,64971,4.450912685829993
KO52,10302451,3.962918157421803
TE-14,2945648,3.3536514379865596
SNU-216,6610355,4.747572050551597
SNU-216,11178236,-4.968620812635702
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
TE-14,11238147,2.2805487405204397
TE-14,selumetinib-navitoclax (8-1 mol-mol),3.149058873033737
SNU-216,navitoclax-gemcitabine (1-1 mol-mol),1.3591320236662334
Hep 3B2.1-7,9549297,3.612635734062334
NCI-N87,156414,-4.435299577962505
Hs 611.T,375860,-0.3365508956402739
KE-39,25183872,0.9093858643796752
BT 112,54619267,3.469133833703133
SNU-216,6450551,3.3089706641589887
SNU-1077,9907093,4.090287424165682
TE 441.T,444795,4.4291459900533185
SK-MEL-28,16722836,3.336821512402233
TE 441.T,navitoclax-pluripotin (1-1 mol-mol),-1.1792340009266518
KE-39,10385095,1.3052459079941114
KO52,439501,-3.705469726802315
SNU-1077,1242560,3.950980625831431
TE-14,31703,-0.3184881435605857
JHUEM-7,11609586,1.0506407698142153
TE-14,5281321,-2.027409379087563
TE 441.T,23725625,5.29244610855438
Hs 611.T,4917,2.7287652733771157
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029
KO52,46191454,1.8283467695557307
YD-38,9866186,1.1653654970339402
YD-8,3038522,3.692005573373659
Hs 611.T,11234052,3.914558100850381
Hs 611.T,tretinoin-carboplatin (2-1 mol-mol),4.0918925815927585
GOS-3,54619267,4.509336729831847
JHUEM-7,25195348,3.048899669301698
Hep 3B2.1-7,89183176,5.237319789926979
TE-14,44566777,1.206992079610698
KO52,tanespimycin-gemcitabine (1-1 mol-mol),-1.9669297663564216
KE-39,11964036,1.1014936748281658
JHUEM-7,25102847,1.6787689105881445
SNU-216,26596,-1.178501170162628
SNU-216,9915743,-0.7074992417120266
TE 441.T,241158,4.026754207652904
OE33,400769,-1.041750401680879
GOS-3,16722836,1.9168472063673057
YD-8,241158,4.108189803137544
BT 112,44607530,0.8844189369301123
SNU-216,5470400,1.1191844243922604
TE-14,11427553,3.380820340782394
OE33,135984461,4.2867065871619445
YD-8,568763,0.5213428887941817
Hs 611.T,44202524,0.9839909825075092
SNU-216,2858523,3.0909848672396847
SNU-1077,selumetinib-JQ-1 (4-1 mol-mol),1.9000830670563744
YD-8,5311281,1.1979218299648091
KO52,23635314,-5.1824728926411945
TE-14,10302451,1.496270675992236
Hs 611.T,135398516,0.8524576808653034
L3.3,54613361,-0.6336215633441857
SW1573,5287620,-0.7347028317725576
KE-39,72193861,3.4588346249762534
SW1573,54678924,1.9184875438403524
BT 112,5291,3.7853178637094262
NCI-N87,2708,3.9537199090854673
YD-8,60750,-0.3003196445505364
B-CPAP,241158,3.71370211344078
Hs 611.T,73707371,4.8158547045226605
B-CPAP,11238147,2.5075756320642197
BT 112,51039095,3.5175679175043437
KE-39,11222830,1.621114920928245
OE33,2749,1.9089382041131728
OE33,44185566,2.1268011513186784
L3.3,3038522,4.529448646795259
SK-MEL-28,216239,1.7130315366514903
BT 112,5280436,1.7556445184150695
YD-8,5282054,3.5246749530230996
SK-MEL-28,73707398,1.5724586228934123
BT 112,1242560,3.547587200922832
KO52,24753719,3.780928273062828
OE33,9915743,2.242004758711727
KO52,navitoclax-sorafenib (1-1 mol-mol),-1.8167289238614717
KE-39,2708,5.6188157628289925
SNU-216,piperlongumine-MST-312 (1-1 mol-mol),1.4822768997213789
B-CPAP,5329102,2.213007712516747
BT 112,36314,2.3721535443352013
L3.3,135411,0.9568641453583406
SK-MEL-28,119607,5.84656156074382
JHUEM-7,387447,-4.291919985887575
SNU-1077,10127622,3.7411047555393937
OE33,3062316,1.1582623844191091
L3.3,53495165,2.194695518305113
TE-14,9884685,0.211407416382201
OE33,5278396,3.859810746963463
KE-39,4788,5.3862218822227925
SNU-216,carboplatin-etoposide (40-17 mol-mol),3.92091665954738
SF295,11964036,4.121760093461903
SF295,navitoclax-MST-312 (1-1 mol-mol),1.0395557070559365
JHUEM-7,5278396,3.6718347402198614
L3.3,54618771,1.1558037208399272
YD-8,327653,2.805787909326678
L3.3,6918328,0.6582944097969459
JHUEM-7,25183872,-0.5022360342939903
NCI-N87,navitoclax-piperlongumine (1-1 mol-mol),-1.185093256857405
KO52,5329102,1.292288709166054
SW1573,4788,4.2029613497215195
KE-39,25126798,4.078237420502305
TE 441.T,216239,1.860492007917197
YD-38,selumetinib-JQ-1 (4-1 mol-mol),-0.3338451182587707
YD-8,126941,-2.1622153409475593
OE33,1566236,1.7756816603120642
YD-38,9903786,2.8631306213752103
SNU-216,5311,0.7634319585662608
Hs 611.T,25154868,4.657650960162059
SNU-1077,72193861,2.5371059791462276
KE-39,44566777,-1.173452220483867
JHUEM-7,3136844,4.744963133957354
TE 441.T,104842,-4.99363646788543
Hep 3B2.1-7,135421197,0.863862977673099
SK-MEL-28,9967941,2.8664024889360644
TE 441.T,46398810,1.584533251647572
YD-8,selumetinib-decitabine (4-1 mol-mol),5.345294149747968
OE33,285033,-2.4461062565957685
SNU-216,100016,6.2010021575017085
SNU-216,11404337,-0.7436610925810526
SK-MEL-28,53392493,3.0895758155089363
SW1573,89183176,3.862510153781557
SNU-216,JQ-1-navitoclax (2-1 mol-mol),1.0505128735313087
TE-14,11964036,0.758879773642312
KE-39,15547703,1.7331793905971136
BT 112,12001922,0.29456942425987
SNU-1077,11364421,-1.165916970108604
KE-39,421610,5.566154561454864
SNU-1077,119607,4.993790856001467
Hs 611.T,136227331,5.417316134562269
YD-38,11626560,1.7689072058111928
TE 441.T,9907093,4.1774168455492955
SK-MEL-28,10296883,3.852008110979885
YD-8,148198,-3.6074550947406863
KO52,11494412,-1.6308846276697513
KE-39,409805,5.860910954246773
KO52,selumetinib-decitabine (4-1 mol-mol),-2.793838380317763
SNU-216,4378219,1.8378393827834911
YD-38,44607531,0.7317750141243352
KO52,65064,5.236519181387881
YD-8,400769,-0.3423435574112426
YD-8,11656518,3.459144048405474
TE-14,52912189,0.4775769524845665
SK-MEL-28,11626560,2.4011846012689424
B-CPAP,11964036,2.6070306321605794
Hs 611.T,11955716,-2.6596703890647606
OE33,16725315,5.2011012279074755
B-CPAP,66577038,3.003282888618189
Hs 611.T,16741245,4.2114778773539365
YD-38,36462,2.856164296020876
JHUEM-7,23939,4.409621105076689
SF295,6917907,-4.699028520371913
YD-8,9956119,4.565288309306219
TE 441.T,2733487,6.33277661976693
KO52,5113032,4.556788931704779
SNU-216,1641662,3.8517544087442177
JHUEM-7,71466380,4.245325443887442
TE-14,46191454,2.3442901104587857
JHUEM-7,10296883,3.9492602271456065
SNU-216,JQ-1-vorinostat (2-1 mol-mol),0.1929169552366828
TE 441.T,vorinostat-carboplatin (1-1 mol-mol),3.7419271028225687
TE-14,71751553,4.6389654689543205
SNU-216,89928392,1.393246340046015
TE-14,46215462,1.938607091392658
KO52,4261,0.81751905802646
SNU-216,11497983,3.958297162007762
YD-8,984333,0.1177037476689329
TE 441.T,439501,-2.08185324910289
TE-14,9444,3.9425992179299354
TE-14,11494412,0.7185329040944464
L3.3,9907093,5.18450339753338
YD-8,208908,2.493595047729409
SF295,122327,5.77820322560813
BT 112,10410894,4.183510098776423
BT 112,73707398,0.9645515230778364
Hs 611.T,241158,2.625430045012582
BT 112,6252,1.5654239988674197
SNU-1077,1716436,3.6351328790412993
BT 112,11364421,2.5919971436685816
KO52,25150857,1.2754464236425893
SF295,6918837,-2.4914384138435466
GOS-3,5281321,1.1585317053456523
L3.3,2858523,3.1166554672991604
NCI-N87,327653,3.392428289503534
YD-38,9911830,2.6731616519017827
NCI-N87,11228183,1.1576925814137384
TE-14,2749,2.1595293138620235
BT 112,9887053,4.183653051540166
BT 112,11977753,-1.1582463708963373
SNU-1077,5311,1.163107558524668
Hs 611.T,24978538,1.8342555493439971
OE33,1641662,3.6587847982037087
GOS-3,49836020,5.837697611269413
YD-38,carboplatin-UNC0638 (2-1 mol-mol),3.201820043094107
YD-38,5284373,-0.9392180251426282
SNU-216,5351362,1.0978136193927086
KO52,JQ-1-navitoclax (2-1 mol-mol),-2.7248025297093825
TE 441.T,54639701,4.699929542545323
SNU-1077,65064,5.355049721805472
YD-8,24856436,0.1714275656823875
KE-39,135421197,0.9510973278490732
KE-39,451668,5.747427565955262
OE33,JQ-1-vorinostat (2-1 mol-mol),0.5031627227324542
B-CPAP,2749,3.278243683054658
TE 441.T,4096211,1.8114806464908777
Hep 3B2.1-7,selumetinib-UNC0638 (4-1 mol-mol),2.3003422063073993
KO52,11238147,3.117687457157308
SNU-1077,15547703,3.1840803381638114
B-CPAP,246676,4.303313026788405
KE-39,11455910,-0.1151631297895284
L3.3,135875424,3.974579804692541
KE-39,24772860,-2.1888261700101954
Hep 3B2.1-7,637858,2.0545585773513517
KO52,3025986,-1.0982287315100452
SNU-1077,46901937,3.8594891831371503
L3.3,2828334,6.9353242086196225
Hs 611.T,135928012,2.863158989308795
L3.3,44137675,3.3686484205760783
BT 112,11238147,2.441031684026273
L3.3,124202324,3.558321901620073
YD-38,375860,-0.9666963323879848
KE-39,navitoclax-MST-312 (1-1 mol-mol),0.6605550109712996
YD-38,322968,3.862943250611184
KO52,613000,2.3498906607917345
B-CPAP,24785538,1.7494023419831553
YD-38,46224516,2.9311306290981185
KO52,107970,1.5787465596439585
OE33,15983966,1.5108968468845063
B-CPAP,1716436,3.297193822138579
B-CPAP,10410894,1.808776781971955
GOS-3,5566,2.9543896668680287
YD-38,3634881,3.402679726514247
Hs 611.T,969516,1.8842702632758987
B-CPAP,219104,3.4420114060064084
TE-14,navitoclax-piperlongumine (1-1 mol-mol),2.8509611645469772
KE-39,JQ-1-MK-0752 (1-1 mol-mol),1.6726733394588664
SF295,702558,5.622003718276879
SK-MEL-28,72193861,3.1864248921579716
JHUEM-7,11175137,1.5119865026515042
JHUEM-7,11494412,0.4868890434989014
L3.3,67156097,-1.9530361511710264
SK-MEL-28,262093,2.757579366484628
KO52,4096211,1.0563203120780016
B-CPAP,navitoclax-piperlongumine (1-1 mol-mol),1.412897736514235
Hs 611.T,72193861,0.334004825230036
YD-8,46224516,2.247250860191912
OE33,46199207,3.627716303184323
YD-8,5281321,-0.940156182693946
Hs 611.T,23725625,2.1031489949937745
BT 112,322968,2.3735338663741192
JHUEM-7,navitoclax-gemcitabine (1-1 mol-mol),-2.6519969618816877
KE-39,52912189,1.824719595124253
KE-39,4261,1.550964775863626
SK-MEL-28,123631,2.412238783254816
Hs 611.T,44486219,3.678181271691003
L3.3,5281321,2.3391738882410813
Hs 611.T,2746,3.500782789021053
KE-39,alisertib-navitoclax (2-1 mol-mol),1.220028581355411
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
KE-39,selumetinib-navitoclax (8-1 mol-mol),1.4458639992966646
L3.3,10074640,3.5317966219825414
OE33,462382,0.892421497092823
Hep 3B2.1-7,11717001,1.6772570179474775
BT 112,navitoclax-pluripotin (1-1 mol-mol),-0.5614812394120877
JHUEM-7,6852167,1.350724801432494
TE-14,55508,4.487500956099637
JHUEM-7,navitoclax-PLX-4032 (1-1 mol-mol),2.564492004109999
KE-39,6184667,4.527415561727204
SNU-216,216468,4.120916530747277
Hs 611.T,67156097,-2.5654198026723205
KE-39,9915743,-0.5446321163343049
SNU-216,2828334,6.28449233238118
TE-14,54596558,4.372286949597904
TE-14,446155,3.6247355762230975
TE 441.T,24779724,4.334447186977638
Hs 611.T,24856436,-1.828552922418544
BT 112,16659841,3.2885249851469065
TE 441.T,25102847,1.567543065001864
OE33,25126798,4.081846745518951
YD-8,123631,2.5277035528733145
B-CPAP,439501,-2.790842155958922
TE 441.T,1641662,3.5521434775790137
BT 112,navitoclax-PLX-4032 (1-1 mol-mol),3.450284426710319
YD-8,20959075,0.9850613920765108
NCI-N87,3854666,1.2679317332294615
JHUEM-7,selumetinib-piperlongumine (8-1 mol-mol),2.711360769969603
OE33,5351362,2.0764063167480256
KO52,71751553,4.277873961450632
KE-39,navitoclax-piperlongumine (1-1 mol-mol),-0.2152074007553692
SW1573,71680916,4.0865163925225385
Hep 3B2.1-7,2729026,3.0424078117099222
TE 441.T,5113032,4.52213527523865
KO52,168313016,6.361073320142098
OE33,5328940,1.6046897075970823
Hs 611.T,navitoclax-pluripotin (1-1 mol-mol),-3.3446923826201305
SK-MEL-28,409805,5.67996042379304
YD-8,1716436,3.08383873816405
B-CPAP,446155,2.447419494553645
KO52,216239,1.4330207183659796
BT 112,4259181,0.804943209632055
TE 441.T,11404337,-0.8068289898007032
SF295,24772860,-1.4622312055585494
SNU-216,11167602,2.868305973285908
Hs 611.T,vorinostat-navitoclax (4-1 mol-mol),0.7220678906769918
TE 441.T,1566236,2.5728062109815335
B-CPAP,49850262,4.514828878116323
YD-38,2858523,3.190176264794637
KO52,11213558,1.2433594255309357
KE-39,67156097,5.133612548665442
OE33,25195348,1.5538095022055836
JHUEM-7,100016,7.782886537779513
Hep 3B2.1-7,16038120,-0.1087057777184335
SNU-1077,54618771,3.2500418975361347
SNU-1077,16038120,0.7532653564850753
Hs 611.T,65628,3.4812835817833183
KE-39,10410894,3.265010081493446
Hs 611.T,selumetinib-decitabine (4-1 mol-mol),3.479340016202746
KO52,3503,1.43557058273406
TE-14,5470400,-0.7410754005193283
JHUEM-7,9907093,2.991703648440714
KE-39,208908,0.8342774772445833
TE-14,126941,-3.8659791476469567
SNU-1077,219104,4.067743553544223
Hs 611.T,24772860,-2.634213469371387
TE-14,72193861,1.3253754048467814
KO52,11152667,-1.2056266729151108
TE-14,4261,2.2635095803242975
GOS-3,285033,-3.584870880949546
KE-39,56949517,4.944572827336268
SNU-216,107970,2.273840953303944
OE33,24785538,1.6498643953368404
SNU-216,BRD9876-MK-1775 (4-1 mol-mol),0.716748175884836
SNU-216,135999136,4.192311948123392
SNU-216,selumetinib-JQ-1 (4-1 mol-mol),1.428202673212368
TE-14,11497983,5.0471587627827885
TE 441.T,409805,4.133178498098395
BT 112,JQ-1-navitoclax (2-1 mol-mol),4.422337220171912
SNU-1077,3062316,-1.266961456390888
KE-39,25022340,3.482670600325695
KE-39,216239,3.497758173664419
YD-38,11222830,1.7512115538590254
SNU-216,11612883,2.937874366044306
L3.3,20959075,-2.193253801628986
Hs 611.T,selumetinib-MK-2206 (8-1 mol-mol),1.4654390706585927
KE-39,176870,3.2545182858471953
GOS-3,6918328,0.9203199321907972
YD-38,11404337,-1.21391516825444
BT 112,6450551,1.6386256333107696
OE33,2871966,0.1098909707191732
YD-8,49793307,-2.0913800226876704
OE33,6917907,-5.84340241991552
KO52,44486219,3.943229748737328
YD-8,4917,3.030228999243137
Hep 3B2.1-7,1641662,3.626354997928835
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
NCI-N87,24772860,-4.531203546207334
YD-8,57519531,2.847740049841003
KE-39,216468,3.956294605283877
YD-8,5746,2.1470622280203693
NCI-N87,44819697,-2.3159908553894932
YD-8,421610,4.166965318185822
SNU-1077,selumetinib-UNC0638 (4-1 mol-mol),4.639240284834
TE-14,400769,-0.918938158881206
L3.3,9911830,2.6705572013337195
YD-8,10127622,4.990106068897982
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
SNU-1077,selumetinib-vorinostat (8-1 mol-mol),2.452404658166729
SNU-1077,446155,2.117109617978931
JHUEM-7,2708,5.089129361016784
JHUEM-7,6918638,0.5834631364682521
NCI-N87,9903786,2.403456427338335
GOS-3,3081361,3.4367790874806015
SNU-1077,24964624,3.288685400990077
KE-39,9929138,5.605001473491643
KE-39,10231331,4.477976749120646
OE33,637858,2.678273035808489
JHUEM-7,24901704,3.3697536869757547
JHUEM-7,46926350,-4.455736364930407
TE-14,11396600,4.264622215416366
Hs 611.T,9911463,2.4472090052981104
SNU-1077,6918328,0.7978049082152888
BT 112,selumetinib-PLX-4032 (8-1 mol-mol),4.754861395931308
SW1573,23582824,0.5044187481506299
TE 441.T,46843906,3.455798223811649
TE 441.T,156422,3.746221772014217
Hs 611.T,navitoclax-birinapant (1-1 mol-mol),0.029722324205262
OE33,24901704,3.637339861643036
TE-14,3025944,4.5268699531424845
OE33,46398810,3.1246731128423275
Hs 611.T,327653,2.4585049182672525
YD-8,alisertib-navitoclax (2-1 mol-mol),2.5230617442547163
YD-8,44607530,2.028458223492934
SNU-216,6918638,0.1724072866575592
GOS-3,46843906,3.599659815664158
SK-MEL-28,11238147,3.8496418591646298
YD-8,168313047,2.079031997957418
GOS-3,1242560,4.3763601819059526
Hep 3B2.1-7,9915743,1.8474397407384695
SNU-216,11152667,-0.1857708456890594
OE33,selumetinib-BRD-A02303741 (4-1 mol-mol),3.869393320615985
SK-MEL-28,676352,2.519073281227085
YD-38,67156097,-1.8583293127593263
Hep 3B2.1-7,6450551,2.1727853612128394
Hep 3B2.1-7,3099980,3.523994590060619
SNU-1077,selumetinib-piperlongumine (8-1 mol-mol),4.266694584287947
TE-14,2828334,6.478723150548911
OE33,6918638,-0.1523417231642655
GOS-3,71466380,4.9000171792124
SNU-1077,9935249,3.485135676518772
YD-38,25126798,3.840262904092756
KE-39,4521392,3.820577252344618
NCI-N87,44137675,2.149558923433186
KE-39,JQ-1-UNC0638 (2-1 mol-mol),1.0358339499253313
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937
TE 441.T,56946209,-5.510252140122737
NCI-N87,44620216,3.650574309449747
L3.3,613753,4.077511547969464
KE-39,168312962,1.831477708522254
B-CPAP,15953870,3.3315928326884756
KE-39,6610216,4.077734835238396
JHUEM-7,selumetinib-JQ-1 (4-1 mol-mol),0.2978252775763586
Hep 3B2.1-7,SNX-2112-bortezomib (250-1 mol-mol),-2.3755334670867025
BT 112,BRD-A02303741-navitoclax (2-1 mol-mol),4.211528826599794
KO52,45279963,2.0128357488117694
YD-38,89928392,0.9805718232086792
SNU-216,5284616,3.778121920515909
KE-39,9967941,2.56940062250581
KO52,24772860,-1.0448231719232914
JHUEM-7,decitabine-navitoclax (2-1 mol-mol),1.3680027102230077
Hs 611.T,676352,1.6943733521846909
YD-8,25183872,-0.0392840886179466
B-CPAP,alisertib-navitoclax (2-1 mol-mol),-0.5748876741449156
B-CPAP,702558,4.9966107855915025
YD-38,25195348,3.0604251570911587
KO52,54618305,4.665930774043992
KE-39,262093,2.516325504276674
BT 112,156414,0.8059624645319847
BT 112,54678924,1.7826120968253354
TE 441.T,9915743,0.2395120621423657
JHUEM-7,1242560,3.5007407035321285
Hs 611.T,5746,-0.904729846900881
KO52,637858,1.0718331271712598
KE-39,46843906,2.072114054574841
TE 441.T,vorinostat-navitoclax (4-1 mol-mol),0.6103917311018806
JHUEM-7,5113032,4.7199076302075875
GOS-3,241158,4.584939515140501
Hs 611.T,5460769,0.2348324565646969
KO52,5335621,3.91616082408733
SNU-216,11213558,0.8182724505522939
Hep 3B2.1-7,56946209,-4.073417170136715
SW1573,9935249,2.8664920450292852
SF295,4261,1.626313472689182
JHUEM-7,vorinostat-carboplatin (1-1 mol-mol),3.6475944430152114
OE33,448949,1.5374919283154538
KE-39,44589607,3.0776272038529475
NCI-N87,vorinostat-carboplatin (1-1 mol-mol),2.026584102601564
KE-39,24951314,0.9296568060846556
SW1573,53245473,3.5468633352222287
KE-39,262093,2.516325504276674
YD-8,322968,3.497203303162591
KO52,23725625,4.165793696925613
YD-8,3634881,3.215634292733124
BT 112,54596558,3.9811658460437673
GOS-3,24785538,1.563454655561809
NCI-N87,54618164,3.997308077582706
SK-MEL-28,3689413,3.3385356968233744
YD-8,60700,2.5320757446413222
BT 112,1641662,3.733134142495612
YD-38,24785538,3.26638360961171
KO52,decitabine-carboplatin (1-1 mol-mol),3.5937342622341792
TE 441.T,11977753,-1.3955565522419031
TE 441.T,135423438,2.5250342402764816
Hep 3B2.1-7,439501,-1.9738642324779276
OE33,3503,2.5193951312514655
NCI-N87,322968,2.9452063604799417
JHUEM-7,11626560,1.4043790745396552
GOS-3,navitoclax-piperlongumine (1-1 mol-mol),2.852873715439821
NCI-N87,208908,-2.7799590207113014
TE 441.T,3689413,-1.0112421393817166
SNU-1077,serdemetan-SCH-529074 (1-1 mol-mol),3.0247217263802493
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453
TE-14,969516,2.4677635627082397
KE-39,49766530,-2.0647642539816715
SNU-216,5329102,2.019950725447892
SF295,9936388,1.8656949469177304
TE-14,24772860,-2.25752573478565
YD-8,54618164,4.2297332581599525
YD-38,25262965,-1.039531503301445
TE 441.T,selumetinib-BRD-A02303741 (4-1 mol-mol),6.646410101697854
SW1573,65628,4.136448104244246
TE 441.T,676352,1.4981171427085485
KO52,UNC0638-navitoclax (1-1 mol-mol),-2.0411974213550965
YD-8,10074640,2.718644140629287
B-CPAP,55283,0.7506377686050446
SNU-216,11494412,1.6343036804588515
YD-8,5738263,3.505877458565359
KO52,135411,0.3217608625451301
TE 441.T,46926350,-6.6989678936733705
SW1573,17759555,4.342323370433329
YD-8,12003241,-1.7142863629727714
JHUEM-7,5460769,0.024222502884872
BT 112,erlotinib-PLX-4032 (2-1 mol-mol),5.222233695296922
NCI-N87,9444,3.5890718830627923
TE-14,54649381,3.7440272990463774
KE-39,docetaxel-tanespimycin (2-1 mol-mol),2.396953201231709
TE-14,10410894,4.7642256864799535
SK-MEL-28,25150857,3.0463129162914875
B-CPAP,11497983,6.291424169078015
GOS-3,46215462,1.654053851935072
SNU-216,3025986,-1.2543587626887052
B-CPAP,15983966,-3.675968487068789
KE-39,6918328,-0.2708141535303604
TE-14,3062316,1.0220468638658171
TE-14,4917,3.116532733648005
Hep 3B2.1-7,60700,3.115990637519541
GOS-3,1641662,3.7460543636412535
SNU-216,23582824,-0.2398151877654648
SW1573,6623618,2.3278245092002936
YD-8,5280436,4.27125727704808
Hep 3B2.1-7,crizotinib-PLX-4032 (2-1 mol-mol),1.8626333424530424
TE-14,702558,5.373973014510599
L3.3,25195348,5.818157346447802
L3.3,56946209,-3.919110396505915
YD-38,3081361,0.0909927406814885
KO52,6914657,-6.464336066123526
TE-14,24797083,1.7981487248976569
GOS-3,navitoclax-MST-312 (1-1 mol-mol),2.0809346375553877
KO52,12001922,1.5749423624462988
L3.3,vorinostat-navitoclax (4-1 mol-mol),2.138826011171234
OE33,SNX-2112-bortezomib (250-1 mol-mol),-1.4938738793145026
JHUEM-7,6917907,-5.779408240081831
KO52,5479543,3.70628144154809
YD-8,11485656,2.558902022570011
YD-38,1641662,2.8671869639496386
SNU-1077,3385,5.110303692270896
SF295,5746,1.3493075789474522
L3.3,5978,-0.2603821575839845
SNU-1077,6917907,-0.4505142138964601
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
TE-14,148198,-4.134736941909179
L3.3,44589607,3.517286764473911
KO52,216468,2.9064188892685383
KO52,89928392,0.7106504990592801
YD-38,11175137,3.1873863961797233
KO52,219104,1.56489843823841
Hs 611.T,tanespimycin-gemcitabine (1-1 mol-mol),-4.917658608482378
B-CPAP,16722836,1.2819939562752407
SNU-1077,5280436,3.835908210015818
KO52,31703,-1.3814684432186313
KO52,5311,-0.0281160213778733
TE 441.T,135928012,2.9186612392594107
SNU-216,SNX-2112-bortezomib (250-1 mol-mol),-2.7353446692772363
B-CPAP,carboplatin-etoposide (40-17 mol-mol),3.8440063702085463
TE 441.T,44607531,0.5546870829701779
KE-39,2874250,5.478930029290199
NCI-N87,448949,2.160730221150561
SW1573,285033,-0.3175288260868649
BT 112,11234052,4.430633213786369
KO52,11222830,1.115568752483846
KE-39,123631,1.2600830788760988
SK-MEL-28,5278396,4.387256339592576
SNU-216,53392493,1.8000675338447445
KE-39,5281321,1.7518256992041978
JHUEM-7,135421197,2.2083604774336973
SW1573,9884685,-1.2788581073527363
BT 112,25227462,0.01299535421097
NCI-N87,2749,1.4538564926114168
Hep 3B2.1-7,16115403,-5.404378567626671
L3.3,24785538,3.6784067404983394
NCI-N87,serdemetan-SCH-529074 (1-1 mol-mol),1.7996053995650736
YD-8,carboplatin-UNC0638 (2-1 mol-mol),3.392730087781214
YD-38,11485656,2.58437498447116
BT 112,ISOX-bortezomib (250-1 mol-mol),-0.0253360091538834
KE-39,5311,1.0787821402256168
SF295,60750,0.8931682172733182
B-CPAP,3025986,-0.4402744991779203
JHUEM-7,11238147,1.5963726140500234
TE-14,6450551,3.6230287269279224
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
Hs 611.T,54143018,1.1106544508037073
TE 441.T,54143018,4.031896610161229
KE-39,451668,5.747427565955262
JHUEM-7,216345,1.7329243793640925
Hs 611.T,4788,5.886904507162304
BT 112,2746,3.687274706255036
JHUEM-7,168312962,3.604501244150348
SK-MEL-28,5284616,3.125378124469527
NCI-N87,navitoclax-MST-312 (1-1 mol-mol),0.8705289738440536
KE-39,25262965,-0.0093824287359457
L3.3,135398744,6.452563021638662
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
JHUEM-7,10427712,3.9815551329629337
TE-14,107970,2.304242218577071
JHUEM-7,5978,-3.12331603933377
GOS-3,11964036,2.3854684921529525
GOS-3,54618164,5.027817061073729
JHUEM-7,7326481,2.983877429785858
SNU-216,44566777,-0.1164976312937838
Hep 3B2.1-7,3503,1.329326984042977
L3.3,135421197,2.5730452840447415
SF295,25150857,3.038892661380135
KE-39,3038522,3.2295476949923874
KO52,25105715,3.69197677171084
TE-14,5351362,1.5520567596648778
KE-39,2945648,3.0904060650662477
L3.3,10410894,2.582309203973784
KO52,613753,2.783890275158845
L3.3,285033,-1.389904047242399
B-CPAP,5978,-2.928384954309986
Hep 3B2.1-7,5311281,2.4201746510263495
SNU-216,4477,0.9014976111645492
SK-MEL-28,12001922,1.76503761159643
KE-39,66577038,2.843797644710323
Hep 3B2.1-7,49793307,-3.270961359893231
YD-8,446155,1.4211540199964532
NCI-N87,148198,-3.7864178683693774
KO52,25062766,2.019050283662434
YD-38,4477,0.3282500775583097
KE-39,44507138,1.957284753077253
TE 441.T,252682,3.603333128187029
KE-39,66577038,2.843797644710323
L3.3,11234052,5.199825372855332
Hep 3B2.1-7,46191454,3.0876078258592248
KE-39,44185566,2.219569875640091
OE33,16722836,2.4111815990528624
SNU-216,285033,-0.9871717950363058
SNU-216,676352,1.9648190392617515
KE-39,5566,2.5519005230377574
YD-38,25062766,1.8351513575471845
JHUEM-7,9915743,2.288162918918336
TE-14,445643,5.402404326079723
TE 441.T,44137675,2.4216853844667985
SK-MEL-28,16038120,2.5189867530231065
YD-38,54686904,4.452675789569271
YD-38,262093,2.9761292729070954
KE-39,6918328,-0.2708141535303604
TE 441.T,selumetinib-decitabine (4-1 mol-mol),5.065210849845612
TE 441.T,9884685,0.7848536864337075
KE-39,44489675,3.66901218347382
BT 112,4096211,1.2803456710080927
KO52,52947716,2.706684159725711
SNU-216,6917907,-6.3927212972155445
BT 112,65064,5.244324782512833
SF295,327653,3.6466695589164857
KE-39,doxorubicin-navitoclax (2-1 mol-mol),0.2720331289565558
SNU-216,10296883,4.064330575642344
SK-MEL-28,89928392,1.8249955752671516
SNU-216,4917,2.962272493292141
SW1573,3025986,2.659291536752942
KO52,12003241,-1.0632598943321483
JHUEM-7,46843906,1.6266748117762575
L3.3,51037431,2.2305263064792396
GOS-3,vorinostat-navitoclax (4-1 mol-mol),3.0226897716285905
SW1573,2828334,5.538488922798482
JHUEM-7,135398738,4.332846858207987
KO52,11640390,3.55946469667695
Hs 611.T,11609586,-0.3385496005015009
YD-8,3815108,3.012285181299406
GOS-3,selumetinib-piperlongumine (8-1 mol-mol),4.534264258970437
Hs 611.T,15953870,4.69578906059893
B-CPAP,3689413,-2.370401360424748
GOS-3,60750,-1.363518575342279
SNU-216,10184653,-2.329073802450239
KO52,11234052,4.403544599113535
KO52,5281321,-1.995850617560654
TE 441.T,9903786,2.9236317230426465
BT 112,23725625,2.6047701146720774
SNU-216,24785538,1.9334759902538288
KO52,49846579,4.097285176904078
BT 112,10302451,3.727610987508193
L3.3,637858,2.497804094781357
KE-39,11455910,-0.1151631297895284
KE-39,44493528,4.79040409668691
BT 112,613753,3.334694062247594
Hep 3B2.1-7,44137675,3.4497824153941528
TE-14,60700,-0.2266801281432034
KE-39,136227331,5.536038659908766
SNU-216,4096211,2.421698037098144
SF295,107970,2.6813754727325203
JHUEM-7,3025986,-1.7101726787729836
TE 441.T,11647372,2.9005403388289865
B-CPAP,5280436,3.7013840992858986
GOS-3,3062316,3.7135401373010426
YD-8,262093,2.4929271706284433
KO52,5280436,1.3391511343144182
KE-39,135999136,4.6219900849735325
KE-39,2708,5.6188157628289925
SW1573,11609586,3.686627979451031
YD-38,6914657,-4.843121659772695
NCI-N87,53232,3.890681715203442
KE-39,445643,4.20721403949293
SNU-216,44489675,4.697421360276724
KE-39,4259181,-0.84210776373342
Hep 3B2.1-7,15983966,2.1753156236836904
JHUEM-7,5311,2.0992694237496203
YD-38,17755052,0.4117641046622947
B-CPAP,322968,4.123801708547431
KE-39,25183872,0.9093858643796752
YD-8,JQ-1-navitoclax (2-1 mol-mol),3.0006612821736978
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
JHUEM-7,46398810,1.861705663086365
SNU-1077,17759555,4.679973171236535
TE-14,selumetinib-JQ-1 (4-1 mol-mol),0.562522938991472
Hs 611.T,51037431,3.420580051721121
KO52,11656518,1.0654338145229658
TE-14,65064,5.250482767878561
L3.3,168313016,5.4672449278411595
TE-14,67156097,-1.6218628153120256
YD-38,26596,-1.5752818654632963
SNU-216,11214940,3.6076029036400383
TE-14,11625818,5.294592263134467
NCI-N87,124202324,1.1856737577999816
B-CPAP,44259,0.6950106705233007
B-CPAP,444795,4.737983928137852
L3.3,3081361,5.558675862138055
JHUEM-7,148198,-3.5780143567355336
JHUEM-7,53232,2.6111749392558985
Hep 3B2.1-7,10184653,2.312706900660966
OE33,176870,4.3422171612501765
SK-MEL-28,2749,2.6265102765061936
Hs 611.T,65064,2.5117915945141513
YD-38,11507802,1.1214950322056845
SK-MEL-28,1716436,3.730773917114669
Hep 3B2.1-7,3025986,0.9790399772963276
JHUEM-7,44607531,1.4804103640247843
KO52,11964036,1.6912487507512317
Hep 3B2.1-7,3384730,4.3929373666383755
SNU-1077,2828334,5.956147733949382
B-CPAP,1242560,3.0777193347384495
SNU-216,72376,-2.746748523707645
Hs 611.T,374536,0.8136051559871417
YD-8,erlotinib-PLX-4032 (2-1 mol-mol),2.8218609512009603
GOS-3,5351362,2.3365334015432686
NCI-N87,568763,-0.5346616138078667
BT 112,11396600,2.640188999201151
BT 112,11404337,-0.2767075951827175
L3.3,44489675,4.5650706631267175
KE-39,42642645,1.367345124375733
BT 112,56963564,-0.0795668388707357
NCI-N87,3038522,3.5877635056945443
B-CPAP,46224516,3.1901698351737537
YD-38,123631,-2.2340739565295133
SF295,5351362,1.2959766054388189
YD-8,227681,3.132944737961843
YD-8,11317348,1.928861961863856
KE-39,53392493,2.6188157997279817
SW1573,53495165,2.229023421141798
YD-8,31703,-0.6418507819689356
GOS-3,44589607,2.926429501470136
KE-39,selumetinib-UNC0638 (4-1 mol-mol),3.3038481766151704
SNU-216,156414,-1.34829160644196
KO52,135421197,1.227280721989531
SF295,54618164,4.313739773462804
BT 112,44137675,3.190081046640756
SW1573,25126798,4.147065453172024
SK-MEL-28,241158,4.1117452183175445
OE33,vorinostat-carboplatin (1-1 mol-mol),3.3331184929351183
NCI-N87,9911830,2.159086109533926
B-CPAP,65064,5.136940139923551
GOS-3,3825829,4.328758127334123
KO52,52912189,-1.11352091818438
YD-38,89183176,-2.2975625174244767
YD-8,54618771,-1.0700457769979232
B-CPAP,tretinoin-navitoclax (4-1 mol-mol),3.2232408113370745
GOS-3,navitoclax-pluripotin (1-1 mol-mol),1.020256272208372
GOS-3,6918837,-2.1176912664371144
KO52,4705,3.2027960620979576
NCI-N87,5281321,-1.2852273423113845
TE 441.T,10172275,2.5399848906693876
Hs 611.T,5291,3.6117786538687806
TE-14,5328940,1.6282109394306992
SK-MEL-28,11427553,4.064061219701421
KE-39,2113511,5.681400956118445
GOS-3,5278396,3.876962723891849
YD-38,156414,-3.156839755481009
OE33,25150857,2.936522836186344
SNU-216,11234052,4.859150413061991
SNU-1077,676352,2.603885974708996
SF295,2841722,4.852383814735036
TE-14,4578,4.814976900495172
Hep 3B2.1-7,4096211,4.158740683452708
JHUEM-7,54678924,1.7960871559050613
KO52,8515,2.033649946407287
TE 441.T,2113511,5.892047863834905
KE-39,11364421,0.2339323182946827
L3.3,46398810,3.0103098250539846
L3.3,navitoclax-pluripotin (1-1 mol-mol),0.1565483194262438
JHUEM-7,44498493,4.377210363637701
KE-39,2729026,2.715568279593477
GOS-3,26596,5.630360863540023
TE-14,9915743,-2.4468727006504483
NCI-N87,135398516,0.1780104282584799
KO52,3081361,3.265083976806624
JHUEM-7,44819697,-0.2962478078392037
KE-39,9907093,4.662236703806896
SNU-1077,3503,2.435554549347499
B-CPAP,60750,0.8198284894100664
KO52,135999136,3.8823895578085743
TE 441.T,5351362,0.9223527014919144
JHUEM-7,3503,1.4827187688333288
KE-39,9915743,-0.5446321163343049
KE-39,46398810,2.5573643680926432
Hep 3B2.1-7,tanespimycin-gemcitabine (1-1 mol-mol),0.5954817730235583
YD-8,2842253,4.968157953189597
JHUEM-7,2733526,4.791818477991272
KO52,11612883,1.73729331381162
SNU-216,navitoclax-sorafenib (1-1 mol-mol),2.0000007108124236
Hep 3B2.1-7,24964624,2.658455822553618
SF295,49793307,1.7013463653748198
SNU-216,135928012,4.770569050642353
BT 112,6918638,0.7933014260092189
YD-38,60700,0.7565499239393401
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
SF295,selumetinib-piperlongumine (8-1 mol-mol),4.570084707393715
TE 441.T,5978,4.23833386156951
KO52,67156097,-3.4687606598121143
SK-MEL-28,JQ-1-MK-0752 (1-1 mol-mol),3.9574265003121942
TE 441.T,122327,3.79939442487586
SNU-216,2126,4.983009808045007
B-CPAP,10322450,5.621210843033534
JHUEM-7,salermide-PLX-4032 (12-1 mol-mol),5.137483886109144
NCI-N87,10385095,0.9731458206829144
SNU-1077,5738263,3.1464059503037576
SF295,doxorubicin-navitoclax (2-1 mol-mol),-1.7398898013341806
OE33,219104,2.3175757982951932
KO52,969516,2.728197317619067
NCI-N87,135421197,1.227136310912881
SW1573,159324,2.9705070550476274
SNU-216,10385095,1.0317587818104637
OE33,44589607,2.028602004448122
SNU-216,6438330,1.9826411062954432
JHUEM-7,54618771,2.242796216513649
KE-39,5278396,4.063811246360968
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
KO52,6610355,3.452775078666614
TE-14,53245473,3.8089317117921846
TE 441.T,54596558,4.189884310587091
OE33,327653,3.4722328346839246
SF295,60700,-0.7516800911363736
B-CPAP,49766530,-2.4408790709837396
L3.3,9903786,3.5860218860878263
SK-MEL-28,637858,2.5948993681356276
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
KE-39,doxorubicin-navitoclax (2-1 mol-mol),0.2720331289565558
BT 112,168312962,1.7814785578943482
JHUEM-7,107985,-5.321387186988869
TE-14,135440466,2.7792250864497334
OE33,65064,5.377911946662184
YD-8,3081361,2.3090851828651835
KE-39,54626689,5.72659105113371
SF295,selumetinib-navitoclax (8-1 mol-mol),3.9987598351011937
KE-39,71680916,5.592111276065997
Hs 611.T,53232,2.2904107627158536
SW1573,3543504,3.864321270652805
Hs 611.T,119182,-1.580209779636656
L3.3,262093,4.054875705556861
TE 441.T,2746,2.0767838467856654
GOS-3,51039095,2.831868271027857
KO52,984333,-0.7180338735578685
L3.3,5311,1.4084906886854671
TE 441.T,60750,-4.3172121092953875
B-CPAP,148198,-2.876725444252461
GOS-3,5738263,2.3320703610233724
OE33,216468,3.798936261748522
TE 441.T,5278396,3.614745829557785
L3.3,5328940,2.2327140114261597
SNU-1077,44607531,1.618519036163535
KE-39,11404337,-0.6939323202576905
OE33,12003241,0.2230817721074321
SNU-216,4578,4.165906698786389
B-CPAP,piperlongumine-MST-312 (1-1 mol-mol),1.4552601260130695
Hep 3B2.1-7,5280436,3.8626122969934262
SNU-216,9907093,3.375254195669079
TE-14,216468,5.501928961508749
KE-39,10302451,3.0941257531868858
YD-38,alisertib-navitoclax (2-1 mol-mol),3.864824475515297
BT 112,387447,-5.550366096650992
B-CPAP,374536,5.570137344225874
TE-14,9967941,4.79837679092974
B-CPAP,BRD-A02303741-carboplatin (1-1 mol-mol),4.469579900896245
NCI-N87,11625818,1.9405356473547937
SNU-216,24771867,2.909916707277168
KE-39,6918638,0.3873788369468276
B-CPAP,9926054,2.1103473685311043
B-CPAP,navitoclax-gemcitabine (1-1 mol-mol),-1.2071982143787798
L3.3,11427553,3.3742390950754984
SNU-1077,24785538,1.8612325565822845
B-CPAP,11609586,4.122165381910798
KE-39,9927531,6.019185228760376
TE-14,104842,-2.7863717541611597
SF295,10184653,2.7634367645890987
NCI-N87,375860,-0.928197184659684
SK-MEL-28,56963564,3.9128786084446543
SNU-216,176870,1.140167349620938
TE 441.T,9825149,0.0204286562118866
KO52,16013152,3.657905355539016
Hs 611.T,56946209,-6.985017847440336
Hep 3B2.1-7,374536,3.6821717267000103
YD-8,1242560,3.4576125136726805
NCI-N87,56963564,-0.4773091963101655
Hs 611.T,51039095,1.584846388229858
KO52,54765302,5.5636252834337565
TE 441.T,piperlongumine-MST-312 (1-1 mol-mol),-0.0477223559946464
TE 441.T,11964036,3.258752022533959
TE 441.T,1474550,4.431040328467024
TE-14,5291,3.8275001484723057
SNU-216,54649381,4.402747428048603
YD-8,46199207,3.544065292305842
BT 112,135440466,3.4260770877758207
TE-14,44185566,2.4599717728863735
NCI-N87,9967941,2.944195178928737
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
KO52,BRD-A02303741-navitoclax (2-1 mol-mol),-1.279248349469784
YD-38,crizotinib-PLX-4032 (2-1 mol-mol),1.1156857231715736
TE 441.T,3025944,3.9894481767551024
Hs 611.T,49836020,3.6507368971801983
KO52,4259181,-1.031664922111082
Hs 611.T,tretinoin-navitoclax (4-1 mol-mol),2.8699882476270355
KE-39,3025944,4.4635566230619945
KO52,11625818,4.5522450622851105
OE33,6852167,2.347290735103793
SNU-216,24821094,-1.8638157046721129
TE-14,7251185,3.069214722812887
OE33,9903786,4.225835285233996
OE33,241158,5.920302917932962
BT 112,44607531,0.6377481559529096
SF295,11427553,2.948387594592759
SNU-216,9911463,4.000497828097352
YD-38,3385,3.5406106671082886
YD-38,24951314,1.5391329353480026
KE-39,67156097,5.133612548665442
SNU-216,15547703,3.0901716634646874
YD-8,JQ-1-vorinostat (2-1 mol-mol),1.7372019591077774
SNU-216,25105715,3.66555605767721
NCI-N87,107985,-3.2122311985508136
B-CPAP,12003241,-1.7111954205398938
SNU-216,24901704,2.7455586339564126
SF295,54618771,1.9072877365394525
KO52,11317348,-0.6673416896175152
B-CPAP,60700,-0.0698828360303767
SNU-216,219104,3.3692374344662457
SF295,6918878,3.614414318774816
BT 112,46174525,4.318783265075236
L3.3,selumetinib-piperlongumine (8-1 mol-mol),4.6860683758170145
GOS-3,568763,1.0345737986601573
KE-39,24785538,4.0612751994912335
L3.3,52947716,-5.849313058865459
KE-39,16720766,4.546084140767303
SNU-1077,alisertib-navitoclax (2-1 mol-mol),1.6049595607856426
Hep 3B2.1-7,3689413,-0.8676280815745859
KE-39,54618164,4.766262408385177
BT 112,676352,1.6174631516365394
L3.3,6918837,-1.6341527445290025
B-CPAP,11152667,-0.1979921497288642
JHUEM-7,56946209,-4.688751747414188
Hs 611.T,5287969,-3.1044324087553963
TE 441.T,71751553,4.471943805545609
KO52,135440466,2.642581102340019
SNU-1077,11396600,4.998092576249027
JHUEM-7,24797083,1.6268225461289076
TE-14,25262965,0.1112542376470163
KO52,56973724,2.0714628306435507
KE-39,11213558,4.569088998170507
TE 441.T,9887053,1.638763624659808
KO52,568763,0.0919093108671874
YD-38,654092,-0.0694963905270349
SF295,tanespimycin-gemcitabine (1-1 mol-mol),1.178179005676627
KE-39,23725625,5.622319720398273
SW1573,24821094,3.391149888356164
KO52,135659046,3.503950077041595
BT 112,54613361,-2.861738596856594
KE-39,16038120,1.0564410098934849
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
L3.3,446155,3.865906870912223
TE 441.T,24821094,3.3384989046098945
SF295,54618359,4.37820605202468
B-CPAP,24964624,2.8727163930328863
OE33,2828334,6.036524421736953
KO52,doxorubicin-navitoclax (2-1 mol-mol),-1.6802250262186946
JHUEM-7,44185566,2.2115462684333855
SK-MEL-28,2945648,3.075728962525901
KO52,54678924,2.3208002144974778
YD-8,122327,5.600297817210885
KE-39,4261,1.550964775863626
Hep 3B2.1-7,piperlongumine-MST-312 (1-1 mol-mol),1.9337544959120967
KO52,46215462,1.4911343495601384
SNU-1077,1750826,-2.704976435926544
Hep 3B2.1-7,6918328,0.1282647742333688
B-CPAP,151289,0.3803775246447248
BT 112,24797083,1.2381958000259223
Hep 3B2.1-7,11152667,0.7681962822393275
KE-39,3634881,3.3710219028006474
TE-14,68056272,3.626133272295782
OE33,65628,4.337074317818266
KE-39,60700,1.8919776900280405
KE-39,9908783,5.748750979730715
Hs 611.T,JQ-1-vorinostat (2-1 mol-mol),0.5452078653021686
YD-38,1242560,3.082772810737216
TE-14,23582824,1.075600439558685
JHUEM-7,12003241,-3.5765771521887246
Hep 3B2.1-7,carboplatin-etoposide (40-17 mol-mol),3.715246114743024
NCI-N87,969516,2.8189934287936733
BT 112,24856436,0.5972809342094648
TE 441.T,4477,0.6885101231400689
B-CPAP,BRD-K27188169-navitoclax (2-1 mol-mol),4.542627193137736
SW1573,11640390,3.5338327701281176
TE 441.T,44819697,-3.063263646717018
JHUEM-7,135411,0.5518757066941595
KO52,54626689,4.497055456581237
KO52,36462,1.66960340133658
Hs 611.T,12003241,-4.3632527403619425
NCI-N87,123631,-0.3933912143385343
KO52,227681,2.1146823151840715
GOS-3,2871966,0.5648988653696159
BT 112,135411,-0.6618805280288009
YD-8,selumetinib-MK-2206 (8-1 mol-mol),2.9104774003059415
YD-8,54619267,4.1728433428246365
B-CPAP,3552672,3.704866420763203
JHUEM-7,24772860,-2.354213215472605
GOS-3,46398810,2.269718225041391
SNU-216,49793307,-3.858318805980409
BT 112,9840324,5.678931191449396
KO52,9884685,2.8647583667584553
SNU-216,15983966,-2.0364381172241854
YD-38,JQ-1-navitoclax (2-1 mol-mol),-0.452478253024042
B-CPAP,44241473,5.575826833143993
YD-8,119607,5.2875629658247805
KE-39,2749,1.448224267904264
JHUEM-7,448949,1.0789337294372523
TE 441.T,5746,-0.3912335705950193
Hs 611.T,9911830,0.7898774616432335
KO52,4521392,4.342251998569949
YD-38,3384730,3.3867880230006477
BT 112,119607,5.928336850661068
SNU-1077,568763,0.523765917176441
TE 441.T,445455,4.976483288324393
KE-39,11427553,2.9196701777014415
GOS-3,56649450,5.993657371981695
TE 441.T,24772860,-4.205282472336712
KO52,piperlongumine-MST-312 (1-1 mol-mol),1.3163609440241515
KE-39,9911830,2.572250482212608
TE 441.T,3634881,3.217168446108213
SNU-1077,25062766,2.424890615917259
YD-8,54613361,3.562533264649823
OE33,11977753,-4.125573657432353
B-CPAP,4477,0.711157079816854
TE 441.T,227681,2.4502408119810006
NCI-N87,9825149,1.7110175659097178
KE-39,25161177,3.7405174690773366
TE-14,54678924,2.4580217895933334
SNU-1077,24951314,1.2105006017046815
NCI-N87,docetaxel-tanespimycin (2-1 mol-mol),-6.128008635109833
B-CPAP,9935249,3.6331972825505474
GOS-3,1750826,-2.070069963305823
B-CPAP,vorinostat-carboplatin (1-1 mol-mol),2.390336914365316
Hs 611.T,6505803,0.4096396664447451
SF295,66577038,3.081420284451991
JHUEM-7,selumetinib-UNC0638 (4-1 mol-mol),6.50365850141335
YD-8,613753,3.309509462802455
SF295,49766530,-1.8796707032595965
JHUEM-7,119607,5.3622103716766905
KO52,9826308,-1.4432821349389238
JHUEM-7,5281321,-3.009296919443196
SF295,65064,5.224650721968281
SK-MEL-28,6610355,5.590676722177881
Hs 611.T,4261,2.1145176676896487
TE-14,BRD9876-MK-1775 (4-1 mol-mol),0.905009353447916
KO52,46174525,3.5997508179953615
B-CPAP,676352,2.971281112098332
SF295,119182,-1.4526751303422951
L3.3,56963564,0.8777502284965835
NCI-N87,3825829,3.9513849877108207
Hs 611.T,53495165,-2.569937214874966
TE-14,JQ-1-UNC0638 (2-1 mol-mol),1.1497905104271977
TE-14,25183872,-0.523282113433947
BT 112,241158,4.111283984788845
KO52,11178236,-1.9034207953273736
Hep 3B2.1-7,11427553,2.2734282767619876
Hep 3B2.1-7,135875424,3.596529657657783
KO52,2749,1.7174149313892582
KE-39,1641662,4.193135241199752
Hs 611.T,9967941,3.710009045681017
YD-8,2708,5.154021841255303
SNU-1077,5281321,-1.036948413736443
TE-14,6852167,2.6176714040781977
Hs 611.T,156414,0.8748600228800256
SK-MEL-28,2729026,2.910502254408236
L3.3,3384730,1.5710194033023062
KE-39,54596558,4.365324822394714
TE 441.T,9967941,3.4581563869345557
TE-14,16720766,0.8168993099137034
KE-39,15983966,1.9494927934805544
OE33,11427553,3.683958966235938
B-CPAP,5470400,-0.1113879304471415
Hs 611.T,36314,3.613162965661777
B-CPAP,selumetinib-vorinostat (8-1 mol-mol),2.3348701814890904
YD-8,2130404,2.9369369304984994
YD-8,9884685,0.4288602362117117
YD-38,148198,-2.2054243046269044
TE-14,selumetinib-piperlongumine (8-1 mol-mol),4.350440406210289
L3.3,navitoclax-MST-312 (1-1 mol-mol),2.4950782279808656
KO52,448949,1.7278683789034708
TE-14,73707398,2.073714083306327
Hs 611.T,2742550,3.744335328422511
TE 441.T,24797083,1.0154681927969065
GOS-3,tanespimycin-gemcitabine (1-1 mol-mol),3.128044986938021
L3.3,16741245,2.275908063521695
TE-14,151289,1.2863290145875046
YD-38,9911463,4.143159410614896
SNU-216,11626560,2.093989475443438
JHUEM-7,24771867,-0.3037567272373623
SK-MEL-28,168313047,3.5931899532955147
KE-39,selumetinib-MK-2206 (8-1 mol-mol),2.7514173486302544
B-CPAP,252682,6.481152760334254
Hep 3B2.1-7,107970,2.24352532481949
SNU-1077,9911830,1.9332136731221603
NCI-N87,613753,3.043533794547513
SNU-216,alisertib-navitoclax (2-1 mol-mol),1.1611123296094812
SNU-216,4261,2.1071310683491236
BT 112,216468,1.2826036756590016
KE-39,11178236,-2.7855564912156128
SNU-216,3384730,2.2202403454445117
TE-14,4477,0.6111489051508033
YD-8,135999136,6.481795126986557
YD-8,25062766,2.0362931594826055
JHUEM-7,446155,2.408217764237835
KO52,11404337,0.1772123930911338
KO52,6610216,4.150836928578526
B-CPAP,44185566,3.01783805282662
TE-14,9956119,4.291552086105828
KO52,9907093,4.4065902785902304
KE-39,219104,3.854039065759246
Hs 611.T,44489675,3.810034889959883
B-CPAP,4788,5.4024442798763905
Hs 611.T,123631,1.6815281040146308
JHUEM-7,11222830,1.5565352005988358
GOS-3,44486219,4.351702661257634
TE 441.T,135398516,1.7674231638740454
KE-39,11238147,3.713228695438772
GOS-3,31703,-1.1173409595108883
BT 112,42642645,0.6970367427086502
KE-39,3634881,3.3710219028006474
TE-14,10074640,3.2849249616435165
TE-14,3854666,0.9160893400358509
TE 441.T,644241,1.5282801612003003
JHUEM-7,72376,-2.504472205859212
Hs 611.T,16038120,0.988688783392196
TE 441.T,441298,3.105895146082189
TE-14,19582717,3.998622953586376
KO52,11955716,-1.8953160699263083
KO52,10322450,3.562187913985661
TE 441.T,285033,-3.368841628531522
SW1573,51039095,4.568767182944777
Hs 611.T,6450551,2.170846858416241
YD-38,400769,-0.713411362177007
GOS-3,44137675,4.312209162350938
SF295,135999136,4.283449365552917
JHUEM-7,25154868,5.093350914915029
JHUEM-7,16722836,0.6728003897520018
Hep 3B2.1-7,42642645,-0.3061550717373256
SNU-216,322968,3.383720063707372
L3.3,6252,0.2429415263286948
Hep 3B2.1-7,44589607,3.2305437071939127
YD-38,65064,4.931541588162588
Hep 3B2.1-7,46224516,4.480641922862564
Hs 611.T,984333,1.4054326287403642
SK-MEL-28,11364421,2.320063094924172
B-CPAP,24856436,0.7730146540222972
KO52,JQ-1-UNC0638 (2-1 mol-mol),0.0630474759486333
SNU-216,375860,0.5464638688972412
TE 441.T,2729026,1.9676389921183184
Hs 611.T,11960529,3.955998634111423
SF295,vorinostat-carboplatin (1-1 mol-mol),3.5334833945464057
YD-8,9825149,2.435749778516473
KE-39,5738263,4.084504768293086
YD-38,4521392,4.3096596325383185
SNU-216,446155,1.8144703535429705
L3.3,448949,2.9670184834605244
KE-39,24951314,0.9296568060846556
L3.3,9956119,3.8207787288773063
TE 441.T,49766530,-1.0459972469347878
KE-39,5281321,1.7518256992041978
SNU-1077,navitoclax-pluripotin (1-1 mol-mol),-1.01883972326763
SNU-216,JQ-1-UNC0638 (2-1 mol-mol),2.1879565366107494
JHUEM-7,24753719,4.234902187840303
TE 441.T,702558,3.4312087803919837
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322
SNU-216,568763,-0.2099527873774199
JHUEM-7,selumetinib-MK-2206 (8-1 mol-mol),2.058966868877447
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
SW1573,25102847,2.4268351657646874
JHUEM-7,25262965,-4.73461775117277
SW1573,10074640,3.956421484938757
TE 441.T,89928392,-1.2176780680226276
TE-14,219104,4.149508556383155
SNU-216,25062766,1.683528058325665
YD-8,24748573,2.6006584758291735
JHUEM-7,carboplatin-etoposide (40-17 mol-mol),1.5968743771599203
YD-38,25183872,-0.9372891340826588
YD-38,6917907,-5.942937976928353
B-CPAP,675434,3.8124437970633194
NCI-N87,tretinoin-navitoclax (4-1 mol-mol),0.6005709555160592
GOS-3,135421197,1.697146176044067
KO52,702558,3.3833897196407645
SNU-216,104842,-1.0763257291976505
KE-39,carboplatin-UNC0638 (2-1 mol-mol),3.611149814611224
KO52,44137675,4.99436004315741
TE-14,5311281,4.284827588254178
SK-MEL-28,969516,4.521483044042875
YD-8,44607531,1.5829374298976635
L3.3,16722836,1.76831050763334
SK-MEL-28,docetaxel-tanespimycin (2-1 mol-mol),3.8902509419677105
TE 441.T,5284616,2.983388290354193
KO52,9956119,3.9050821856051185
JHUEM-7,4788,5.917235759280994
KO52,11396600,3.051627581840025
Hs 611.T,selumetinib-PLX-4032 (8-1 mol-mol),4.80293901868776
TE-14,375860,-0.5133657303817126
L3.3,6918736,-1.7247535795274376
SNU-216,54613361,1.5924941592542603
SW1573,25183872,-2.56928333929943
JHUEM-7,docetaxel-tanespimycin (2-1 mol-mol),-6.631978799043623
KE-39,12001922,1.538248730222034
TE-14,16065773,3.8068226311803457
KE-39,crizotinib-PLX-4032 (2-1 mol-mol),2.410215231277302
BT 112,7251185,1.5687647885823757
YD-8,73707398,1.1339237170250962
GOS-3,carboplatin-UNC0638 (2-1 mol-mol),3.2409123088113194
BT 112,selumetinib-tretinoin (2-1 mol-mol),5.260723410115697
GOS-3,11497983,4.172510051232983
KE-39,11213558,4.569088998170507
SNU-216,5287620,-2.2856125915273067
SNU-216,6918837,-3.2579868157497707
SNU-1077,12001922,2.14758213265239
JHUEM-7,5335621,4.966853078493816
OE33,54618771,0.6463967742027482
Hs 611.T,9926054,1.8280926290746755
L3.3,44507138,2.7873723049829544
SW1573,6918328,0.8267852089643692
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854
TE-14,5287969,-1.4099886323192448
Hep 3B2.1-7,navitoclax-gemcitabine (1-1 mol-mol),2.7755624885487187
SK-MEL-28,selumetinib-UNC0638 (4-1 mol-mol),1.787760879928494
YD-38,16736978,2.1471918071797975
SK-MEL-28,46398810,3.208248420081512
JHUEM-7,135875424,3.03961944002969
Hep 3B2.1-7,doxorubicin-navitoclax (2-1 mol-mol),-0.2796093527142125
SNU-1077,5281672,4.971178348467827
SNU-1077,46199207,3.446749693577103
Hep 3B2.1-7,9911463,3.814987656182777
TE 441.T,11955716,-2.4135075379254607
SF295,3062316,3.5425681199487085
Hep 3B2.1-7,71680916,4.65916730827728
SNU-1077,49850262,4.98017250965326
NCI-N87,54618771,0.8863121899707505
SK-MEL-28,4261,2.2324553955764115
YD-8,135875424,4.059859189077627
JHUEM-7,3689413,-2.2301251225415255
JHUEM-7,67156097,-2.2957753342542127
NCI-N87,11427553,2.9770783714757005
L3.3,9866186,0.5756442482063215
B-CPAP,135984461,1.7006873444468935
JHUEM-7,11152667,-1.617539087588013
SW1573,12001922,2.294011710402099
JHUEM-7,5328940,0.6709710255807081
SF295,19582717,3.4877179279198076
L3.3,53392493,3.3534830778032045
KO52,168312962,3.725113432796697
KE-39,9907093,4.662236703806896
SF295,31703,1.2019493541868402
Hep 3B2.1-7,44185566,2.8600797246910297
SF295,navitoclax-sorafenib (1-1 mol-mol),0.8492487168306413
OE33,5470400,-2.8362706163601743
TE-14,6918638,0.7581256744070354
SNU-1077,3689413,-1.655364429789056
NCI-N87,1750826,1.3506728687975464
SF295,5311281,3.133467459671144
SK-MEL-28,4705,3.074639735007158
YD-8,ISOX-bortezomib (250-1 mol-mol),1.1639507987176203
YD-8,vorinostat-carboplatin (1-1 mol-mol),3.421403122872885
OE33,15547703,3.1621106125500127
KE-39,5280436,3.8449675100084417
JHUEM-7,3025944,3.7681035622574255
JHUEM-7,5287969,-2.561176724900928
TE-14,2874250,5.1128953719748935
SK-MEL-28,148198,-1.1695105826491254
KE-39,11964036,1.1014936748281658
NCI-N87,11656518,1.4544081811160725
TE-14,56963564,-0.0020475710880836
GOS-3,3634881,3.062788872748443
Hep 3B2.1-7,selumetinib-MK-2206 (8-1 mol-mol),2.068814020685818
B-CPAP,76446078,4.324455702979326
NCI-N87,9952709,5.048469263792704
JHUEM-7,24180125,3.52789412824338
Hs 611.T,9840324,5.787468969670089
OE33,10410894,3.5996316585738057
KO52,44495899,4.429122430834432
NCI-N87,135875424,4.206412745126992
SNU-216,selumetinib-MK-2206 (8-1 mol-mol),0.5399979997327916
GOS-3,7251185,3.0018815610418694
TE 441.T,53495165,-2.662306662249335
SW1573,5328940,2.8151731448483424
NCI-N87,71466578,5.1108247117444865
L3.3,5282054,4.901570069575592
B-CPAP,selumetinib-JQ-1 (4-1 mol-mol),2.8675411473634917
KO52,9823820,4.034259962160193
B-CPAP,49793307,-2.3843688094258453
SNU-216,71729975,0.1345091184633045
KE-39,12003241,0.559414259019648
JHUEM-7,3825829,4.01020461765645
YD-8,2749,4.008728292988675
BT 112,7326481,3.170225390322452
JHUEM-7,SNX-2112-bortezomib (250-1 mol-mol),-2.50050098100693
BT 112,10184653,1.1503631618042085
TE-14,156414,0.150817369290719
Hs 611.T,44137675,1.8104045902610284
KE-39,3503,2.236149027269379
SNU-216,54454,3.4585023319896497
BT 112,44566777,0.6331747644646614
OE33,45279963,4.0955269526771865
GOS-3,9911463,4.370946765627494
YD-38,126941,-2.780314283606951
Hs 611.T,3025944,3.853000998701116
GOS-3,100016,7.242262816552233
NCI-N87,navitoclax-gemcitabine (1-1 mol-mol),-3.6490042770502815
KE-39,135440466,2.490274182929518
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
Hep 3B2.1-7,vorinostat-navitoclax (4-1 mol-mol),1.71019933879999
SNU-216,JQ-1-carboplatin (1-1 mol-mol),3.8633664512106622
KO52,selumetinib-UNC0638 (4-1 mol-mol),-0.866257907363459
SNU-1077,53232,1.8565166460541551
YD-8,5278396,3.5154412560153068
KE-39,1641662,4.193135241199752
KO52,decitabine-navitoclax (2-1 mol-mol),-1.7889510477453996
TE 441.T,10296883,4.028933328577424
B-CPAP,navitoclax-MST-312 (1-1 mol-mol),0.2564145417879402
SNU-216,9908783,3.7818471710413606
SW1573,10322450,3.835483834832597
YD-8,72193861,2.3860591543368046
L3.3,10113978,3.760524207236511
YD-38,selumetinib-UNC0638 (4-1 mol-mol),1.2165328685019954
YD-8,5978,2.5175590604708584
B-CPAP,44137675,4.622984618218968
KE-39,44486219,6.242583973184527
SNU-216,11317348,6.023030542317429
SW1573,124202324,3.209850220678193
TE 441.T,5470400,5.687935465815988
SNU-216,11609586,3.629418809049709
B-CPAP,448949,0.8631671075369705
SNU-216,4705,1.5383436923122542
NCI-N87,216239,2.2423368269273753
Hs 611.T,6917907,-6.1157509983755345
KE-39,51039095,2.7316148787408427
JHUEM-7,46907787,-0.7019339701280191
Hs 611.T,10074640,2.358628598504818
JHUEM-7,24180719,2.9437043979916413
NCI-N87,16722836,0.5704530263405226
L3.3,969516,2.9670664389679677
BT 112,navitoclax-piperlongumine (1-1 mol-mol),3.2143536144775084
L3.3,5311281,4.47128753759965
YD-8,11609586,3.1428816496644147
YD-8,3062316,-2.7006453915936497
B-CPAP,6450551,2.6982491790934824
YD-8,54454,1.7837031222985251
YD-8,5566,3.0799845846164047
SNU-216,216239,2.119918357767876
B-CPAP,11640390,4.47725622860835
Hep 3B2.1-7,11222830,1.7633990776161406
L3.3,9936388,-5.444309252993802
Hs 611.T,6852167,0.4305744814723918
TE-14,9866186,1.111834547028208
GOS-3,19582717,5.639915925254865
TE-14,262093,3.712272001874861
YD-8,135398516,2.8864583978084473
TE-14,25102847,2.1237054903905306
KE-39,11222830,1.621114920928245
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005
KE-39,44241473,4.750329858029805
KO52,navitoclax-gemcitabine (1-1 mol-mol),-4.345603571038749
SF295,6918289,2.5556705911617654
L3.3,8515,4.3523389716154455
NCI-N87,5280436,4.116578666931142
TE 441.T,71466578,6.000761540631799
OE33,53495165,-2.9883375308758424
SNU-1077,vorinostat-carboplatin (1-1 mol-mol),3.2108686769377717
SK-MEL-28,387447,-4.492461513664045
KE-39,46174525,4.365046515434029
BT 112,44202524,1.0325728707890818
TE-14,72376,-1.758934357423353
YD-8,25126798,3.822441714978281
TE 441.T,54639665,4.381195082349918
NCI-N87,159324,0.0331676951949142
KE-39,445643,4.20721403949293
Hep 3B2.1-7,10074640,2.637469456252606
B-CPAP,2729026,3.008270694147531
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037
YD-8,24797083,1.7826041410647693
NCI-N87,65628,4.009039012864223
JHUEM-7,72734382,4.444949272371647
GOS-3,vorinostat-carboplatin (1-1 mol-mol),4.212232190110438
YD-38,135421197,2.8276318584619022
JHUEM-7,24821094,2.3762342489012047
YD-8,1566236,1.8146289426775175
Hs 611.T,8515,3.543970428456994
Hep 3B2.1-7,44819697,-1.6757920452059003
Hep 3B2.1-7,24753719,3.3025122123493573
SW1573,16725315,3.253832365815957
SNU-1077,navitoclax-piperlongumine (1-1 mol-mol),2.376186895274424
KO52,44632017,0.0907134536946377
KO52,9887053,3.73966963035621
OE33,387447,-5.027649776547387
JHUEM-7,51037431,4.159503637934766
KO52,9952709,3.149976936491048
NCI-N87,5335621,4.88881532131479
TE 441.T,selumetinib-PLX-4032 (8-1 mol-mol),5.081053140358277
TE 441.T,613000,2.584906530054027
SNU-1077,2708,5.365576184997209
SNU-216,44589607,2.546181662293819
TE-14,5311,1.7407317026621147
KE-39,11427553,2.9196701777014415
B-CPAP,638278,3.199746181468372
SNU-1077,10184653,2.0946597853188833
JHUEM-7,24856436,-1.8426006966748285
YD-8,11497983,4.407361911086299
KE-39,crizotinib-PLX-4032 (2-1 mol-mol),2.410215231277302
Hs 611.T,44819697,-0.3560757455908935
SNU-216,24856436,0.1450337924373276
OE33,10184653,1.4543634096464415
YD-38,11612883,2.6536932325208413
TE-14,46199207,3.6455428697652112
TE-14,44607530,1.4398604991203954
TE 441.T,10184653,1.2967896851155565
YD-8,SNX-2112-bortezomib (250-1 mol-mol),-1.2949761873623031
TE 441.T,49846579,1.6293260082614165
SNU-1077,navitoclax-gemcitabine (1-1 mol-mol),2.6315006611829004
SNU-216,71751553,4.1520368918370965
GOS-3,216345,3.7028655718770502
KO52,tretinoin-navitoclax (4-1 mol-mol),-2.9404392116104767
JHUEM-7,36462,0.060815321002826
Hep 3B2.1-7,docetaxel-tanespimycin (2-1 mol-mol),0.6913294153617894
L3.3,216345,4.451682719982746
KO52,1641662,2.14069731624562
B-CPAP,136227924,3.258845757188781
SNU-216,6610216,4.217598364125196
NCI-N87,46398810,2.1002609832839187
B-CPAP,5746,2.211923482717491
SK-MEL-28,44507138,4.029027628545452
KO52,9926054,1.7676529122170044
SW1573,16722836,2.4665820842388606
Hs 611.T,42642645,0.1847495299149886
SNU-216,637858,1.4153180245301518
SK-MEL-28,carboplatin-UNC0638 (2-1 mol-mol),3.933934894554171
SF295,11222830,2.002595135391655
SNU-216,25150857,2.6497407085575286
TE 441.T,107970,1.1503901417213285
B-CPAP,20959075,-3.002686370695369
SNU-216,2729026,3.021777506017218
SNU-216,19582717,4.5653066313925645
SK-MEL-28,10302451,4.268902771891611
OE33,11485656,2.057023759496841
KO52,53232,4.022283845582505
KE-39,11609586,3.026982810256724
SNU-216,23725625,5.133844991489014
SW1573,5113032,6.532830278238065
OE33,5281321,-2.864418891042976
L3.3,44607531,2.464561691878258
SNU-1077,409805,6.04127283545163
SF295,5328940,2.1232695938998924
Hs 611.T,crizotinib-PLX-4032 (2-1 mol-mol),1.0036854600016174
TE 441.T,crizotinib-PLX-4032 (2-1 mol-mol),0.249854268469704
GOS-3,25227462,1.8095270845710951
Hs 611.T,57519531,0.5632668661616677
L3.3,25183872,0.3957917888669793
SNU-216,5291,3.786158286064785
SNU-216,11396600,3.905215698607568
KE-39,11497983,4.192627154878264
BT 112,71304818,2.5450175334418987
GOS-3,12001922,1.73057519179838
B-CPAP,navitoclax-birinapant (1-1 mol-mol),0.9967286045428472
L3.3,ISOX-bortezomib (250-1 mol-mol),1.440349868344241
KO52,ISOX-bortezomib (250-1 mol-mol),-0.2750046766745305
SF295,3689413,-1.7224429364651286
B-CPAP,54454,-0.0949556487225395
SK-MEL-28,227681,3.6340510763763367
KO52,148124,-8.023122181205325
Hs 611.T,54596558,3.959669685296965
SNU-216,4521392,3.879147487551532
KO52,5746,-1.4374461820450624
YD-38,selumetinib-PLX-4032 (8-1 mol-mol),1.695274932451559
KE-39,1750826,-2.36387280589116
YD-38,vorinostat-carboplatin (1-1 mol-mol),3.8658653780233174
SK-MEL-28,16725315,5.297717320845617
SNU-216,navitoclax-pluripotin (1-1 mol-mol),-1.7154939293198777
OE33,44607530,1.1212304736058718
BT 112,3062316,2.6021941524202674
SNU-1077,46907787,0.7852146377897988
OE33,tretinoin-carboplatin (2-1 mol-mol),4.82616719932518
SK-MEL-28,675434,4.199457479728167
Hs 611.T,25227462,-5.211715043272956
B-CPAP,11175137,3.0252495703695668
Hs 611.T,UNC0638-navitoclax (1-1 mol-mol),0.5214150649691321
KE-39,vorinostat-navitoclax (4-1 mol-mol),0.0592807411548529
BT 112,400769,-1.0288775980123002
BT 112,11178236,-4.407924823586387
SNU-216,tanespimycin-gemcitabine (1-1 mol-mol),2.5069863823835807
GOS-3,25262965,-1.0893957364274085
BT 112,2871966,-0.611805318298209
SF295,124202324,3.278195850827405
KO52,6918638,-1.0658834160946808
YD-38,9907093,4.292442922710312
KE-39,24964624,2.267142563952713
SW1573,4705,3.887877577681455
B-CPAP,2113511,4.9053992251679475
JHUEM-7,ISOX-bortezomib (250-1 mol-mol),0.2456218281827208
JHUEM-7,JQ-1-MK-0752 (1-1 mol-mol),0.4170318281290994
KO52,11719255,2.53220812210846
OE33,446155,2.7014033624900056
B-CPAP,selumetinib-PLX-4032 (8-1 mol-mol),2.742765597384798
KE-39,5329102,2.0429162006260566
TE 441.T,9933475,1.6906034306149391
YD-8,11640390,3.0697082624281093
YD-8,54626689,4.483773401424057
SW1573,12003241,-0.6702221198842615
KE-39,2945648,3.0904060650662477
YD-38,208908,-0.2609771273149361
B-CPAP,71304818,2.781278016768635
Hep 3B2.1-7,72193861,4.912921910575128
OE33,selumetinib-PLX-4032 (8-1 mol-mol),2.872439488722446
TE-14,erlotinib-PLX-4032 (2-1 mol-mol),2.1473842568297608
JHUEM-7,6610216,4.204761293016812
TE 441.T,9936388,-8.412031296278057
B-CPAP,637858,2.2733284631239044
Hep 3B2.1-7,135398516,2.0615134468665235
Hep 3B2.1-7,25126798,3.844518464246068
Hs 611.T,11178236,-6.535511147964887
JHUEM-7,637858,1.2462680133442194
OE33,11640390,3.4389828580946027
TE-14,2842253,6.030990988096264
SK-MEL-28,9956119,4.5331880736005745
JHUEM-7,60700,-1.134830771722302
SF295,11396600,4.282405011310363
SW1573,46398810,3.5765453048302933
KO52,9911830,0.3090306906252232
L3.3,12001922,2.4292832661010557
SK-MEL-28,5280436,4.781465110454219
TE-14,9903786,3.4903828938175354
SF295,25126798,4.081083799796345
OE33,9967941,4.5959638784699814
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
B-CPAP,24180719,2.0507449605485033
SNU-1077,753704,5.47540794782016
TE 441.T,3136844,3.779446579435195
L3.3,11238147,4.461700161811432
BT 112,17755052,2.3447671065006106
SF295,676352,2.981550138485967
BT 112,57519531,1.0837379770359268
SNU-216,2842253,6.543596407087795
SW1573,11178236,-2.507507612037206
NCI-N87,44607531,-2.3963447234482196
GOS-3,5746,1.4150119127186604
Hs 611.T,11625818,1.6161775946459724
KE-39,11497983,4.192627154878264
TE 441.T,54626689,4.404200006363088
YD-38,54454,1.8632122515216116
B-CPAP,17755052,3.4143751871388788
JHUEM-7,262093,2.8461427698978197
OE33,23635314,-2.3350122759353984
Hs 611.T,6914657,-3.242080936188609
NCI-N87,17755052,-1.4521000328048816
SNU-216,54596558,4.461743711323361
SK-MEL-28,9911463,4.538912500786334
TE-14,5479543,5.724048245895776
OE33,1716436,3.5856703745637195
OE33,322968,2.6320987801023747
TE 441.T,doxorubicin-navitoclax (2-1 mol-mol),-3.743628559569693
SK-MEL-28,5282054,3.2979328784688606
Hs 611.T,9903786,0.3508528062947837
SF295,25262965,-0.3132434701889637
L3.3,568763,0.380782352657369
GOS-3,148198,-2.930015056129616
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
BT 112,4261,1.960966237703145
TE-14,637858,2.3337222437177454
SNU-1077,17755052,2.9989648032129477
SF295,51039095,3.485537910967478
SF295,24785538,2.7839874159397873
SK-MEL-28,JQ-1-UNC0638 (2-1 mol-mol),3.2511291788687218
NCI-N87,3062316,-1.4174361948917271
Hs 611.T,24180719,3.465286559859583
B-CPAP,6914657,-4.791775338722752
Hs 611.T,11396600,2.963461604358696
TE 441.T,23635314,3.6399625079566778
KO52,10296883,3.770873498157397
SF295,11152667,-1.2215974796941085
SK-MEL-28,9866186,3.06280870304389
TE 441.T,11228183,-0.1265557493209269
TE-14,44137675,3.833594169028412
SK-MEL-28,10184653,3.6821110044494056
JHUEM-7,tanespimycin-gemcitabine (1-1 mol-mol),-0.4399381866621512
Hep 3B2.1-7,selumetinib-tretinoin (2-1 mol-mol),2.5143967997897905
B-CPAP,navitoclax-PLX-4032 (1-1 mol-mol),1.4465369536509338
Hep 3B2.1-7,11364421,1.1768671556641792
SK-MEL-28,7326481,2.655717270384107
KE-39,44137675,4.4813975845381755
YD-38,73707398,1.113777458655618
OE33,piperlongumine-MST-312 (1-1 mol-mol),1.672425698921404
SNU-216,25102847,1.8923376874468665
TE-14,246676,5.320033654623924
SK-MEL-28,6610216,4.386997968475678
B-CPAP,9911463,3.799628401356715
KO52,44607531,1.055709895972932
TE 441.T,16722836,0.9060116885921192
TE 441.T,421610,1.6817541866444998
NCI-N87,51039095,3.189774410902983
JHUEM-7,156414,1.092092573669373
Hs 611.T,selumetinib-UNC0638 (4-1 mol-mol),2.0633053659958387
YD-38,124202324,1.7206527447558553
Hs 611.T,24180125,0.9846355561262036
BT 112,JQ-1-vorinostat (2-1 mol-mol),1.5924494369146067
TE 441.T,52912189,3.963434296707395
L3.3,3025986,-0.2391966335119921
GOS-3,10385095,1.261141423395055
SK-MEL-28,6917907,3.4714209878856463
TE-14,doxorubicin-navitoclax (2-1 mol-mol),-0.0232060070462323
JHUEM-7,carboplatin-UNC0638 (2-1 mol-mol),3.8228401587465273
BT 112,3689413,-2.4519950955667764
TE 441.T,11427553,0.678900025478344
SK-MEL-28,1750826,2.919051261248512
YD-38,9887053,5.000290179411191
KO52,44491742,3.2759729423779103
KO52,60750,-4.433214876259525
KE-39,3384730,3.7070900081119
B-CPAP,3062316,-0.9733025466609652
KE-39,54626689,5.72659105113371
GOS-3,54596558,4.225745385987354
YD-8,11612883,2.3714565826019247
Hs 611.T,11964036,-0.4768166238763608
TE 441.T,JQ-1-carboplatin (1-1 mol-mol),3.6275074638677465
Hep 3B2.1-7,135999136,2.2984722485990567
YD-8,2113511,5.249485368051986
KE-39,16038120,1.0564410098934849
JHUEM-7,57519531,2.2164320410194063
NCI-N87,656346,-0.0410900008101642
JHUEM-7,1566236,1.715043210679705
JHUEM-7,216468,-0.983442120709978
BT 112,9911463,2.5169416957375015
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645
JHUEM-7,4096211,1.3301455757291742
NCI-N87,6184667,4.346047693042568
Hep 3B2.1-7,selumetinib-decitabine (4-1 mol-mol),2.836342370986182
Hs 611.T,216345,0.9522164623488846
SK-MEL-28,selumetinib-piperlongumine (8-1 mol-mol),1.8874017474559768
KO52,4917,3.71660896485238
B-CPAP,12001922,1.695452056973735
OE33,4788,6.0138200333522756
TE 441.T,4259181,0.3231515403820576
YD-38,46907787,-0.5393505828045682
Hs 611.T,1566236,1.2731219518363013
B-CPAP,11485656,2.2559715729134204
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
KE-39,2874250,5.478930029290199
Hep 3B2.1-7,tretinoin-carboplatin (2-1 mol-mol),4.761305966090253
NCI-N87,10302451,0.4744399528749561
TE-14,docetaxel-tanespimycin (2-1 mol-mol),-2.865186321246779
SNU-216,4259181,-0.1596508841879307
YD-38,72193861,-0.2812075597733648
NCI-N87,72376,-2.7230406051655676
Hs 611.T,3503,1.8435127052167164
Hep 3B2.1-7,57519531,1.9372348197743336
JHUEM-7,10113978,2.9707685491739357
BT 112,6438330,0.2152284023246567
NCI-N87,12001922,1.750767235665954
GOS-3,3011155,4.288572340636914
NCI-N87,5311,0.9556802173694716
SF295,12001922,1.8411518312335016
KE-39,216345,4.364087845878577
L3.3,2749,2.0470310524130717
TE 441.T,54678924,3.0050403923877997
YD-8,57330099,4.8709299916964905
SNU-1077,136227924,3.612132735883527
SF295,54649381,4.030819741798211
Hs 611.T,5281672,3.453848815463362
KE-39,5287620,-2.6517518735784495
Hs 611.T,400769,-4.476338089842472
Hep 3B2.1-7,BRD-A02303741-carboplatin (1-1 mol-mol),4.439487706091506
SNU-216,3081361,1.3320694095529937
SW1573,5281321,-2.072955292880288
JHUEM-7,135398516,1.61969532142052
TE-14,54618164,4.303760954268937
KE-39,24771867,5.944751904846296
Hs 611.T,89928392,-0.4076263350125617
OE33,5329102,3.567520971541263
BT 112,148198,-3.0030353997640074
NCI-N87,676352,1.7095816234371617
YD-38,6852167,2.552467124707018
NCI-N87,119607,4.916125105909822
TE-14,135398744,6.394251875306054
TE-14,445091,5.539095923057867
GOS-3,navitoclax-gemcitabine (1-1 mol-mol),-2.24576809498804
BT 112,56946209,-5.137911214748189
KE-39,5281672,4.420099730026252
YD-38,5351362,1.0893723537078008
B-CPAP,6852167,2.612580501807676
B-CPAP,vorinostat-navitoclax (4-1 mol-mol),0.850582052340713
JHUEM-7,16038120,-0.0246766201458601
YD-8,6918837,-2.6695996874336605
GOS-3,56946209,-4.9562360028209795
Hs 611.T,46224516,0.7122499414823305
SK-MEL-28,SNX-2112-bortezomib (250-1 mol-mol),0.1110740577987287
SK-MEL-28,11404337,1.5828408993005263
L3.3,1641662,3.117391597616944
GOS-3,16038120,1.102104110747453
KE-39,135984461,4.3782777468955745
KO52,5291,3.753312170095506
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
Hs 611.T,11404337,-3.0246332650270777
GOS-3,135875424,4.516628943420056
YD-8,piperlongumine-MST-312 (1-1 mol-mol),2.2719488759687385
Hs 611.T,11238147,1.6550317102691343
GOS-3,126941,-1.2183252312090715
GOS-3,alisertib-navitoclax (2-1 mol-mol),5.122405699516746
JHUEM-7,9884685,-1.60078111934439
B-CPAP,36314,-5.684441003557772
YD-38,54618771,0.1066197400708346
OE33,439501,-1.244619642300935
Hs 611.T,navitoclax-gemcitabine (1-1 mol-mol),-4.9472551912531895
SK-MEL-28,navitoclax-sorafenib (1-1 mol-mol),2.0059633351475847
KO52,5460769,4.4327211318187745
SNU-216,ISOX-bortezomib (250-1 mol-mol),0.1706448686157683
Hs 611.T,JQ-1-navitoclax (2-1 mol-mol),0.3532354709872614
SNU-1077,selumetinib-tretinoin (2-1 mol-mol),4.583316472072012
KO52,5287969,-2.47195117056353
SNU-1077,73707438,4.486121622695642
YD-38,3543504,4.296053294803378
Hep 3B2.1-7,3815108,3.427138188438471
SNU-216,216345,4.791407156997153
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667
TE 441.T,24901704,3.444757616833086
Hep 3B2.1-7,9907093,4.032589776825258
SF295,5280436,4.399869533580907
BT 112,136227924,2.645928432247734
KE-39,54686904,4.41883981342939
SNU-216,24797083,1.440697359194003
SW1573,1566236,3.3872191513469025
JHUEM-7,12001922,1.974346294613864
BT 112,107985,-2.3005939746155244
Hs 611.T,ISOX-bortezomib (250-1 mol-mol),0.0926232298221139
YD-8,3543504,4.346865658912418
SNU-216,11647372,-0.4885753208043211
SNU-216,2749,0.6721262653187517
JHUEM-7,5291,3.7790279347789264
YD-38,135440466,2.581080778395821
SNU-216,serdemetan-SCH-529074 (1-1 mol-mol),2.5997678860617985
L3.3,10427712,3.981964931961501
B-CPAP,9936388,2.314754665986152
Hep 3B2.1-7,54649381,3.772857705678292
NCI-N87,selumetinib-navitoclax (8-1 mol-mol),1.647881556522465
OE33,9936388,2.0912313369341287
OE33,3825829,6.240341971286144
Hs 611.T,44607530,0.8778374574907751
SNU-1077,54143018,3.614598545959328
TE-14,1566236,3.7463982876900177
YD-38,969516,2.5252476984932852
SK-MEL-28,4477,0.9697986591939786
GOS-3,5329102,1.5794439698416267
B-CPAP,2828334,5.722656317072071
Hs 611.T,46901937,3.50612252080814
TE 441.T,3025986,2.750603927254004
GOS-3,11234052,4.638302294933858
L3.3,5351362,1.6156165657787482
KO52,11167602,0.9021081553845208
SNU-1077,54619267,4.150403156100443
SNU-216,9866186,3.275692258984255
SK-MEL-28,6918289,3.2211222821081327
OE33,24180719,3.6753594192286583
YD-8,24978538,3.298771682891298
TE 441.T,637858,0.3313302982061412
TE-14,BRD-K55473186,3.7462141776356783
TE 441.T,4521392,4.893069505839197
SW1573,16741245,2.047879460545898
L3.3,23582824,1.1997888978910711
BT 112,66577038,3.1162446017420575
YD-38,49850262,4.287575827533871
KO52,17755052,4.2754643530208005
YD-38,selumetinib-navitoclax (8-1 mol-mol),-1.130877487567506
TE 441.T,11707110,3.68916480155614
BT 112,2945648,1.3917420344498488
NCI-N87,11175137,1.8903805503335804
Hs 611.T,5278396,3.7948314243215977
TE 441.T,42611257,3.348993947419179
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
BT 112,56649450,3.981227494013605
SF295,216345,4.417343990747713
L3.3,23635314,-2.194996881934531
KO52,10385095,0.862604455305029
YD-8,56946209,-4.261193272731818
Hs 611.T,JQ-1-UNC0638 (2-1 mol-mol),0.315420207793623
TE-14,11612883,2.9605017038638497
NCI-N87,44486093,4.414725106733636
SW1573,5280436,3.0542460563059253
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
Hs 611.T,11152667,-4.000300813330283
KO52,56946209,-4.209607693817565
SNU-216,10410894,3.834946704146114
KE-39,2746,3.4287978126101337
SNU-216,navitoclax-MST-312 (1-1 mol-mol),1.1762974749345434
OE33,5280436,2.3782801743487547
SNU-216,53495165,-0.2866928310723041
SNU-216,9956119,4.016386926893835
JHUEM-7,44607530,1.0267127591964027
YD-8,44819697,-2.7739089583765684
TE-14,53392493,3.7810173274345567
SK-MEL-28,selumetinib-tretinoin (2-1 mol-mol),2.7944825477960062
SW1573,24964624,5.100144587499453
SK-MEL-28,44607530,2.6983056844197257
NCI-N87,10074640,2.8038201142488504
SW1573,51037431,1.8928004764191728
KE-39,decitabine-navitoclax (2-1 mol-mol),1.2325731360672605
TE-14,2708,5.504190603838346
SNU-216,9967941,3.401351668838213
Hs 611.T,5470400,2.207943495778688
SK-MEL-28,25183872,-1.0681222891293745
KO52,25161177,1.7926893873102905
Hs 611.T,1714884,3.592336326448464
YD-8,72376,-1.7625580612803151
KE-39,navitoclax-sorafenib (1-1 mol-mol),0.8141438831550822
KE-39,10113978,4.138536532448647
B-CPAP,navitoclax-pluripotin (1-1 mol-mol),-1.221055695527546
BT 112,5329102,1.915457190932002
NCI-N87,26596,-0.8687464208841552
Hs 611.T,135999136,3.4823204763051487
TE 441.T,12003241,-1.1939319008466374
Hs 611.T,4378219,1.8492709684076516
SNU-1077,73707398,1.6899308948113645
SF295,4788,5.92202321962467
L3.3,16038120,1.9292348544241311
BT 112,216239,1.682447495531753
KE-39,10074640,3.0601585781096268
YD-38,3815108,3.839333644300384
GOS-3,676352,1.7019961079374837
L3.3,123631,2.1308858538649456
Hep 3B2.1-7,24180125,2.3898780520203164
BT 112,24753719,4.155930680700891
JHUEM-7,2746,3.3298840403754153
KO52,9915743,1.1549502462375985
SNU-216,2945648,1.2585954802718622
KE-39,387447,-3.456484721663708
B-CPAP,54649381,3.6438923395842298
Hs 611.T,3385,2.153573733073161
BT 112,10427712,3.9873037991521594
TE-14,navitoclax-MST-312 (1-1 mol-mol),1.4294421973877265
L3.3,16065773,3.089788322580725
SF295,46199207,3.279135151816124
B-CPAP,selumetinib-piperlongumine (8-1 mol-mol),4.578396816065636
TE 441.T,25154868,5.000611195687775
OE33,73707398,1.4892412668396968
SNU-216,42611257,3.1766256251755767
Hs 611.T,107970,1.3823074139293197
SNU-216,25183872,-0.6946707113423909
KE-39,675434,4.431531195571141
KE-39,JQ-1-UNC0638 (2-1 mol-mol),1.0358339499253313
SNU-1077,135875424,3.798963502018643
Hs 611.T,25161177,3.714857639299869
SNU-1077,57519531,4.1391342628233945
SW1573,135421197,1.3915330004591782
SNU-1077,89928392,2.605284731621756
OE33,60700,0.5372665759656965
KO52,25262965,-1.468267644417411
JHUEM-7,3552672,1.9150315294075648
SW1573,49766530,-2.79322841384178
TE 441.T,45279963,3.895495545742963
NCI-N87,piperlongumine-MST-312 (1-1 mol-mol),3.209921452990857
GOS-3,9907093,6.267214731972656
SNU-216,36314,-4.404810418439445
NCI-N87,16115403,-3.919428944380448
L3.3,3385,2.739789505554014
SF295,6610216,4.890664911877899
KE-39,2749,1.448224267904264
TE 441.T,9952709,3.74423263883626
OE33,49867930,4.382431849404375
Hep 3B2.1-7,6918878,4.528640003086307
NCI-N87,selumetinib-UNC0638 (4-1 mol-mol),3.172064031081815
L3.3,44819697,-3.2466678771673427
SK-MEL-28,11175137,3.580764276336763
B-CPAP,107985,-3.233876642304658
KE-39,6184667,4.527415561727204
TE 441.T,60700,-2.323903916183343
BT 112,doxorubicin-navitoclax (2-1 mol-mol),-3.3405934698905555
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
YD-38,5278396,3.842438825501423
SF295,3038522,3.824879559064492
JHUEM-7,25062766,1.192560693708174
KO52,2126,4.780292619636026
KO52,5351362,0.8431188891689549
BT 112,72734382,4.824193200647447
SNU-216,25154868,4.898166250003578
JHUEM-7,104842,-3.6182664698495928
OE33,135421197,1.9963159792783505
Hep 3B2.1-7,5287620,-3.003659512886778
SK-MEL-28,salermide-PLX-4032 (12-1 mol-mol),7.2362275808894925
YD-38,439501,-2.4363640234681347
KE-39,navitoclax-pluripotin (1-1 mol-mol),-0.4984280760345316
TE-14,45279963,4.011483934941965
SF295,9911463,4.265275017996558
NCI-N87,104842,-4.261750557946528
KE-39,11625818,4.741005492826134
SF295,135411,-0.4035877293475021
BT 112,16065773,1.6561708801047088
SNU-1077,SNX-2112-bortezomib (250-1 mol-mol),1.1680740109276928
BT 112,5287969,-2.475133352382641
SNU-216,135984461,4.361470667524811
NCI-N87,17759555,3.435080423112301
SK-MEL-28,44589607,3.4025366741016585
JHUEM-7,969516,2.4810699197008654
TE 441.T,25126798,3.702297594434671
L3.3,54618164,4.298111449535211
KE-39,73707398,1.3252144554958445
BT 112,3025986,-1.5928563780305742
KO52,SNX-2112-bortezomib (250-1 mol-mol),-0.6640872675170002
TE-14,11175137,2.8824808413518443
SNU-216,BRD-K55473186,3.911233764269249
JHUEM-7,doxorubicin-navitoclax (2-1 mol-mol),-2.086233890960524
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972
L3.3,119607,5.267929584666067
TE 441.T,31703,-4.286329362488478
GOS-3,24797083,1.855899364684227
SK-MEL-28,serdemetan-SCH-529074 (1-1 mol-mol),2.401587214304783
SF295,89928392,1.4979001161224754
TE-14,4705,1.5857323028822543
KE-39,46907787,0.5111190203360444
YD-8,36462,2.7241354710815
KE-39,5284616,2.799589028326303
TE-14,448949,2.4483560079301365
SNU-1077,4788,5.080655668711155
Hs 611.T,16736978,0.4246623410303011
YD-38,11625818,3.4273815897822817
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
TE-14,navitoclax-pluripotin (1-1 mol-mol),-0.0154318957409185
TE-14,46843906,1.6085964044970718
NCI-N87,selumetinib-tretinoin (2-1 mol-mol),6.374104250530425
TE 441.T,1750826,-1.7032858666361108
SK-MEL-28,446155,4.354539024748469
GOS-3,9933475,1.7482363497307876
BT 112,selumetinib-piperlongumine (8-1 mol-mol),3.6452165297650505
KE-39,5281672,4.420099730026252
Hs 611.T,4578,4.214276908646158
YD-38,25102847,4.016473882164608
KO52,54613361,-1.011400617715983
L3.3,24964624,2.8332468869362115
NCI-N87,11507802,1.464328650743575
YD-8,11364421,1.2930032708337824
JHUEM-7,71466445,4.651705041978002
SNU-1077,135984461,3.620374859792411
SK-MEL-28,53495165,3.601883113184374
TE-14,11257553,0.8839079809046841
JHUEM-7,675434,3.8524415825681193
TE 441.T,navitoclax-piperlongumine (1-1 mol-mol),-0.1552458462581421
KO52,10184653,1.4838473316294571
TE 441.T,12001922,1.15774914966468
Hs 611.T,11977753,-5.421009329967
KE-39,100016,6.665188081944046
OE33,7251185,2.7830194550177216
B-CPAP,5311,1.0199016089886117
TE-14,4788,5.86758680209458
SNU-216,107985,-4.706172049082236
TE-14,10385095,2.0741734466244424
Hep 3B2.1-7,6610216,4.203161900181635
NCI-N87,5566,2.8110881508350567
YD-38,219104,3.8700105403979
YD-8,9967941,3.7717076559680702
KO52,2113511,5.296200545877212
KO52,5284329,4.405190261988607
KO52,11960529,4.1257752289583225
TE-14,11222830,1.8970734039157555
BT 112,24901704,4.366815856328311
GOS-3,4259181,0.7347951046145877
NCI-N87,6914657,-3.795056001746233
Hs 611.T,54626689,4.8749619996750475
TE-14,24821094,0.2881557601852942
KO52,23582824,1.49303559449636
YD-8,selumetinib-piperlongumine (8-1 mol-mol),4.259135274147536
TE-14,17755052,0.5442113476863433
B-CPAP,11427553,2.722415626304352
Hs 611.T,135411,0.3015901655387148
Hs 611.T,11647372,-1.5231732525531485
TE-14,60750,-2.768464568716924
JHUEM-7,11625818,3.132369782082216
B-CPAP,54143018,-0.4654948157340908
KO52,3136844,3.587765010729267
B-CPAP,6438330,1.022180565528926
TE-14,54618795,3.1512290522553568
Hs 611.T,24951314,0.9859373233713288
B-CPAP,56946209,-3.554958382916866
KO52,selumetinib-vorinostat (8-1 mol-mol),-0.9100667251350252
OE33,5282054,4.473462161437885
NCI-N87,25150857,2.476373943211786
KE-39,44462760,3.8715042571516993
Hs 611.T,675434,3.7211808615746977
KE-39,135875424,3.891762591841876
B-CPAP,72376,-1.8039181485690416
KE-39,2858523,2.690923627236344
BT 112,6918736,-3.569526346741858
YD-8,9952709,3.080336399855263
Hep 3B2.1-7,9935249,3.6352240530651008
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
TE 441.T,5479543,3.431992856190103
Hs 611.T,168313016,4.489282789911296
TE 441.T,57519531,4.154057386971314
TE-14,navitoclax-gemcitabine (1-1 mol-mol),-2.5567633390591493
YD-38,3025944,4.16116392503138
NCI-N87,16720766,-1.168414694473064
OE33,9884685,-1.0024057051138902
GOS-3,11427553,2.487045066954577
TE-14,44491742,4.678720015809428
BT 112,11625818,4.486916503071115
YD-8,17755052,1.5678870901115745
KE-39,2949965,4.248558977491982
Hs 611.T,7251185,0.6156146774178182
B-CPAP,89928392,1.5244385280363368
TE-14,tanespimycin-gemcitabine (1-1 mol-mol),-1.3668083775041322
KE-39,5351362,1.2382997191060965
BT 112,46926350,-4.347811941752451
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
YD-38,46199207,3.3090935288824115
YD-38,54649381,3.807168630789832
Hs 611.T,56963564,0.1633765045598278
Hs 611.T,10113978,2.000755909117364
TE 441.T,decitabine-navitoclax (2-1 mol-mol),1.414024011786789
BT 112,23635314,-3.8768038728819025
TE 441.T,5951923,4.312791643847806
OE33,24964624,3.1725420320614095
Hep 3B2.1-7,46199207,3.3405336212593113
Hep 3B2.1-7,327653,3.179957662955071
KO52,2874250,4.969283597945665
SF295,5278396,3.96342600457057
SNU-216,11364421,-3.4931065773065564
TE-14,6918736,-1.9728740219926633
B-CPAP,JQ-1-carboplatin (1-1 mol-mol),6.304556077558474
BT 112,5113032,4.617227577008262
SNU-216,753704,4.505570675332015
SF295,25062766,1.8265353330761955
OE33,11494412,2.705114225479706
KE-39,24797083,3.5589598878178497
NCI-N87,5479543,3.770784511292927
JHUEM-7,219104,3.3113513931291036
SF295,148198,-2.5868327776728517
KE-39,JQ-1-navitoclax (2-1 mol-mol),0.0790402407130846
SNU-1077,613753,3.232559060750619
JHUEM-7,5351362,1.1021792980329406
KO52,66577038,3.1415883423480655
BT 112,crizotinib-PLX-4032 (2-1 mol-mol),1.4315306190333636
L3.3,702558,3.3585745644546474
YD-38,9444,3.627999315336627
BT 112,11955716,-2.698255200036422
GOS-3,216239,2.237593713178657
Hs 611.T,46199207,2.9870879689298726
SNU-1077,9926054,3.1436307505327123
KO52,46199207,2.692692607294932
SNU-1077,docetaxel-tanespimycin (2-1 mol-mol),4.730062209802919
KO52,1750826,-4.467141679047344
GOS-3,2858523,3.344991232469259
SNU-216,3062316,-2.85606665835974
TE-14,5287620,-2.010012399945898
YD-38,387447,-4.020257287464525
JHUEM-7,5280436,2.292992298066188
L3.3,3689413,1.7908878640591075
SF295,119607,5.866143301773754
JHUEM-7,11977753,-4.885412245364533
OE33,12001922,2.146874521539325
SW1573,4261,3.544037815747042
KO52,15547703,3.0734769425929236
SF295,100016,6.949657377166824
BT 112,4477,0.3430018022640513
OE33,25102847,1.6700654423608574
B-CPAP,6610216,4.017338863517876
KO52,446155,3.831951232060963
Hs 611.T,36462,-1.281964415022038
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559
GOS-3,46224516,1.1736861645065142
Hs 611.T,753704,3.904676648691391
Hep 3B2.1-7,11964036,0.5496327492001817
SK-MEL-28,5566,3.135754874944302
YD-8,16736978,2.484760794127255
KE-39,10427712,4.785980320384278
NCI-N87,73707398,0.9429301881187698
SNU-216,9444,3.917162944195096
KE-39,122327,6.317857137620034
OE33,15953870,4.191063320508706
YD-38,3025986,-0.8375229391852794
JHUEM-7,53392493,1.8634549643352745
KO52,7326481,2.795216556097651
BT 112,72193861,1.04293508394768
SNU-216,10113978,3.6175956355825543
JHUEM-7,11612883,1.3024764146581809
Hep 3B2.1-7,5738263,5.008705895489243
SNU-1077,15983966,0.623370554406356
YD-8,vorinostat-navitoclax (4-1 mol-mol),2.141910659803834
KO52,327653,2.901066573817011
KE-39,6918837,-3.138673306335868
KE-39,126941,-2.7828178616251984
YD-38,5566,2.9447153211285997
KO52,46843906,1.029937825595367
TE 441.T,262093,1.5238346929960052
SNU-1077,54454,1.8410579173588877
Hs 611.T,4096211,1.356974463538243
TE 441.T,3385,4.290076098692374
YD-8,44507138,1.814494867453689
JHUEM-7,409805,3.8541488067969785
B-CPAP,159324,2.672075580393903
YD-38,11396600,4.074151932666014
YD-38,676352,3.0652558990883314
B-CPAP,24901704,2.8811872687700277
YD-38,656346,-0.1512212437985599
L3.3,60700,-1.0594098724228993
TE 441.T,448949,1.4593910601153928
TE 441.T,10074640,3.840762234626516
SK-MEL-28,19582717,5.671095391465724
SNU-216,969516,2.758026915780333
SNU-1077,52912189,3.050441247854127
SF295,9866186,-0.0910697648043791
KE-39,24978538,-0.2539808437524994
TE 441.T,4378219,2.137715670751678
Hep 3B2.1-7,46174525,4.569141878122872
TE-14,selumetinib-PLX-4032 (8-1 mol-mol),5.293913907002749
KE-39,4259181,-0.84210776373342
YD-38,navitoclax-MST-312 (1-1 mol-mol),0.6131752469119803
GOS-3,docetaxel-tanespimycin (2-1 mol-mol),-1.4336653490933862
KE-39,11640390,4.498462110577166
TE 441.T,salermide-PLX-4032 (12-1 mol-mol),4.956216871423134
TE 441.T,11609586,1.0030388735282174
JHUEM-7,4261,0.9558193049766148
TE-14,89928392,2.6756823198343085
JHUEM-7,44495899,4.33874446499724
KO52,navitoclax-pluripotin (1-1 mol-mol),-1.853817353117152
KE-39,17755052,3.062972722223711
TE 441.T,24785538,-1.9188481727224669
GOS-3,selumetinib-vorinostat (8-1 mol-mol),4.505292657728925
KO52,9803433,5.79600278203547
OE33,11364421,2.1514891211235505
GOS-3,11626560,1.8119824279577827
OE33,72376,-2.0753030447695933
Hep 3B2.1-7,11612883,4.071301915196382
SK-MEL-28,107970,3.16887671769628
SNU-216,9952709,3.2961556134652743
YD-8,9823820,4.576416589140342
BT 112,11175137,1.5585592210455712
TE-14,1716436,4.07265498806864
SNU-1077,9868037,3.077547755538649
TE 441.T,984333,-0.9428429639665394
YD-8,168312962,3.8254536486741
YD-8,5311,1.737118017629579
NCI-N87,54143018,-0.5822633828546482
L3.3,107985,-3.199791523822717
Hep 3B2.1-7,alisertib-navitoclax (2-1 mol-mol),1.3987072559750775
KO52,216345,3.536975928684328
Hs 611.T,219104,1.9028887164922637
YD-8,selumetinib-PLX-4032 (8-1 mol-mol),2.7404084947043077
KE-39,selumetinib-UNC0638 (4-1 mol-mol),3.3038481766151704
Hep 3B2.1-7,4259181,-0.0551178259711273
OE33,119607,5.889584953438252
B-CPAP,5282054,3.7840154230687295
SNU-216,54618771,-0.3617470583099299
NCI-N87,52912189,1.61892272115858
L3.3,2708,4.48343396675343
SNU-216,6505803,0.9385001329114314
TE 441.T,5281321,-3.2567101399905964
KE-39,44607530,1.389048643742405
SF295,2733487,6.339386329894747
KO52,5470400,-0.2484424992521816
SNU-216,24753719,4.261315806086272
KE-39,3854666,4.449857131704124
BT 112,4578,5.535818023647584
BT 112,107970,1.504371825071881
TE-14,44632017,1.9253849083982173
YD-38,24772860,-2.3179042011152355
SK-MEL-28,6918837,0.4014054147330933
JHUEM-7,5329102,1.651009676583094
OE33,54618305,4.272506927413016
SNU-216,selumetinib-piperlongumine (8-1 mol-mol),3.596313234861266
BT 112,vorinostat-navitoclax (4-1 mol-mol),2.6221867944276993
YD-8,159324,3.1492291636894416
KE-39,5284373,4.108960473804643
Hs 611.T,2749,-1.7253515810899955
YD-38,6918736,-2.384834581056105
L3.3,11455910,1.84757483649511
KO52,24856436,-0.7085491514646743
L3.3,53232,3.8050949011624806
YD-38,4261,1.9941406880799275
JHUEM-7,426756,5.918413566488646
SNU-1077,5746,2.5393754891550877
TE 441.T,42642645,-0.7295119160835342
B-CPAP,10113978,3.7412132766741895
SW1573,9936388,3.0507391751654698
GOS-3,11609586,2.254603724376055
TE-14,9911463,3.9221721376636816
B-CPAP,5566,3.019933897494269
B-CPAP,26596,-2.034534215785694
TE-14,44507138,1.8251480731942025
YD-38,2828334,6.420211851938811
SW1573,89928392,2.032641459256584
Hs 611.T,5311,1.269126331833584
KE-39,3543504,4.7094782670385475
L3.3,3854666,3.761529361474975
SNU-216,46926350,-4.054835664798021
GOS-3,4788,6.125814579723799
YD-8,44185566,2.6803137078691868
B-CPAP,123631,2.319451820706569
KE-39,44487872,4.457727251314366
YD-8,8515,3.9380466861306616
TE 441.T,5738263,2.5234570345783047
Hs 611.T,52912189,1.5591574596969118
YD-8,3025944,4.131674769368578
KO52,44566777,-0.2336377473007494
KO52,55508,2.226115215062858
KO52,444795,3.710694398794004
SF295,2858523,2.846384878516906
OE33,erlotinib-PLX-4032 (2-1 mol-mol),4.063980868806332
OE33,9840324,5.824552886504982
B-CPAP,6918837,-2.529046056121727
KE-39,400769,-0.5095886152507402
SNU-1077,5311281,2.675466174095196
BT 112,11612883,3.767323531047295
Hs 611.T,71466380,4.28085906871445
SNU-216,5278396,3.6820180950330057
BT 112,54618305,3.877432993303292
KE-39,9936388,1.1689372039333712
Hep 3B2.1-7,387447,-4.1626491950883056
BT 112,53392493,1.8363086740890933
SF295,16722836,2.957473304888258
SNU-1077,24180125,4.514438880816518
TE-14,JQ-1-carboplatin (1-1 mol-mol),0.3658378251951246
SNU-1077,25154868,4.181521053773788
OE33,67156097,2.2455878358369725
KE-39,753704,5.009174848734236
YD-38,12003241,-0.5056624439731239
TE-14,11626560,2.6650461689071836
TE 441.T,49793307,-2.249705238530148
Hep 3B2.1-7,262093,2.5027011818139964
L3.3,36462,1.8942720792997911
KO52,selumetinib-PLX-4032 (8-1 mol-mol),-1.2002620728634303
BT 112,11640390,4.0217292152504
YD-38,15983966,-3.779713141534824
GOS-3,11485656,3.367022375162814
KO52,11485656,1.6797102251271416
KE-39,11404337,-0.6939323202576905
BT 112,208908,1.6511587160909196
Hep 3B2.1-7,46398810,2.404873778989621
L3.3,16736978,2.121770338408602
L3.3,24856436,2.4877361998822924
OE33,selumetinib-MK-2206 (8-1 mol-mol),2.157124299869845
TE 441.T,151289,1.049398071450078
JHUEM-7,2858523,3.1374488987928992
TE 441.T,alisertib-navitoclax (2-1 mol-mol),-0.8453426928769932
TE 441.T,25262965,-3.433432645787497
Hs 611.T,alisertib-navitoclax (2-1 mol-mol),-0.8387808311928717
KE-39,676352,2.0662009549778704
KE-39,JQ-1-vorinostat (2-1 mol-mol),0.4197456531616845
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
SNU-216,11175137,2.788278748187906
GOS-3,10296883,4.354871301885758
SNU-216,5287969,-1.6544806621586654
L3.3,25062766,2.9099713416003463
BT 112,168313200,1.7991755506997456
SNU-1077,44259,2.0334917148068707
KO52,44607530,1.0930355607333748
OE33,navitoclax-sorafenib (1-1 mol-mol),5.131240989911406
SNU-216,31703,-0.3566749197029411
KO52,36314,-6.8423574459706025
L3.3,6852167,2.807934515358382
YD-8,UNC0638-navitoclax (1-1 mol-mol),2.814214671394628
KE-39,387447,-3.456484721663708
BT 112,104842,-6.929937328010905
KE-39,409805,5.860910954246773
TE-14,1641662,3.6714613860593217
YD-38,44202524,1.2907890971172833
BT 112,5394,4.526138920769001
KE-39,BRD-A02303741-navitoclax (2-1 mol-mol),0.7696843090662393
SK-MEL-28,ISOX-bortezomib (250-1 mol-mol),1.2537607855267825
JHUEM-7,54143018,1.2737177342737822
SNU-216,navitoclax-birinapant (1-1 mol-mol),2.3534531780783667
SK-MEL-28,9936388,2.4934378473061902
L3.3,89928392,2.03013195184945
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
B-CPAP,2858523,3.8252210780622753
JHUEM-7,135440466,2.2183951118949
SNU-216,42642645,0.8137216939792844
Hs 611.T,49867930,5.716629304512967
Hs 611.T,9907093,3.4448624086289987
L3.3,400769,-0.1977482396353321
NCI-N87,selumetinib-decitabine (4-1 mol-mol),3.433626364692319
KE-39,11396600,3.848773124810753
KE-39,60700,1.8919776900280405
GOS-3,piperlongumine-MST-312 (1-1 mol-mol),1.994862701912013
TE 441.T,72376,-2.0825298958308496
B-CPAP,6623618,2.626931921666511
TE-14,selumetinib-BRD-A02303741 (4-1 mol-mol),3.442750300003047
JHUEM-7,119182,0.6933164692379293
NCI-N87,374536,0.3041613365805376
GOS-3,66577038,3.060096848137411
TE-14,136227924,3.1216716097465365
B-CPAP,54618164,4.142992093020013
YD-38,42642645,1.3600120162800655
SK-MEL-28,24797083,2.1143227978428714
TE 441.T,36314,0.618723009103468
Hep 3B2.1-7,15547703,3.062790819925602
B-CPAP,3854666,1.7042245826351512
KE-39,71466445,5.518940973386278
KE-39,44491742,3.945663107977575
B-CPAP,36462,2.9049699830233733
KE-39,piperlongumine-MST-312 (1-1 mol-mol),2.040458418548574
KE-39,49850262,4.0074037431422385
KO52,6917907,-6.077503902553056
KO52,151289,-0.2495262689960944
TE 441.T,5702613,3.453881896146182
B-CPAP,10302451,2.5954421947302344
TE-14,25154868,4.8719382106388744
KO52,71466445,2.839981960673523
SNU-216,5113032,4.5325079385306735
L3.3,2729026,3.1026966432102863
Hep 3B2.1-7,6505803,-0.5491843508320539
TE 441.T,selumetinib-UNC0638 (4-1 mol-mol),2.335720091395641
KE-39,216345,4.364087845878577
KO52,11497983,-3.595547093152317
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985
SNU-216,448949,2.4814824001359463
OE33,5746,1.19489933136352
SNU-1077,54618305,5.347093142592056
L3.3,5113032,6.1935482945866545
GOS-3,45279963,4.315465934949481
KE-39,3815108,3.17346514425842
Hs 611.T,10385095,0.6904393672995198
SW1573,24797083,0.9725439959134782
Hs 611.T,2113511,3.8884746215924455
B-CPAP,168313016,4.426367892913076
BT 112,46215462,1.7689414169857487
TE 441.T,168313200,1.7491212896878472
TE 441.T,123631,2.609571206523274
SNU-216,11964036,0.2683367381565513
NCI-N87,12003241,-2.470820657410725
SK-MEL-28,51039095,3.7679772711161887
TE-14,387447,-3.5543881689563483
B-CPAP,46907787,3.372107688619731
SNU-216,25126798,4.2068088728358735
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782
KO52,54618164,3.705714044840163
SNU-1077,JQ-1-carboplatin (1-1 mol-mol),3.099930951012761
SNU-1077,44185566,3.0312162489563
GOS-3,24821094,3.805948767285243
GOS-3,81146,4.428248018506032
L3.3,19582717,4.421931624871946
YD-8,107985,-2.331165064329628
JHUEM-7,168313016,6.3518310954698824
OE33,doxorubicin-navitoclax (2-1 mol-mol),0.8925970329334316
SW1573,9866186,2.2605214925080035
BT 112,11507802,1.1612523205296417
OE33,46174525,4.146144152426377
TE 441.T,71680916,3.746145752189325
TE 441.T,66577038,2.551752209338962
SNU-1077,67156097,4.729819017533421
TE-14,24785538,3.6660323705503832
YD-38,JQ-1-vorinostat (2-1 mol-mol),-1.3657042657685192
Hep 3B2.1-7,25183872,-0.1200261699851997
B-CPAP,135398516,1.1534562761305718
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317
L3.3,serdemetan-SCH-529074 (1-1 mol-mol),2.4729213733544366
NCI-N87,11178236,-2.6087498623354977
YD-38,11364421,-3.571577351726304
YD-38,44137675,2.339878994758295
KO52,erlotinib-PLX-4032 (2-1 mol-mol),3.627940402925763
KE-39,675434,4.431531195571141
SF295,16720766,0.3216166889304212
TE 441.T,11178236,-2.618794428548956
SNU-1077,159324,3.2853516722485994
B-CPAP,119607,5.422554804486835
SNU-1077,11964036,1.4394318176037413
YD-38,tanespimycin-gemcitabine (1-1 mol-mol),-1.3171548769509314
TE 441.T,5281672,3.596407838275987
JHUEM-7,23725625,6.309121610229004
TE 441.T,1285940,4.276454926516712
SW1573,11238147,3.4967804964098517
BT 112,448949,1.863535813652351
SNU-216,11640390,3.7653393946493776
TE-14,5738263,3.0368996929484715
L3.3,6610355,5.020819543145525
L3.3,doxorubicin-navitoclax (2-1 mol-mol),-0.9996417914636118
L3.3,5280436,4.8128342001361
SNU-216,56649450,0.2964485531702788
SF295,387447,-4.188925622132866
KO52,11427553,-1.0437328756331057
TE 441.T,11222830,1.0550250936664465
BT 112,46843906,3.5145309028016953
SF295,44259,0.8800000851970594
TE 441.T,9926054,1.7722508105545176
TE-14,vorinostat-navitoclax (4-1 mol-mol),1.7878412556891814
SNU-1077,51039095,2.124353715617282
SF295,1750826,-2.513397555573866
KE-39,54678924,3.7130157242485184
JHUEM-7,11396600,4.730722840017514
TE 441.T,3062316,3.3189110651259437
Hs 611.T,387447,-5.303952237268001
KE-39,439501,-0.0752815835977172
JHUEM-7,2874250,4.229178527781167
L3.3,10296883,4.354494828099719
Hep 3B2.1-7,11238147,3.2165923834999335
OE33,31703,0.6827631013317258
B-CPAP,JQ-1-vorinostat (2-1 mol-mol),1.1019909807743078
SW1573,42642645,1.1024283721976142
GOS-3,10410894,4.409774071454934
TE 441.T,44202524,3.7966072370628408
TE-14,5282054,4.432967217136438
YD-8,56649450,2.606046956482712
L3.3,176870,2.4076894274707947
KO52,65628,3.991598666523216
KE-39,16722836,1.1586688757429142
BT 112,753704,3.3999292862808077
B-CPAP,4917,2.9839600010766896
KE-39,24180719,4.116999771545502
TE-14,9935249,3.117284410933106
B-CPAP,409805,5.0770120967965795
NCI-N87,19582717,3.5520999296373437
YD-8,3025986,-0.972358646883598
Hep 3B2.1-7,serdemetan-SCH-529074 (1-1 mol-mol),2.322040052367719
OE33,53392493,1.6963254365441045
L3.3,4259181,-1.5745308976200183
Hs 611.T,25126798,3.8367967681796697
TE-14,216345,3.792651654584129
TE-14,3825829,4.1158266662634
TE 441.T,JQ-1-vorinostat (2-1 mol-mol),1.924106246622056
SNU-216,24964624,3.0205376038107437
SNU-216,3854666,1.5615804262646893
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
JHUEM-7,10385095,0.8646007643870881
KO52,4578,4.496766222375734
BT 112,439501,-2.896282798681624
KO52,15953870,3.5562610214324653
BT 112,6917907,-5.932626557425448
YD-8,11213558,0.4605208185550022
Hs 611.T,25102847,2.1388544065059687
KE-39,11707110,5.749858449286614
JHUEM-7,46943432,1.400588495445252
KO52,24180719,3.93533100976642
KE-39,3503,2.236149027269379
YD-38,selumetinib-piperlongumine (8-1 mol-mol),1.5896132857534184
SW1573,16013152,3.6979705228045354
NCI-N87,25126798,3.678424158745535
B-CPAP,568763,0.5693864802501477
KE-39,71466445,5.518940973386278
KO52,2945648,2.667880655920765
NCI-N87,44486219,4.180509732108111
BT 112,tretinoin-carboplatin (2-1 mol-mol),4.36566401221058
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
BT 112,45279963,3.846989137571412
SNU-216,11977753,-2.621089063571139
TE-14,24951314,1.384333623307948
TE-14,10322450,4.592810153102171
L3.3,9444,4.344069420298931
YD-38,31703,-1.0114412442149527
TE-14,1750826,2.8876732240340246
BT 112,46398810,1.9166680275447008
GOS-3,5328940,2.3255367780793432
JHUEM-7,11960529,4.681162039691551
SW1573,656346,0.5263129478884733
SNU-1077,BRD-K99584050,5.679511546826054
GOS-3,selumetinib-MK-2206 (8-1 mol-mol),3.670573645172849
BT 112,3825829,4.160828844250468
Hs 611.T,31703,-4.374956167524402
Hep 3B2.1-7,6914657,-4.207104834520046
SNU-216,1474550,4.311507267346721
SNU-216,1716436,2.816824645868314
YD-38,44185566,1.975044849479651
NCI-N87,446155,3.321702095578996
B-CPAP,216468,4.208328548217155
SNU-1077,11626560,2.319948092502867
SK-MEL-28,1566236,1.6963201581644038
L3.3,navitoclax-gemcitabine (1-1 mol-mol),-4.48479777241671
TE 441.T,selumetinib-JQ-1 (4-1 mol-mol),4.709536906442107
TE-14,selumetinib-UNC0638 (4-1 mol-mol),3.0620672493728427
YD-8,650361,3.8896393800715297
SNU-216,selumetinib-navitoclax (8-1 mol-mol),2.3249400693013804
SK-MEL-28,5351362,1.7510141514144195
B-CPAP,11178236,-2.8753118537912226
BT 112,4917,2.125230450219151
NCI-N87,5978,-2.9043455823279185
SW1573,9956119,4.0915863238100645
SNU-1077,doxorubicin-navitoclax (2-1 mol-mol),-0.1731301626607988
KO52,5738263,2.2712409628703027
GOS-3,3503,2.7215232573825605
OE33,25183872,-1.848598152169528
SNU-1077,44489367,4.954217803557541
YD-8,salermide-PLX-4032 (12-1 mol-mol),5.298830023268121
KO52,24748573,0.4293193487594113
YD-8,73707440,4.452607469919264
SF295,9911830,5.317347771430753
TE 441.T,9927531,5.546705362793043
SNU-1077,15953870,3.3476247633777585
JHUEM-7,6918837,-3.184749956799345
SK-MEL-28,2828334,6.345313377915581
NCI-N87,73707386,2.4106113659233723
GOS-3,24753719,4.687766883023854
L3.3,44202524,1.4046743198353957
SF295,44202524,4.053119392508637
KE-39,alisertib-navitoclax (2-1 mol-mol),1.220028581355411
GOS-3,72193861,3.4413196800383044
NCI-N87,11485656,1.873926788766734
SNU-216,44137675,2.116529403425987
KE-39,104842,1.1494054436800256
L3.3,241158,3.9670067644952702
SNU-1077,6610216,4.195845914467317
KO52,selumetinib-tretinoin (2-1 mol-mol),-1.7708890002818076
TE-14,54619267,4.240613760232744
B-CPAP,71680916,4.790234553157112
B-CPAP,46398810,2.9553918901926965
KE-39,285033,0.1893383361723871
YD-38,SNX-2112-bortezomib (250-1 mol-mol),-2.1871556108671255
YD-38,16038120,1.3512560240951477
B-CPAP,400769,-0.8210838787379329
L3.3,10385095,1.3503663642800654
TE 441.T,2749,0.2808222316332103
Hep 3B2.1-7,322968,3.4200690068475508
JHUEM-7,16065773,2.5862180470687792
SF295,6505803,0.007344164780963
JHUEM-7,676352,1.6647076610932632
YD-8,5328940,1.5878995115689818
JHUEM-7,3634881,2.904041587079114
L3.3,54454,4.824648171697031
TE 441.T,2858523,3.209267360707008
KE-39,vorinostat-carboplatin (1-1 mol-mol),2.810386853434761
Hs 611.T,49793307,-4.88808281505329
TE 441.T,54618164,3.69134760573576
TE-14,10427712,4.366154841577515
TE 441.T,15983966,0.8494922312809629
JHUEM-7,42642645,-0.2590687534288647
B-CPAP,3543504,4.96016997847966
TE-14,11167602,2.7334128910951514
TE 441.T,7251185,0.7748595428921464
B-CPAP,16725315,3.8186556720671025
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
TE 441.T,JQ-1-UNC0638 (2-1 mol-mol),1.283080729500337
SF295,25154868,5.07468348600147
TE-14,11178236,-0.8618088962131637
SK-MEL-28,11455910,1.7343524639503471
KE-39,11178236,-2.7855564912156128
KO52,44462760,2.8997426516295617
Hs 611.T,3854666,0.606015378482523
YD-8,11964036,1.157152109498934
TE 441.T,2871966,-1.1981997879898243
TE 441.T,UNC0638-navitoclax (1-1 mol-mol),1.000062005612718
SNU-1077,66577038,3.753869643566382
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
GOS-3,219104,4.122096403169316
TE-14,5978,-3.20065607846914
GOS-3,107985,-2.049266528770901
SF295,11214940,1.0789191404244332
NCI-N87,5351362,0.9196567139345124
